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Abstract
Repetitive, gene-poor regions termed heterochromatin are typically transcriptionally silent
and mostly located at speciﬁc chromosomal loci such as (peri)centromeres and telom-
eres, but are also found interspersed throughout the rest of the genome. Heterochro-
matin silencing is associated with epigenetic features such as DNA methylation and post-
translational modiﬁcation of histone tails, e. g. trimethylation of histone 3 lysine 9
(H3K9me3), which is set by the histone methyltransferases SUV39H1 and SUV39H2
among others. However, the mechanisms underlying establishment and stability of repres-
sive histone marks as well as their contribution to transcriptional silencing remain unclear.
Here, I show that the SUV39H histone lysine methyltransferases recognize heterochro-
matin downstream of the methyl-DNA binding protein MECP2 and remain chromatin-
bound throughout the cell cycle, linking these enzymes to the speciﬁcity and memory of
heterochromatin. In addition, SUV39H isoforms displayed distinct non-redundant func-
tions. SUV39H2 contributed more to establishing H3K9me3 than SUV39H1 in mouse
embryonic ﬁbroblasts and loss of SUV39H-dependent H3K9me3 was not suﬃcient for
transcriptional derepression. Since tools to resolve the kinetics of transcriptional activa-
tion with high spatial and temporal resolution are currently scarce, I devised the Blue
Light-Induced Chromatin Recruitment (BLInCR) tool to dissect the activation of the re-
pressed heterochromatin state. I used BLInCR to rapidly and reversibly target the viral
transactivator VP16 to an integrated reporter in the U2OS 2-6-3 cell line and to mea-
sure the activation kinetics of an initially repressed reporter gene locus. First transcripts
were detectable within minutes after triggering the relocalization of VP16 and activation
progressed in two phases. Thus, even a strong activator was not able to activate silenced
gene clusters in one step. The BLInCR tool introduced here enables the use of complex
activation patterns, which will also be valuable to assess the eﬀect of repeated activa-
tion and, more generally, to probe the stability of chromatin states to understand the
regulation of epigenetic memory. Taken together, these results indicate that only some
genes are susceptible to SUV39H- and H3K9me3-mediated repression and that the hete-
rochromatin state can be overwritten by strong, targeted activators. The insights gained
within this study on the mechanisms of silencing and activating heterochromatin can help
understand heterochromatic deregulation. The latter is frequently observed in disease,
e. g. in cancer, and thus, the heterochromatin network might harbor promising targets
for epigenetic drug development.

Zusammenfassung
Repetitive Teile des Genoms, welche wenige Gene enthalten und in der Regel nicht trans-
kribiert werden, werden als Heterochromatin bezeichnet. Diese Sequenzen beﬁnden sich
überwiegend in speziellen Regionen der Chromosomen wie den (Peri-)Zentromeren oder
Telomeren, sind aber auch im übrigen Genom vorhanden. Die transkriptionelle Inakti-
vität des Heterochromatins wird durch epigenetische Faktoren wie DNA-Methylierung
und posttranslationale Modiﬁkationen von Histonproteinen gewährleistet. Eine solche
Modiﬁkation ist die Trimethylierung von Lysin 9 des Histons 3 (H3K9me3), welche unter
anderem durch die Histonmethyltransferasen SUV39H1 und SUV39H2 katalysiert wird.
Durch welche Mechanismen repressive Histonmodiﬁkationen etabliert und stabilisiert wer-
den und welche Rolle sie in der transkriptionellen Inaktivierung spielen, ist bisher weitest-
gehend unklar. In meiner Arbeit zeige ich, dass die Erkennung von Heterochromatinregio-
nen durch SUV39H-Enzyme dem methyl-DNA-bindenden Protein MECP2 untergeordnet
ist. Außerdem bleiben sie während des Zellzyklus` an Chromatin gebunden und könnten
somit zur Speziﬁtät und Erhaltung von Heterochromatin beitragen. Des Weiteren haben
die beiden SUV39H-Isoformen unterschiedliche Funktionen. SUV39H2 trägt in embryo-
nalen Mausﬁbroblasten mehr zur Trimethylierung von H3K9 bei als SUV39H1 und der
Verlust von SUV39H-abhängiger Trimethylierung von H3K9 ist nicht hinreichend für eine
transkriptionelle Reaktivierung. Da es derzeit nur wenige Strategien zur Analyse der
Kinetik der Transkriptionsaktivierung mit hoher zeitlicher und räumlicher Auﬂösung gibt,
habe ich ein Verfahren zur lichtinduzierten Rekrutierung von Eﬀektoren an Chromatin
namens BLInCR entwickelt, um die Aktivierung eines inaktivierten Lokus zu untersuchen.
Mit BLInCR konnte der virale Aktivator VP16 schnell und reversibel an einen heterochro-
matischen Reporterlokus in der U2OS 2-6-3-Zelllinie gebunden werden um dessen Ak-
tivierungskinetik zu messen. Die Aktivierung konnte innerhalb weniger Minuten nach der
Bindung von VP16 durch RNA-Visualisierung detektiert werden und lief in zwei Phasen
ab. Das bedeutet, dass selbst ein starker Aktivator einen inaktivierten Lokus nicht in
einem Schritt anschalten konnte. Das hier vorgestellte BLInCR-Verfahren ermöglicht die
Anwendung verschiedenster Beleuchtungsmuster, was genutzt werden kann um mehrfach
Aktivierung zu initiieren. Im Allgemeinen kann so die Stabilität von Chromatinzustän-
den geprüft und die Erhaltung von epigenetischen Zuständen untersucht werden. Die hier
präsentierten Ergebnisse zeigen, dass nur einige Gene SUV39H- und H3K9me3-vermittelt
inaktiviert werden und dass der heterochromatische Zustand durch starke Aktivatoren
überschrieben werden kann. Die Erkenntnisse aus dieser Arbeit hinsichtlich der Mechanis-
men, welche die transkriptionelle Inaktivierung und Reaktivierung von Heterochromatin
steuern, können hilfreich sein, um ihre Deregulation zu verstehen. Diese tritt häuﬁg im
Krankheitsfall, z. B. bei Krebs, auf und somit könnten im hier untersuchten Heterochro-
matinnetzwerk Kandidaten zur Entwicklung epigenetischer Medikamente zu ﬁnden sein.
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PIPES . . . . . . . . . . . . . . piperazine-N,N'-bis(2-ethanesulfonic acid
PMSF . . . . . . . . . . . . . . . phenylmethylsulfonyl ﬂuoride
pol II . . . . . . . . . . . . . . . DNA-directed RNA polymerase II
PTM . . . . . . . . . . . . . . . . post-translational modiﬁcation
qRT-PCR . . . . . . . . . . . quantitative real-time PCR
Rb . . . . . . . . . . . . . . . . . . retinoblastoma
RNA-seq . . . . . . . . . . . . RNA sequencing
ROI . . . . . . . . . . . . . . . . . region of interest
RPKM . . . . . . . . . . . . . . reads per kilobase of exon per million mapped reads
RT . . . . . . . . . . . . . . . . . . room temperature
SDS . . . . . . . . . . . . . . . . . sodium dodecyl sulfate
sem . . . . . . . . . . . . . . . . . standard error of the mean
SETDB . . . . . . . . . . . . . SET domain bifurcated
sn . . . . . . . . . . . . . . . . . . . single null
SSC . . . . . . . . . . . . . . . . . saline-sodium citrate
TAD . . . . . . . . . . . . . . . . transactivation domain
TAE . . . . . . . . . . . . . . . . Tris base, acetic acid, EDTA
TAF . . . . . . . . . . . . . . . . TBP-associated factor
TALE . . . . . . . . . . . . . . . transcription activator-like eﬀector
TBME . . . . . . . . . . . . . . tert-butyl methyl ether
TBP . . . . . . . . . . . . . . . . TATA box-binding protein
TBS . . . . . . . . . . . . . . . . Tris buﬀered saline
TCA . . . . . . . . . . . . . . . . trichloroacetic acid
TE . . . . . . . . . . . . . . . . . . Tris EDTA
TF . . . . . . . . . . . . . . . . . . transcription factor
TSS . . . . . . . . . . . . . . . . . transcription start site
VRC . . . . . . . . . . . . . . . . vanadyl ribonucleoside complex
WB . . . . . . . . . . . . . . . . . western blot
wt . . . . . . . . . . . . . . . . . . wild type
Zfp . . . . . . . . . . . . . . . . . . Zinc ﬁnger protein
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Eukaryotic genomes are eﬃciently packaged into nuclei through interactions with a variety
of proteins and RNA  an assembly termed chromatin. Traditionally, loosely packaged,
gene-rich euchromatin is distinguished from tightly packaged, gene-poor heterochromatin
(Heitz 1928). The latter comes in two ﬂavors: the invariantly condensed constitutive
heterochromatin and the cell type-dependent facultative heterochromatin. In general,
constitutive heterochromatin contains a high proportion of repetitive sequences, is repli-
cated late in S-phase and lacks recombination. In contrast, facultative heterochromatin
denotes genomic regions that are only `heterochromatinized' in a subset of cells or only
for one homolog (Richards & Elgin 2002). Importantly, even though heterochromatin
appears denser, it is not dense enough to virtually exclude proteins due to its spatial
conﬁguration thereby preventing DNA binding. Reportedly, proteins ≤10 nm in diam-
eter (corresponding to ∼1 MDa) display basically no accessibility diﬀerences in hetero-
compared to euchromatin (Gorisch et al. 2005, van Steensel 2011). Diﬀerences in tran-
scription between those two major compartments are therefore generally attributed to
post-translational modiﬁcations (PTMs) of histone tails, DNA methylation or diﬀerential
enrichment of other protein factors that regulate the accessibility of DNA on the molec-
ular level (van Steensel 2011). Due to the variety of features that have been described
so far, eﬀorts have been made to ﬁnd functional combinations and segregate all possible
modiﬁcation patterns into a deﬁned set of chromatin states (Baker 2011). Diverse cell
systems from plant seedlings (Roudier et al. 2011) to human lymphocytes (Ernst & Kellis
2010) have been analyzed by diverse statistical approaches and yielded diﬀerent numbers
of chromatin states. Those states are associated with diﬀerent functions including re-
pression of developmental genes in diﬀerentiated cells, silencing of repetitive sequences or
active transcription (van Steensel 2011).
I.1 Pericentric heterochromatin  a model system for constitutive
heterochromatin
Pericentric heterochromatin (PCH) refers to the centromere-ﬂanking regions that form a
distinct chromatin compartment that is associated with repressed chromatin states. The
containing repeat sequences and their organization in the nucleus vary greatly between
diﬀerent organisms suggesting that epigenetic regulation rather than binding of conserved
DNA sequence motifs govern PCH formation (Saksouk et al. 2015). In mice, the adjacent
centromers harbor the 120 bp minor satellite repeats (Pietras et al. 1983, Wong & Rattner
1988), whereas PCH comprises the AT-rich, 234 bp major satellite repeat DNA (Horz &
Altenburger 1981, Manuelidis 1981) (Fig. 1a). Murine PCH makes up ∼3% of the mouse
genome (Martens et al. 2005) and is a model system for constitutive heterochromatin
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since it forms distinct nuclear patterns in interphase nuclei of diﬀerentiated cells. In
mouse embryonic ﬁbroblasts (MEFs) PCH can be easily distinguished from surrounding
euchromatic regions by light microscopy (Fig. 1b). It is organized into characteristic
densely packed DNA foci  the chromocenters  that are enriched in trimethylated lysine
9 of histone H3 (H3K9me3) and the H3K9me3-binding heterochromatin protein 1 (HP1)
as seen by DAPI and immunoﬂuorescence (IF) staining (Fig. 1b). PCH domains of several
chromosomes coalesce within a chromocenter, whereas the neighboring minor satellites are
localized adjacently as separate entities (Guenatri et al. 2004). Notably, the chromocenter
compaction observed by DAPI staining persists upon loss of the heterochromatin H3K9
methyltransferase SUV39H and concomitant loss of H3K9me3/HP1 (Peters et al. 2001).
Figure 1: Pericentromeric major satellite repeats are organized into distinct nu-
clear subcompartments in mouse embryonic ﬁbroblast cell lines. (a) Schematic rep-
resentation of the linear arrangement of centromere and pericentromere in a condensed mitotic
acrocentric mouse chromosome. (b) Confocal laser scanning microscopy (CLSM) images of
interphase nuclei where PCH forms distinct, densely packed nuclear subcompartments that are
trimethylated at H3K9 and enriched for HP1 (as shown by IF staining). Scale bars: 5 µm.
The centromere and the adjacent PCH play distinct roles in the organization of chro-
mosomes within the nucleus throughout the cell cycle. The centromeres are involved in
kinetochore formation during mitosis, whereas PCH is required for sister chromatid cohe-
sion (see (Schalch & Steiner 2017) for a review). Consequently, disruption of PCH leads to
mitotic defects in the form of chromosome missegregation (Guenatri et al. 2004). Taken
together, intact PCH plays a crucial role in protecting the cells from genomic instabilities,
which are associated with impaired viability and an increased tumor risk (Peters et al.
2001).
I.1.1 Suppressor of variegation histone methyltransferases are the central
PCH components
H3K9me3 at PCH depends on the histone lysine methyl transferases (KMTs) SUV39H1
and SUV39H2. Their concurrent loss leads to upregulated transcription of the pericen-
tromeric tandem satellite repeats, genomic instability and mitotic defects (Lehnertz et al.
2003, Martens et al. 2005, Peters et al. 2001). SUV39H enzymes constitute one of three
families of eukaryotic methyltransferases that modify H3K9 (Fig. 2a). The other two
families G9A and SET domain bifurcated (SETDB) have been described to prefer eu-
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chromatic H3K9 as a substrate (Dodge et al. 2004, Schultz et al. 2002, Tachibana et al.
2002). G9A has, however, also been found to be important for heterochromatin silencing
in mouse embryonic stem cells (mESCs) albeit through a mechanism that is independent
of its KMT activity (Dong et al. 2008). In addition, the diﬀerent KMTs preferentially
catalyze diﬀerent degrees of methylation  i. e. mono-, di- or trimethylation  at H3K9
which have diﬀerent biological functions (Martens et al. 2005). SUV39H1 sets H3K9me3
while G9A mostly sets H3K9me1/2 (Peters et al. 2003). SETDB1 can catalyze all three
methylation states, but is more eﬃcient in setting H3K9me1/2 (Basavapathruni et al.
2016). In addition, its speciﬁcity and eﬃciency can be inﬂuenced by interaction with
other proteins (Wang et al. 2003). The ﬁnding that SUV39H1 prefers mono- or dimethy-
lated H3K9 as a substrate implies that it must cooperate with a mono- or di-KMT.
Indeed, SUV39H1, G9A, GLP and SETDB1 participate in a multimeric complex that is
also found at PCH (Fritsch et al. 2010). In addition, H3K9 monomethylation of cytoplas-
mic (i. e. non-nucleosomal) histones is set by PRMD3 and 16. Concurrent knock down of
those two enzymes leads to a reduction of cytoplasmic H3K9me1-modiﬁed histones and
disintegration of PCH (Pinheiro et al. 2012). SU(VAR)3-9 in Drosophila melanogaster
was the ﬁrst protein of the SU(VAR)3-9 family to be identiﬁed and characterized. X-ray-
induced rearrangements cause a variety of phenotypes in D. melanogaster including the
white eye variegation phenotype (Muller 1930). In this case, ﬂies had patches of normal
red pigmentation and patches of white indicating that the white gene was impaired, but
not completely lost. In fact, the phenotype was caused by a rearrangement that placed
the white gene in proximity of PCH and thereby led to its silencing. This eﬀect is termed
position eﬀect variegation (PEV) and ﬂies with a PEV phenotype were used to screen for
enhancers or suppressors of variegation. SU(VAR)3-9 was identiﬁed as an antipodal dose-
dependent suppressor of variegation (see (Elgin & Reuter 2013) for a review). Human
and mouse SUV39H1 proteins display 95% amino acid sequence identity, but diﬀer from
ﬂy SU(VAR)3-9 (42% and 41% identity for human and mouse, respectively) and yeast
CLR4 (38% and 35% identity, respectively). However, there are three regions of sequence
identity across all three species (Fig. 2b): the catalytical SET domain and its adjacent
cysteine-rich regions as well as the chromo domain (CD) (Aagaard et al. 1999, O'Carroll
et al. 2000). The SET domain is a highly conserved structure that is found in dozens of
proteins in diﬀerent organisms. Contrarily, the SET-domain ﬂanking cysteine-rich regions
are only found in a subgroup of KMTs including SUV39H1, SUV39H2, G9A and SETDB1
and might confer speciﬁcity for H3K9 (Kouzarides 2002). Extensive domain deletion and
mutation studies of SUV39H1 revealed that the cysteine-rich regions or speciﬁc muta-
tions within the SET domain abolished KMT activity (Rea et al. 2000). In addition,
the very N-terminus of the protein (amino acids 1-44) and the adjacent CD are required
for heterochromatin targeting (Melcher et al. 2000). The speciﬁc binding of the CD to
H3K9me2/3 was shown in vitro (Wang et al. 2012) and probably contributes to SUV39H1
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targeting in vivo. Lastly, various PTMs of SUV39H1 have also been implicated in its ac-
tivity and cell cycle-dependent regulation. Phosphorylation of SUV39H1 within its SET
domain reduces its gene silencing potential, is set during G1/S transition and persists
until the end of mitosis (Firestein et al. 2000, Park et al. 2014). Upregulation of satellite
transcripts is also observed upon methylation of SUV39H1 by the SET domain-containing
protein SET7/9 (Wang et al. 2013). In contrast, deacetylation of lysine 266 within the
SUV39H1 SET domain by SIRT1 has the inverse eﬀect as it enhances its KMT activity
(Vaquero et al. 2007). Last, SUV39H1 has also been found to be sumoylated between
aa114-140 which might have implications for its interaction with the SUMO ligase UBC9
(Maison et al. 2016).
Figure 2: SUV39H and its relation to other KMTs. (a) Phylogenetic tree of the
three families of eukaryotic KMTs. Homologues from Homo sapiens (h), Mus musculus (m)
Xenopus laevis (x) and Drosophila melanogaster (d) are shown. DIM5 and CLR4P are KMTs
from Neurospora crassa and Schizosaccharomyces pombe, respectively. Adapted and modiﬁed
from (Huisinga et al. 2006). (b) Domain structure of ﬂy SU(VAR)3-9 and its mammalian
and yeast homologues. High sequence similarity is observed in the CD (red), the catalytic
SET domain (black) and its ﬂanking cysteine-rich regions (grey). The mammalian N-terminal
domain (yellow) is also found in SU(VAR)3-9. The displayed mammalian SUV39H proteins are
those from mouse. Adapted and modiﬁed from (Aagaard et al. 1999, O'Carroll et al. 2000).
Even though only loss of both SUV39H isoforms leads to genomic instability and sus-
ceptibility to tumorigenesis (Peters et al. 2001), SUV39H2 has been studied much less.
In mice, SUV39H1 and SUV39H2 show 59% amino acid sequence identity (Fig. 2b).
The most remarkable diﬀerence between the two proteins is the 82 aa N-terminal exten-
sion of SUV39H2 that contains ∼20% basic amino acids (O'Carroll et al. 2000). Recent
studies showed that the SUV39H2 substrate speciﬁcity diﬀers from that of SUV39H1 (Ku-
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dithipudi et al. 2017, Schuhmacher et al. 2015). Functional implications of this diﬀerence
are largely unknown and might involve diﬀerential methylation of non-histone targets
(Kudithipudi et al. 2017). The basic extension of SUV39H2 has also been shown to bind
RNA (Velazquez Camacho et al. 2017), which might contribute to its increased immobi-
lization both at PCH (∼90% vs. ∼20% for SUV39H1) and euchromatin (∼76% vs ∼3%
for SUV39H1) (Muller-Ott et al. 2014). Taken together, SUV39H2 appears to be tethered
more tightly to chromatin possibly also by other factors compared to SUV39H1, which
could indicate that the functions of the SUV39H isoforms are not completely redundant
and that they are also relevant outside of PCH.
I.1.2 SUV39H interacts with several factors to ensure PCH stability
SUV39H is a central component of a larger protein complex that forms speciﬁcally at
PCH. Apart from its possible direct chromatin interaction via H3K9me2/3 mentioned
above, SUV39H1 has been shown to interact with diﬀerent isoforms of HP1 both in vitro
(Maison et al. 2016, Melcher et al. 2000) and in vivo (Krouwels et al. 2005, Muller-Ott
et al. 2014). As SUV39H enzymes set H3K9me3, they establish more binding sites for
HP1, which contains a CD that binds H3K9me3 (Bannister et al. 2001). It has thus been
proposed that SUV39H, HP1 and H3K9me3 are the core components of a network that is
able to propagate the heterochromatic state linearly along the DNA ﬁber (Nakayama et al.
2001). Linear spreading would result in expanding the silenced chromatin state across the
entire genome unless heterochromatin boundaries such as DNA binding sites for speciﬁc
proteins, incorporated histone variants or antagonistically modiﬁed nucleosomes exist (see
(Wang et al. 2014) for a review on limiting heterochromatin spreading). In an alterna-
tive model, heterochromatin spreading is assumed to initiate from sparsely distributed
initiation complexes. Those are characterized by tight SUV39H-binding to PCH chro-
matin. From those complexes, H3K9me3 spreads in 3D and is inherently conﬁned by the
constant activity of counteracting demethylases (Erdel & Greene 2016, Muller-Ott et al.
2014). This model is supported by theoretical studies implicating that nearest neighbor
spreading is not suﬃcient to establish stable domains (Dodd et al. 2007) and that a com-
bination of cis and trans regulation are relevant for the regulation and memory of active
or repressed states (Berry et al. 2017). Apart from the core PCH components, other
factors are speciﬁcally enriched or active at PCH (Fig. 3). Downstream of SUV39H are
the SUV4-20H KMTs that set trimethylation at lysine 20 of histone H4 (H4K20me3).
SUV4-20H activity is directed towards PCH via H3K9me3/HP1 (Schotta et al. 2004).
However, if H4K20me3 is functionally relevant for PCH formation and/or maintenance
is under debate (Sakaguchi et al. 2008). SUV39H1, but not SUV39H2, has also been
found to promote HP1α sumoylation through interaction with the SUMO ligase UBC9,
thereby providing an additional targeting mechanism of HP1α to PCH (Maison et al.
2016). Last, DNA methylation plays an important role at PCH. In particular, seven of
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the eight cytosine-phosphate-guanine (CpG) sites (i. e. ∼87%) found within the consensus
sequences of major satellite repeats are frequently methylated (Horz & Altenburger 1981,
Manuelidis 1981). The 5-methyl-cytosine (5mC)-binding domain (MBD) proteins MBD1
and MECP2 are strongly enriched at PCH, too (Muller-Ott et al. 2014). SUV39H1 and
HP1β also interact with the DNA methyltransferases DNMT3A and DNMT1 establishing
a direct link between the H3K9 and DNA methylation pathway (Fuks et al. 2003a).
Figure 3: Overview of mammalian heterochromatin factors. Histone modiﬁcations 
namely H3K9me3 and downstream H4K20me3  cooperate with the DNA methylation pathway
at constitutive heterochromatin such as PCH in mammals. Stabilized heterochromatin usually
involves the concerted activity of `reader' proteins that recognize modiﬁed histone tails or DNA
(e. g. HP1 or MBDs) and `writer' enzymes that set the respective modiﬁcations (e. g. SUV39H
or DNMTs). `Eraser' enzymes (not depicted here) remove modiﬁcations and are implicated in
the regulation of domain sizes (Erdel & Greene 2016). Various interactions between involved
proteins have been observed (see text for details). UHRF1: ubiquitin-like PHD and RING ﬁnger
domain-containing protein 1 (a ubiquitin-protein ligase). ORC: origin of replication complex.
CpGme: methylated CpG. Figure adapted and modiﬁed from (Saksouk et al. 2015).
The interdependencies of the SUV39H/H3K9me3/HP1 histone modiﬁcation complex
and the DNMT/5mC/MBD DNA methylation complex appear to diﬀer between cell
types. In mESCs, the histone modiﬁcation complex directs DNA methylation (Lehn-
ertz et al. 2003) and cells can proliferate and retain their stem cell characteristics in
the absence of DNMTs and CpG methylation (Tsumura et al. 2006). However, quan-
tiﬁcation of histone marks at PCH using mass spectrometry showed that H3K9me3 and
H4K20me3 are reduced upon loss of all DNMTs (Saksouk et al. 2014). In addition,
Saksouk and colleagues showed that the facultative heterochromatin pathway centered
around H3K27me3 is increased when DNA methylation is lost indicating that compen-
satory eﬀects might be active (Saksouk et al. 2014). H3K9me3 seems thus to be upstream
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of DNA methylation in mESCs, although the latter can modulate the former and plays
a role in suppressing the alternative H3K27me3-centered heterochromatin route. In con-
trast, DNA methylation levels were found to be unaﬀected by loss of SUV39H in MEFs
(Arand et al. 2012). DNA demethylation by 5-aza-2'deoxycytidine (5-aza-C) treatment
only slightly increased SUV39H1 mobility (Krouwels et al. 2005) indicating that the PCH
domain remains mostly intact even in the absence of DNA methylation. Thus, whether
or not the histone methylation pathway at PCH is dependent on the DNA methylation
pathway remains questionable.
I.2 Histone post-translational modiﬁcations and their relation to
transcription
Post-translational modiﬁcations of histone tails have long been accepted to be critical
for a variety of cellular functions including mitosis and meiosis, histone deposition and
gene regulation (Strahl & Allis 2000). The repressive histone methylations at lysine 9
and lysine 27 of histone 3 demarcate constitutive and facultative heterochromatin, re-
spectively. In contrast, histone tails at actively transcribed euchromatin are generally
acetylated at lysines 9 and 14 (H3K9/14ac) among others. However, lysine methyla-
tion, e. g. at lysine 4 of histone 3, can also be attributed to transcriptionally active
chromatin. Altogether, histone acetylation and methylation as well as even more mod-
iﬁcations such as phosphorylation and ubiquitinylation constitute an additional layer of
speciﬁc binding sites for eﬀector proteins apart from the underlying DNA sequence (see
(Lawrence et al. 2016) for a review). The complexity of possible combinations of multiple
marks can be reduced to a limited number of chromatin states by computational methods
(Baker 2011). Some of the modiﬁcations show strong localization at distinct genomic
loci and have been attributed to distinct functions. Trimethylation of histone 3 lysine 4
(H3K4me3) and acetylation of H3K9 & H3K14 for instance are strongly enriched in the
vicinity of the transcription start site (Liang et al. 2004) and play a fundamental role in
transcription initiation (Guenther et al. 2007). In contrast, trimethylation of histone 3
lysine 36 (H3K36me3) is spread across the entire gene body (Barski et al. 2007) and im-
plicated in elongation (Kizer et al. 2005). Other modiﬁcations such as H3K9me3 display
a much less well-deﬁned pattern across the genome (Bulut-Karslioglu et al. 2014, Molitor
et al. 2017) and more diverse functional implications. Despite being generally attributed
to silencing chromatin states (Bannister et al. 2001, Martens et al. 2005, Nielsen et al.
2001), H3K9me3 has also been described to play a role at actively transcribed genes as it
associates with RNA polymerase II (Squazzo et al. 2006, Vakoc et al. 2005) and aﬀects
alternative splicing (Saint-Andre et al. 2011). The relationship between H3K9me3 and
transcription thus remains elusive on the genome-wide scale.
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I.2.1 SUV39H-dependent H3K9me3 outside PCH
Apart from its role at constitutive heterochromatin such as PCH, H3K9me3 has also been
found to play a role in the regulation of gene expression. Several factors have been de-
scribed to direct KMTs to the vicinity of promoters leading to enhanced H3K9me3 and
repression of gene expression. Although H3K9me3-dependent gene regulation is mostly
conferred by G9A, GLP and SETDB1 (Ayyanathan et al. 2003, Ogawa et al. 2002, Roopra
et al. 2004, Schultz et al. 2002), SUV39H1 is directed to a subset of S-phase gene promoters
by retinoblastoma (Rb) protein. The latter is in turn directed to the promoter set by bind-
ing to the E2F transcription factors, leading to H3K9me3 and HP1 binding (Fig. 4a). In
this case, target genes  i. e. cyclin E and cyclin A  are upregulated upon loss of SUV39H,
indicating that SUV39H KMTs can also regulate gene expression by directing promoter
methylation (Nielsen et al. 2001, Vandel et al. 2001). Notably, SUV39H-dependent si-
lencing of S-phase genes is particularly relevant in diﬀerentiating cells that permanently
exit the cell cycle (Ait-Si-Ali et al. 2004). Other studies showed that unliganded thyroid
hormone receptor also silences a reporter gene in a SUV39H-dependent manner (Fig. 4a)
in Xenopus oocytes (Li et al. 2002) and that SUV39H1 and G9A are recruited by the
EVI1 transcription factor to function as repressors of target transcription (Spensberger
& Delwel 2008). In summary, promoter-directed SUV39H-dependent H3K9me3 can reg-
ulate the expression of target genes, but most studies have only considered a few targets
and speciﬁc recruitment pathway, leaving the general contribution of SUV39H to gene
expression unresolved.
Besides genes, SUV39H-dependent H3K9me3 also silences transcription of some repeat
classes throughout the genome. Even though the cumulative enrichment of SUV39H-
dependent H3K9me3 is rather low at long interspersed nucleotide elements (LINEs) and
endogenous retroviruses (ERVs) (Martens et al. 2005), the subgroup of intact, full length
LINEs and ERVs shows strong enrichment for SUV39H-dependent H3K9me3 in mESCs
(Fig. 4b). However, loss of SUV39H only derepresses LINE transcription, whereas ERV
silencing seems to rely mainly on SETDB1 (Bulut-Karslioglu et al. 2014). H3K9me3
of ERVs depends on the presence of intact long terminal repeats (LTRs) and in agree-
ment with this ﬁnding, transcriptional latency of the LTR-containing human immunode-
ﬁciency virus (HIV) has also been attributed to SUV39H, H3K9me3 and HP1 (du Chene
et al. 2007). In committed cells, a reduction of SUV39H-dependent H3K9me3 at LINEs
and ERVs is accompanied by an increase in DNA methylation at those sites, indicating
that retrotransposon silencing is ensured diﬀerently once cells diﬀerentiate. In contrast,
SUV39H-dependent H3K9me3 domains of 1-2 Mbp that contain genes and coincide with
lamina-associated domains (LADs) have been observed in iMEFs, but not in mESCs
(Bulut-Karslioglu et al. 2014). Despite its general association with transcriptional silenc-
ing, H3K9me3 is enriched in the gene body of actively transcribed genes compared to
their promoter regions. This enrichment depends on elongating DNA-dependent RNA
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polymerase II (pol II) and is lost when transcription ceases (Vakoc et al. 2005). Squazzo
and collegues also found H3K9me3 to colocalize with pol II at promoters (Squazzo et al.
2006). However, it is not clear which KMT sets this `active' H3K9me3 mark.
Figure 4: Transcriptional represssion through SUV39H-mediated H3K9me3 out-
side PCH. (a) Gene silencing via SUV39H-dependent promoter methylation (H3K9me3, blue).
SUV39H is either recruited indirectly through a corepresser (e. g. Rb protein, top) or directly
via a repressive transcription factor such as unliganded thyroid hormone receptor (TR, bottom).
Based on results from (Li et al. 2002, Nielsen et al. 2001). (b) SUV39H-mediated H3K9me3
decorates intact interspersed repeats and represses transcription of full-length LINEs. How the
repressor complex is targeted remains unclear, but might be realized through speciﬁc transcrip-
tion factors (TFs). Based on results from (Bulut-Karslioglu et al. 2012).
I.2.2 Translating histone modiﬁcations into function
The information stored in modiﬁed histone tails generally requires so-called `reader' do-
mains for their translation into cellular functions. Methyl-binding CDs, acetyl-binding
bromo domains and phospho-binding 14-3-3 proteins (Fig. 5a) are prototypical examples
for a myriad of speciﬁc domains that have been described (see (Bannister & Kouzarides
2011, Musselman et al. 2012) for reviews). Notably, some of these domains are highly
speciﬁc as they can distinguish between modiﬁcations at diﬀerent residues of the histone
tail (e. g. H3K9 vs. H3K4) and can also be sensitive to the degree of modiﬁcation, e. g.
in the case of methylation (Kim et al. 2006). Those domains can be part of proteins
that serve an adaptor function by binding the modiﬁed histone tail and being a binding
platform for other proteins (e. g. HP1). They can also be part of a catalytically active
enzyme that has some chromatin function itself, e. g. SUV39H which serves a `writer'
function by setting a histone modiﬁcation (Fig. 5b), thereby creating a positive feedback.
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Figure 5: 'Readers' of histone modiﬁcations. (a) Modiﬁed histone tails are recognized
by specialized reader domains. Chromo domains, Tudor domains, plant homeodomains (PHD),
and malignant brain tumor (MBT) domains bind diverse methyllysines and Tudor domains can
also bind methylarginines. Acetyllysines are bound by bromo domains (BD) whereas proteins
from the 14-3-3 family bind phosphorylated serines or threonines (Musselman et al. 2012).
Figure adapted from (Kouzarides 2007). (b) `Reader' domains control downstream functions
either by being part of catalytically active enzymes that might set histone modiﬁcations or by
creating a binding platform for other eﬀectors. Figure adapted from (Musselman et al. 2012).
Isolated reader domains for H3K9me3 have been used eﬀectively to read out chromatin
modiﬁcations in living cells (Muller-Ott et al. 2014) or even for chromatin immunopre-
cipitation (ChIP) instead of antibodies (Kungulovski et al. 2014, Su et al. 2014). In
particular, the CDs of MPHOSPH8 and HP1, which share a conserved recognition mech-
anism (Li et al. 2011), and the ATRX-Dnmt3-Dnmt3L (hADD) domain of the human
ATRX protein have been extensively tested on immobilized modiﬁed histone tails and in
ChIP experiments and showed similar or even higher speciﬁcity compared to antibodies
(Dhayalan et al. 2011, Kungulovski et al. 2014).
I.3 Gene regulation by controlling transcription
Transcription is a fundamental cellular process that is tightly regulated to preserve cell
identity, prevent disease and appropriately react to environmental cues. It is one of the
major control points to regulate gene expression, which can, in addition, be tuned at the
level of RNA processing, transport, degradation and translation (Alberts et al. 1994, p.
403). In eukaryotes, there are three RNA polymerases that can be distinguished through
their sensitivity to α-amanitin and have diﬀerent functions. While RNA polymerase I
transcribes large ribosomal RNAs and RNA polymerase III generates small RNAs such as
transfer RNA, pol II is responsible for the transcription of protein-coding mRNA (Alberts
et al. 1994, p. 367). Here, the focus is on pol II transcription, which generally proceeds
in three main phases  initiation, elongation and termination  that are tightly regulated
and control the overall RNA production rate.
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I.3.1 Transcription by RNA polymerase II
Before transcription of a gene can start, the pol II complex consisting of twelve subunits
associates with the general transcription factors on the promoter DNA to form the pre-
initiation complex (PIC). In the stepwise assembly of the PIC (Figure 6), the general
transcription factor TFIID binds the promoter DNA ﬁrst. The canonical TFIID consists
of a TATA box-binding protein (TBP) and several TBP-associated factors (TAFs) (Sains-
bury et al. 2015). Only some human promoters contain the consensus TATA sequence
near the transcription start site (TSS) (Yang et al. 2007), but several other core promoter
elements that are bound by TAFs have also been identiﬁed (Baumann et al. 2010). TFIID
binding leads to a bend in the DNA, which is stabilized by TFIIA and TFIIB binding the
DNA and TBP. TFIIB then recruits pol II and the associated stabilizing factor TFIIF
thereby completing the assembly of the core PIC. Pol II-binding of TFIIE and recruit-
ment of TFIIH result in the closed PIC. A critical step for productive transcription is the
opening of the promoter DNA (Wang et al. 1992), which depends on the ATPase activ-
ity of the TFIIH subunit XPB. In addition, TFIIH contains a kinase module including
CDK7, which phosphorylates the C-terminal domain (CTD) of the largest subunit RPB1
of pol II and the helicase XPD, which is implicated in DNA repair (Sainsbury et al.
2015). Finally, the formation of the PIC is facilitated and stabilized by interactions with
the multi-subunit mediator complex that interacts with several general transcription fac-
tors as well as DNA-binding transactivators and pol II (see (Conaway & Conaway 2011)
for a review).
Figure 6: Formation of the transcription initiation complex at the core promoter.
The general transcription factors TFIID, TFIIA, TFIIB, TFIIF, TFIIE and TFIIH associate
with the core promoter DNA and pol II to form the pre initiation complex (PIC). DNA is melted
under ATP consumption forming the transcription bubble that renders the single stranded DNA
template accessible. Figure based on (Sainsbury et al. 2015).
Formation of the open PIC with the single stranded DNA template is not suﬃcient
for pol II to enter its productively elongating state. In addition, pol II needs to detach
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from the promoter-bound PIC components to move along the gene, i. e. achieve promoter
escape, and overcome promoter-proximal pausing (Saunders et al. 2006). Upon open PIC
formation, RNA synthesis is rapidly initiated in the presence of nucleotide triphosphates
(NTPs). In this initially transcribing complex, short RNA products are synthesized and
released, a process termed abortive initiation. This phenomenon is markedly reduced once
the fourth nucleotide is added to the growing RNA chain when the transcription complex
is committed to promoter escape (Holstege et al. 1997). After addition of the eighth nu-
cleotide, the rate-limiting step of promoter escape  the transition to the early elongation
complex  takes place. This coincides with the collapse of the upstream portion of the
transcription bubble allowing the early elongation complex with the transcription bubble
to move downstream along the DNA (Pal et al. 2005, Saunders et al. 2006). Another rate-
limiting step is the pausing of pol II, which occurs shortly after promoter escape about
30-60 nucleotides downstream of the TSS (Kwak et al. 2013). Pol II pausing is controlled
by negative elongation factor (NELF) and DRB-sensitivity-inducting factor (DSIF). It can
also depend on core promoter features and associated sequence-speciﬁc transcription fac-
tors as well as nucleosomes (Jonkers & Lis 2015). To release pol II from the paused state,
positive transcription elongation factor-b (P-TEFb) is required as its inhibition prevents
pol II release and blocks transcription almost completely (Cheng et al. 2012, Henriques
et al. 2013). P-TEFb consists of cycline T1 and CDK9 and phosphorylates NELF, DSIF
and the CTD of pol II. CDK9-dependent phosphorylation of NELF and DSIF causes their
dissociation or transformation into a positive elongation factor, respectively. Even though
promoter-proximal pausing appears to be a regulatory event that represses transcription
at ﬁrst glance, it is in fact necessary for maintaining active transcription by competing
with nucleosomes, which prevents the formation of repressive chromatin around the 5'-
end of the gene (Gilchrist et al. 2010). Taken together, the level and duration of pausing
and the pause release depend on the balance of pausing factors like NELF and DSIF
and factors that recruit P-TEFb. This balance is strongly inﬂuenced by the activation of
signaling pathways and could also be mediated by DNA looping that brings together pro-
moters and enhancers thereby targeting additional cofactors possibly including enhancer
RNAs to the pol II complex (reviewed in (Heinz et al. 2015)). Bromodomain-containing
protein 4 (BRD4) is an exemplary activating factor that competes with an inhibitory
complex for binding to P-TEFb and targets the latter to the promoter region by bind-
ing acetylated histones or the acetylated form of the transcription factor NF-κB among
others. However, BRD4 is most likely not strictly required for pol II pause release, since
the interplay of factors that mediate P-TEFb recruitment varies across diﬀerent genes,
cell types and stimuli (Jonkers & Lis 2015). After release from the promoter-proximal
pause site, the RNA is productively elongated as transcription proceeds away from the
5'-end of the gene. Elongation rates diﬀer across diﬀerent genes (Fuchs et al. 2014) and
are inﬂuenced by a variety of factors including histone PTMs, elongation factors, histone
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chaperones, chromatin remodelers and DNA sequence composition (Jonkers & Lis 2015).
I.3.2 RNA polymerase II and histone post-translational modiﬁcations and
the transcription of genes
The pol II CTD is conserved across diﬀerent species and consists of a variable number of
the heptapeptide YSPTSPS that is subject to PTM throughout the transcription process
(reviewed in (Corden 1990)). The most prominent modiﬁcations are the phosphorylation
of serine 5 and serine 2 (Fig. 7a, reviewed in (Egloﬀ et al. 2012)). The modiﬁcation status
of the CTD inﬂuences its conformation and its interaction with enzymes involved in co-
transcriptional nuclear processes such as mRNA biogenesis and chromatin modiﬁcation
(reviewed in (Meinhart et al. 2005) and (Buratowski 2009)). CTD serine 5 is phosphory-
lated early, namely in the PIC, by the TFIIH-subunit CDK7 and recruits the 5' mRNA
capping machinery (Fabrega et al. 2003). It is also presumed to contribute to establish-
ing H3K4me3 around the promoter region by recruiting MLL1 and/or SET1 complexes
(Buratowski 2009). As pol II associates with P-TEFb in the proximity of the promoter to
transition to productive elongation, CDK9 can phosphorylate CTD serine 2. While phos-
phorylation of serine 5 is reduced as elongation progresses, serine 2 phosphorylation is also
set by CDK12 (Bartkowiak et al. 2010) and increases along the gene body (Heidemann
et al. 2013). After transcription through the poly(A) site, pol II is paused, which allows for
eﬃcient transcription termination. Notably, transcription termination is also controlled
by CTD modiﬁcations, in particular by phosphorylation of serine 2 and dephosphoryla-
tion of tyrosin 1 (see (Porrua & Libri 2015) for a review). Phosphorylation patterns of
the CTD are controlled by the kinases mentioned above as well as phosphatases, such as
SSU72, RPAP2, FCP1 and others. The latter dephosphorylates serine 2 at the end of
transcription thereby recycling pol II for a new round of transcription. SSU72 and RPAP2
dephosphorylate serine 5 as the transcription machinery productively elongates the RNA
resulting in the characteristic enrichment of serine 5 phosphorylation at the 5'-end of the
gene (Egloﬀ et al. 2012).
Speciﬁc histone modiﬁcations are typically found along actively transcribed genes
(Fig. 7b) and inﬂuence pol II elongation rates. They also regulate co-transcriptional
processes such as splicing or chromatin remodeling by constituting a binding platform for
the respective complexes that frequently contain histone modiﬁcation reader domains as
described above. Histone acetylation directly inﬂuences pol II elongation as it disrupts the
electrostatic interaction between negatively charged DNA and positively charged histones
thereby facilitating the passage of pol II (Hong et al. 1993, Smolle & Workman 2013).
Thus, histone acetylation is a typical pre-transcriptional mark (Venkatesh & Workman
2015) that has to be removed after passage of the transcription machinery to suppress
aberrant transcription initiation (Carrozza et al. 2005). In contrast, methylation of H3K4
has a rather indirect eﬀect by constituting a binding platform for other histone modiﬁers,
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chromatin remodelers, DNA methyltransferases and others. H3K4me is set by SET1
and/or MLL KMTs that interact with the pol II CTD phosphorylated at serine 5 (Ng
et al. 2003), but also depend on monoubiquitinated H2B (H2Bub), which is another typi-
cal histone mark associated with active transcription (Smolle & Workman 2013). H2Bub
prevents the compaction of chromatin into higher order structures (Fierz et al. 2011) and
promotes the reassembly of nucleosomes after the transcription machinery has passed
through. It thereby favors a transcriptionally active state and intact chromatin after
transcription. In addition, methylation of H3K36 is a typical mark that is associated
with actively transcribed genes. While several H3K36me1/2 KMTs are found in higher
eukaryotes, SETD2 is responsible for virtually all H3K36me3 (Edmunds et al. 2008).
SETD2 interacts with pol II during elongation, possibly via the pol II CTD phospho-
rylated at serine 2 as has been shown for its yeast ortholog SET2 (Smolle & Workman
2013). Last, H3K9me3 is also found at actively transcribed genes, particularly on exons.
Elevated H3K9me3 and HP1γ levels are associated with a decreased pol II elongation
rate thereby favoring inclusion of alternative exons (Saint-Andre et al. 2011). Taken to-
gether, histone modiﬁcations and their `readers' and `writers' are important factors in the
regulation of gene expression as well as co-transcriptional processes such as pre-mRNA
splicing. They therefore contribute to the ordered disassembly and reassembly of chro-
matin in the context of transcription (see (Venkatesh & Workman 2015) for a review on
transcription-associated histone exchange).
Figure 7: Post-translational modiﬁcations of the RNA polymerase II C-terminal
domain and of histones across actively transcribed genes. (a) Phosphorylation of
serine 2 and serine 5 are the most prominent modiﬁcations found on the pol II CTD. The
most prominent enzymes that set (yellow) and remove (blue) those modiﬁcations are depicted,
but more enzymes could play a role (e. g. CDK8 and CDK13 as well as the small CTD
phosphatases). Figure adapted and modiﬁed from (Saunders et al. 2006) and also based on
(Egloﬀ et al. 2012). (b) Most prominent histone marks across a gene. 5'-ends predominantly
harbor histone acetylation and H3K4me3 while H3K36me3 increases towards the 3'-end. Figure
adapted and modiﬁed from (Saunders et al. 2006).
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I.3.3 The viral transactivator VP16
The herpes simplex virus type 1 transcription factor VP16 has been used in numerous
studies to artiﬁcially activate transcription and observe cellular processes associated with
strong activation (e. g. (Tumbar et al. 1999)). In particular, its C-terminal transactiva-
tion domain (TAD) is a potent transcription activator that has been fused to a variety of
proteins, e. g. DNA-binding proteins (e. g. (Janicki et al. 2004)), for a targeted activa-
tion of genes. The VP16 TAD binds to numerous general transcription factors, including
some of the TAF-subunits of TFIID (Hirai et al. 2010). When bound to a TAF, the
TAD assumes an α-helical conformation, whereas it is an unstructured random coil in
its unbound form (Uesugi et al. 1997). VP16 binding to general transcription factors
and mediator components as well as its recruitment of histone lysine acetyltransferases
(KAT) and chromatin remodelers to promoters (Hirai et al. 2010) underlines its impor-
tance in stimulating transcription initiation. The lack of sequence conservation among
strong activators and their low aﬃnity contacts to components of the transcription ma-
chinery led to the proposal of an alternative model of activating initiation. It suggests the
destabilization of promoter nucleosomes as a primary mechanism followed by low-aﬃnity
recruitment of the transcription machinery (Erkina & Erkine 2016). In contrast to some
other transcription activators such as SP1, that mainly stimulates initiation, or HIV Tat,
that mainly stimulates elongation, the VP16 TAD strongly enhances both initiation and
elongation (Blau et al. 1996). Recruitment of VP16 TADs to repetitive heterochromatic
arrays can be observed by live cell microscopy and leads to large-scale decondensation of
the locus in a way that is independent of transcription (Carpenter et al. 2005, Tumbar
et al. 1999). It should be noted, however, that the phenotype of those loci displays a
high cell-to-cell variability as 32-39% of the cells retained compact structures comparable
to the negative control (Tumbar et al. 1999). If and to what extent this decompaction
depends on the ability of the VP16 TAD to recruit KATs such as GCN5, P300 or PCAF,
that result in hyperacetylated histones at the locus, is unclear. Microscopy studies such as
the one described above rely on bacterial DNA sequences at relatively high copy number
for recruiting and visualizing the VP16 TAD and on reporter constructs such as the phage
MS2 RNA that can be visualized by ﬂuorescently labeled MS2 coat protein (MCP) (Shav-
Tal et al. 2004). Those reporter cell lines are valuable systems as they allow for live cell
experiments over time in single cells as well as extensive characterization of factors bound
to the reporter locus in the inactive and active state (Janicki et al. 2004, Rafalska-Metcalf
et al. 2010). In other studies, the very potent VP64 activation domain, which consists
of four copies of the VP16 minimal activation domain (Beerli et al. 1998), was recruited
to endogenous loci. This allowed to precisely trigger the expression of certain genes, but
sacriﬁced single cell resolution (Gao et al. 2014, Konermann et al. 2015, Polstein et al.
2015). Altogether, VP16 is a strong transcriptional activator that has been widely used
to activate both reporter and endogenous genes.
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I.4 Targeting eﬀector proteins
Directing eﬀector proteins such as transcriptional activators, repressors or histone modi-
ﬁers to certain genomic loci is a powerful tool to study the eﬀector function in the native
chromatin environment in living cells. Eﬀector proteins can either be fused directly to
DNA-binding domains (DBD) or to adaptor proteins that interact with their respective
DBD-fused partner proteins under certain conditions.
I.4.1 DNA-binding domains and their use in living cells
One exemplary system to target DNA loci in vivo is the lac operator/repressor system
from Escherichia coli, that has been adapted for use in eukaryotic cells (Fieck et al.
1992). In E. coli, the lac repressor LacI binds to DNA in the presence of the favorable
glucose as energy source, thereby inhibiting transcription of genes involved in lactose
metabolism. If glucose is lacking and lactose is used as an alternative energy source,
LacI-lac operator (lacO) binding is abrogated and transcription activated. LacI binds to
a single operator sequence as a homodimer, but can also form homotetramers and bind
two operator sequences resulting in DNA looping (reviewed in (Swint-Kruse & Matthews
2009)). To monitor a certain part of a genome, multiple copies of the lacO sequence
are integrated into the genome and visualized by transfecting ﬂuorescently labeled LacI
(Robinett et al. 1996). As described above, this system is frequently used to study large-
scale changes in chromatin structure, e. g. decondensation upon VP16 recruitment.
Another bacterial DNA recruitment system is the tet operator/repressor system found
in gram-negative bacteria that is responsible for bacterial resistance to tetracyclines (re-
viewed in (Ramos et al. 2005)). The tet repressor TetR strongly binds to the tet operator
tetO as a dimer which inhibits the transcription of the resistance gene tetA. In the presence
of tetracycline-magnesium complexes, TetR aﬃnity for tetO is reduced by nine orders of
magnitude, which triggers TetR dissociation and transcription of the resistance gene (Led-
erer et al. 1995, Orth et al. 2000). TetR has been used in a variety of studies in eukaryotic
systems both as a direct repressor probably by sterically hindering pol II binding or as
an activator when fused to an activation domain like the VP16 TAD (Berens & Hillen
2003). In the latter case, tetO repeats are placed next to a minimal promoter followed by
a gene of interest such as luciferase, whose expression can be controlled over ﬁve orders
of magnitude using the TetR/tetO system (Gossen & Bujard 1992). However, substantial
drawbacks of this inducible targeting system exist. They include promoter- or integration
site-dependent leakiness, constant exposure to tetracycline to ensure dissociation of the
activator in the non-activated case and slow induction kinetics due to the required wash
out of the inducer. All issues can be overcome or at least be reduced by using reverse
TetR systems that only bind tetO in the presence of tetracycline or doxycycline. Still,
inappropriate expression of the gene of interest in (i. e. leakiness) has also been observed
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when using reverse TetR. This unwanted activity can be attributed to basal activity of
the minimal promoter or residual binding of the activator in the absence of doxycycline
(Berens & Hillen 2003). Doxycycline-inducible systems can be used to induce activator
recruitment within minutes (Normanno et al. 2015) and have been widely used in live cell
studies dissecting the events centered around transcription activation by VP16 (Janicki
et al. 2004, Rafalska-Metcalf et al. 2010).
Last, eﬀectors can be targeted sequence-speciﬁcally to endogenous loci by using tran-
scription activator-like eﬀectors (TALEs) or the CRISPR/Cas9 system. TALEs (see (Boch
& Bonas 2010, Zhang et al. 2014) for reviews) are based on a bacterial system that infects
plants and activates the transcription machinery of the host resulting in the expression
of genes involved in pathogenesis. TALEs can bind speciﬁc DNA sequences through their
repeat domain that contains a hypervariable diresidue. The nature of this diresidue de-
termines the DNA base that is recognized thereby providing a modular system with a
direct protein-DNA binding code that can be tailored to speciﬁc target sequences (Boch
et al. 2009). In contrast, the CRISPR/Cas9 system is a central component of the bac-
terial immune system against viruses (Horvath & Barrangou 2010) and relies on a guide
RNA rather than a speciﬁc protein sequence for DNA sequence recognition (Cong et al.
2013, Mali et al. 2013). The guide RNA contains a speciﬁc CRISPR RNA sequence that
is designed to be complementary to a 23 bp genomic target sequence allowing to target
virtually any genomic site of the form GN20GG (Mali et al. 2013). The other component,
Cas9, is a nuclease that cuts the genomic target sequence rendering the CRISPR/Cas9
system very eﬃcient for homologous recombination-based genome editing. Using fusion
proteins containing an endonuclease-deﬁcient Cas9 version, allows this system to be used
to target a ﬂuorescent protein (CRISPR imaging, (Chen et al. 2013)) or eﬀectors such as
activators to speciﬁc genomic loci (Hsu et al. 2014, Konermann et al. 2015). Both TALE-
and CRISPR/Cas9-targeted gene activation have been shown to be eﬀective and highly
speciﬁc rendering those tools valuable for functional studies of gene activity (Gao et al.
2014, Polstein et al. 2015).
I.4.2 Controlling eﬀector localization with light
Apart from targeting proteins by fusing them directly to DBDs that can be chemically
inducible (see above), eﬀector localization can also be controlled with light. One way
of achieving light sensitivity is the attachment of light-sensitive probes to biomolecules
which leads to caging, i. e. rendering the molecule biologically inert (see (Ellis-Davies
2007) for a review). Upon illumination, the probes are cleaved resulting in the biologi-
cally active form of the molecule. However, the design and synthesis of those probes is
complex and labor-intensive restricting its use. In contrast, optogenetic tools  i. e. light-
sensitive, genetically encoded proteins  occur naturally in plants and corals and are easy
to use (see (Tischer & Weiner 2014) for a review). Three popular plant-based optogenetic
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systems are cryptochromes, light-oxygen-voltage (LOV) domains and phytochromes. In
the presence of red (phytochrome B, PHYB) or blue (cryptochrome 2, CRY2, and LOV
domains) light, the light-sensitive proteins undergo conformational changes that have dif-
ferent consequences, namely hetero- or homodimerization, oligomerization or uncaging of
a functional group.
PHYB associates with the chromophore PCB and the complex changes conformation
upon exposure to red light, resulting in a form that can heterodimerize with its binding
partner PIF. Illumination with far red light reverses PHYB to its inactive conformation
resulting in dissociation from PIF (Ni et al. 1999). LOV domains rely on the chromophore
ﬂavin and their conformation change upon blue light illumination. They can be used to
relieve the autoinhibition of a fused catalytic domain (Wu et al. 2009), to expose a binding
site for homo- or heterodimerization (Motta-Mena et al. 2014, Strickland et al. 2012) or to
expose a localization signal triggering relocalization of a fused protein (Niopek et al. 2014,
2016). CRY2 does not depend on an additional chromophore and changes its conformation
upon illumination with blue light. It interacts with its binding partner cryptochrome-
interacting basic helix-loop-helix 1 (CIB1) in this switched conformation (Liu et al. 2008).
Kennedy and colleagues have adapted this system for use in mammalian cell lines and
showed that only the PHR domain of CRY2 and the N-terminal domain of CIB1 (CIBN)
are required for heterodimerization (Fig. 8a). In this pioneering study, CIBN was fused
to a cytoplasma membrane-anchored GFP and PHR was fused to mCherry (Fig. 8b).
Upon illumination, mCherry colocalized with GFP showing that fusion constructs of
CIBN/PHR with other proteins such as ﬂuorescent domains do not interfere with the
conformation change (Kennedy et al. 2010), rendering the PHR/CIBN system suitable
for live cell experiments. In addition, the interaction is reversible and CIBN and PHR
dissociate within minutes after blue light illumination ceased.
Figure 8: Components of an optogenetic system from Arabidopsis thaliana. (a)
Schematic representation of CRY2 and CIB1 and the PHR and CIBN domains that are required
for heterodimerization. The numbers correspond to the amino acid positions. (b) Principle
of controlling the location of PHR-tagged proteins. The GFP is tethered to the cytoplasma
membrane and mCherry colocalizes with GFP upon exposure to blue light. Within minutes in
the dark, PHR-mCherry disperses again. mCh: mCherry. Figure adapted and modiﬁed from
(Kennedy et al. 2010).
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For the regulation of gene expression, inducible homo- or heterodimerization is particu-
larly suitable to target eﬀectors such as an activator or repressor of transcription to speciﬁc
DNA loci (Fig. 9a,b). In the ﬁrst case, the eﬀector is fused to a LOV domain-containing
protein that does not bind DNA in the dark. Upon illumination, a conformational change
allows rapid homodimerization and DNA binding thereby inducing transcription (Motta-
Mena et al. 2014). In the second case, a DBD is fused to one of the optogenetic interaction
partners (e. g. CIBN) while the eﬀector is fused to the other partner (e. g. PHR). Upon
illumination, the eﬀector colocalizes with the DBD analogous to the scheme depicted in
Figure 8b. Notably, tagging the eﬀector with either one of the optogenetic constructs
has been shown to result in recruitment and activation of the respective gene (Konermann
et al. 2013, Polstein & Gersbach 2015). Alternatively, an eﬀector protein could be tagged
with a nuclear localization signal (NLS) that is blocked by a LOV domain in the dark
and exposed when illuminated resulting in translocation of the eﬀector to the nucleus and
subsequent DNA binding (Niopek et al. 2014) as depicted in Figure 9c.
Figure 9: Strategies to control gene expression with light. Eﬀectors such as activators
or repressors of transcription can be recruited to DNA loci using diﬀerent light-dependent
strategies. (a) LOV domain conformational change can trigger homodimerization and DNA
binding. (b) A DNA-bound optogenetic component can recruit its binding partner fused to an
eﬀector. (c) An NLS can be exposed through conformational change of a LOV domain leading
to translocation to the nucleus and subsequent DNA binding. Figure adapted and modiﬁed
from (Tischer & Weiner 2014).
Although a variety of optogenetic tools are available and have been used for transcrip-
tion activation, transcription readouts can mostly not keep up with the rapid recruitment
strategies since they rely on protein synthesis (e. g. luciferase) or cell lysis and PCR.
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I.5 Scope of this thesis
Covalent modiﬁcations of histone tails are prominent marks that deﬁne chromatin states
and control cell type speciﬁc gene expression programs and other genome activities. How-
ever, their establishment, maintenance and functional relevance in controlling cellular
function are only partly understood. This thesis focuses on epigenetic silencing both at
genes and other genomic elements such as pericentromeres and repeats. Furthermore,
the kinetics of transcription activation of a locus that was initially in an inactive and
heterochromatic state was dissected.
First, the question how speciﬁcity is conferred to silencing complexes and how si-
lenced domains are memorized through cell division was addressed. Murine pericentric
heterochromatin (PCH) was used as a model system for H3K9me3-dependent constitu-
tive heterochromatin since it forms distinct nuclear patterns and can be distinguished
from surrounding euchromatic regions by light microscopy. To that end, three potential
mechanisms were explored: i) recognition of DNA sequence motifs in the major satellite
sequence by speciﬁc transcription factors, ii) targeting of the SUV39H KMT through in-
teraction with an upstream (epigenetic) factor and iii) `bookmarking' of PCH sites via a
factor that remains chromatin-bound throughout mitosis.
Second, the redundancy of epigenetic regulation was addressed in the PCH model sys-
tem. It is often observed for numerous isoforms of histone modiﬁcation `writer' enzymes
and probably confers stability to epigenetic states. However, the two isoforms of SUV39H
show distinct protein mobility diﬀerences both at PCH and euchromatin (Muller-Ott et al.
2014) as well as diﬀerent speciﬁcity proﬁles (Kudithipudi et al. 2017, Schuhmacher et al.
2015) suggesting that their functions might not be completely redundant. A systematic
analysis of SUV39H1/2 single and double null as well as wild type immortalized mouse
embryonic ﬁbroblast (iMEF) cell lines was conducted to assess the redundancy of the two
isoforms for maintaining the integrity of PCH. This analysis was extended to a compar-
ative genome-wide ChIP- and RNA-seq study to gain a broader view on the relation of
SUV39H-dependent H3K9me3 and transcription.
Third, the mechanism by which a heterochromatic locus can be activated was studied.
What is the cause or consequence relation between histone modiﬁcations and transcription
is one fundamental question that cannot be answered by steady-state analysis in func-
tional knock-out cell lines. Accordingly, a time-resolved analysis unraveling the sequence
of events involved in transcription activation was used to answer this `chicken-or-egg'
question. It was implemented by developing a light-inducible chromatin recruitment tool
called BLInCR for Blue Light-Induced Chromatin Recruitment. A thorough character-
ization of its recruitment and reversibility properties was conducted for diﬀerent eﬀector
proteins rendering BLInCR a versatile tool for time-resolved live cell microscopy studies.
Finally, transcription was activated in the human U2OS 2-6-3 cell line with BLInCR to
reverse the initially heterochromatic state of an array of reporter gene repeats. Fluores-
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cently tagged live cell RNA and histone modiﬁcation readers combined with rapid and
reversible induction of transcription shed light on the kinetics of gene regulation and the
stability of the heterochromatic state.
In the ﬁrst two parts of the experimental analysis, the speciﬁcity and memory as well
as the consequences of the loss of heterochromatin-associated H3K9me3 modiﬁcation was
dissected at endogenous loci. This was combined with a transcription activation analysis
of a repressed reporter locus yielding mechanistic insights on silencing and activating
heterochromatin. Heterochromatin is a barrier towards reprogramming of cell identity
(Becker et al. 2016) and its deregulation is associated with disease (Benard et al. 2014).
Hence, understanding the establishment and maintenance of this silenced chromatin state
as well as processes that lead to derepression of transcription is fundamental.
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II Results
II.1 Speciﬁcity and memory of endogenous silencing complexes
To elucidate how speciﬁcity is conferred to protein complexes that localize to PCH and
how the heterochromatic state could be restored after it has suﬀered from replicative
dilution during cell division, three possible targeting mechanisms were explored: i) via a
sequence-speciﬁc factor, ii) via an (epigenetic) signal upstream of H3K9me3/SUV39H and
iii) via a DNA sequence-independent `bookmarking' factor that remains chromatin-bound
throughout the cell cycle and thereby `memorizes' the positions where PCH needs to be
reestablished.
II.1.1 Targeting PCH through PAX transcription factors
PAX transcription factors have been proposed to speciﬁcally recognize PCH and to recruit
other factors that are required for heterochromatin function (Bulut-Karslioglu et al. 2012).
Fluorescently tagged PAX constructs previously described elsewhere (Bulut-Karslioglu
et al. 2012) were transfected into NIH3T3 cells and their enrichment at PCH was ana-
lyzed in confocal laser scanning microscopy (CLSM) images (Fig. 10a). PAX7, which
has a domain structure similar to that of PAX3, but is not usually expressed in MEFs
(Bulut-Karslioglu et al. 2012), showed PCH enrichment in 33% of the cells. When trans-
fecting PAX3-GFP, PCH enrichment was observed in only one cell (5%). Furthermore,
neither PAX9-GFP nor PAX5-GFP was enriched at PCH (Fig. 10a,b). The latter has
no consensus binding site within major satellite repeats and thus served as a negative
control (Bulut-Karslioglu et al. 2012). The mobility of PAX3-GFP at PCH foci and in
euchromatic regions was measured by ﬂuorescence recovery after photobleaching (FRAP).
To distinguish PCH and euchromatin in living cells, an NIH3T3 cell line stably expressing
H2A-mRFP was used (Muller et al. 2009). The PAX3-GFP mobility was not signiﬁcantly
diﬀerent in PCH compared to euchromatin. This was observed for cells with and without
PAX3-GFP enrichment in heterochromatin (Fig. 10c). In general, PAX3 was very mobile
and FRAP curves mostly ﬁtted an eﬀective diﬀusion model (Table 1), indicating that
PAX3 is not a stably bound component of PCH initiation complexes (Muller-Ott et al.
2014).
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Figure 10: Enrichment and mobility of PAX transcription factors at PCH. (a) CLSM
images of NIH3T3 cells transfected with PAX-GFP constructs, ﬁxed and counterstained with
DAPI (top). PAX7-GFP colocalized with DAPI-dense foci in 33% of the cells, PAX3-GFP only
in 5%. PAX5- and PAX9-GFP enrichment at PCH was not observed. Scale bars: 10 µm. (b)
Quantiﬁcation of PAX-GFP enrichments at PCH. PCH/euchromatin ratios were normalized
to chromatin density. (c) Fluorescence intensity traces after photobleaching at PCH foci and
in euchromatic areas in cells without (left) or with (right) PAX3-GFP enrichment at PCH.
Gray/pink lines represent averages of the experimental data, shaded areas are the respective
standard deviations. Diﬀusion model ﬁts are displayed as black/red solid lines. The respective
ﬁt parameters are listed in Table 1. PAX3- and PAX7-GFP images in (a) as well as the FRAP
curves in cells without PCH enrichment in (c) were adapted from (Muller-Ott et al. 2014).
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Table 1: PAX3-GFP mobility ﬁt parameters.
PCH euchromatin
all group 1 group 2 all group 1 group 2
Pax3 enrichment in
PCH
+/- - + +/- - +
n 22 12 6 18 12 4
best ﬁt model d (19/22) d (12/12)
d/rd
(3/6)
d (17/18) d (12/12) d (4/4)
immobile fraction (%) 4.9±5.8 1.9±2.0 5.0±5.9 1.0±1.7 1.4±1.9 0.0±0.0
diﬀusion coeﬃcient D
(µm2 s-1)
0.44±0.27 0.63±0.15 0.56±0.46 0.68±0.33 0.59±0.24 1.13±0.32
Single FRAP curves were ﬁtted using FREDIS (Muller et al. 2009). Average curves of group 1 and 2
are depicted in Figure 10c (a ﬁt of the average curves is displayed; ﬁt parameters of the average were
comparable to the single curve ﬁts and are not listed here). Only cells that could be conﬁdently assigned
to the groups were used for the group analysis. The best ﬁt models were either an eﬀective diﬀusion
model (d) or a model also accounting for binding of the factor to chromatin (reaction-diﬀusion model,
rd). Mean and standard deviation of the single curve ﬁts are listed for the immobile fraction and the
diﬀusion coeﬃcient.
II.1.2 MECP2 mobility was not inﬂuenced by SUV39H enzymes
The mobility of the methyl-DNA-binding protein and PCH component MECP2 was mea-
sured by FRAP in the presence and absence of SUV39H in wild type (wt) iMEFs and
SUV39H double null (dn) iMEFs, respectively. GFP-MECP2 was transfected and FRAP
was performed at PCH foci and euchromatic regions. PCH foci were clearly identiﬁed by
enrichment of MECP2 in both wild type and SUV39H dn iMEFs (Fig. 11a). A fraction
of GFP-MECP2 (∼15% in both wt and SUV39H dn iMEFs) was immobilized at PCH
foci (Fig. 11b). This fraction was reduced to ∼3% in euchromatic regions in both cell
types (Table 2). These results indicate that the mobility of GFP-MECP2 is diﬀerent in
PCH compared to euchromatin, but this diﬀerence did not depend on the absence or pres-
ence of SUV39H. GFP-MECP2 might thus act completely independently and upstream
of SUV39H enzymes and could play a role in targeting the latter to PCH.
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Figure 11: GFP-MECP2 mobility remained unchanged in the presence and absence
of SUV39H enzymes. (a) CLSM images of wild type (top) and SUV39H dn (bottom)
iMEFs transfected with GFP-MECP2, which was then enriched at PCH foci in both cell types.
Scale bars: 5 µm. (b) Fluorescence recovery curves after photobleaching of PCH foci (left) or
euchromatic regions (right) in wt or SUV39H dn iMEFs. Gray/pink lines represent averages of
the experimental data, shaded areas are the respective standard deviations. Eﬀective diﬀusion
(euchromatin, wt) or reaction-diﬀusion model ﬁts (all other curves) of the average curves are
displayed as black/red solid lines. The respective ﬁt parameters are listed in Table 2.
Table 2: GFP-MeCP2 mobility ﬁt parameters.
PCH euchromatin
wild type SUV39H dn wild type SUV39H dn
n 31 33 32 33
best ﬁt model rd (27/31) rd (22/33)
d/rd (18
and 14/32)
rd/d (17
and 16/33)
immobile fraction (%) 13.9±7.7 16.6±10.0 3.1±3.7 2.6±4.4
diﬀusion coeﬃcient D
(µm2 s-1)
0.013±0.004 0.012±0.004 0.15±0.1 0.16±0.08
Single FRAP curves were ﬁtted using FREDIS (Muller et al. 2009). The best ﬁt models were either an
eﬀective diﬀusion model (d) or a model also accounting for binding of the factor to chromatin (reaction-
diﬀusion model, rd). Average curves for GFP-MECP2 mobility in wild type and SUV39H double null
iMEFs at PCH and in euchromatic regions are depicted in Figure 11b (a ﬁt of the average curves is
displayed; ﬁt parameters of the average were comparable to the single curve ﬁts and are not listed here).
Mean and standard deviation of the single curve ﬁts are listed for the immobile fraction and the diﬀusion
coeﬃcient.
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II.1.3 SUV39H1 colocalized with DNA throughout the cell cycle
To assess if SUV39H1 dissociates from chromatin during cell division, living NIH3T3
cells stably expressing SUV39H1-GFP upon induction with doxycycline were imaged.
Hoechst 33342 was used to counterstain DNA and evaluate the cell cycle phase. As shown
in Figure 12, SUV39H1-GFP (top) colocalized with Hoechst 33342 (middle) during
interphase and early prophase as well as during anaphase, telophase and cytokinesis. From
prophase through metaphase until early anaphase, a substantial amount of SUV39H1-
GFP was evenly distributed throughout the nucleus or cytoplasm. However, a fraction
of SUV39H1-GFP was enriched at sites of condensed DNA throughout the cell cycle,
possibly constituting a `bookmarking' factor for the reestablishment of PCH domains
after cell division.
In summary, sequence-speciﬁc PAX transcription factors are unlikely to contribute to
targeting of silencing complexes. Rather, MECP2 and DNA methylation could be up-
stream factors that direct SUV39H enzymes to mouse PCH. Alternatively or in addition,
a fraction of the silencing machinery could remain chromatin-bound thereby contributing
to both speciﬁcity and memory of PCH.
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Figure 12: SUV39H1-GFP colocalized with DNA throughout the cell cycle. NIH3T3
stably expressing SUV39H1-GFP were incubated with the DNA stain Hoechst 33342 prior to
CLSM imaging. Depicted are diﬀerent cells from diﬀerent cell cycle phases. A substantial
amount  but not all  of SUV39H1-GFP dissociated from DNA-dense regions during prophase,
metaphase and early anaphase. Hoechst is represented in red in the merge, so that colocalization
with green SUV39H1-GFP appears yellow. Scale bars: 5 µm. Images adapted from (Muller-Ott
et al. 2014).
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II.2 The apparent redundancy of SUV39H histone methyltrans-
ferases in transcriptional silencing
Both SUV39H isoforms are signiﬁcantly immobilized at PCH, but the fraction of immo-
bilized protein is diﬀerent at PCH and euchromatin (Muller-Ott et al. 2014) suggesting
that SUV39H1 and SUV39H2 might have diﬀerent functions. To dissect the role of the
SUV39H isoforms, iMEFs with functional knock-out of either one or both of the isoforms
were analyzed with respect to their H3K9me3 levels as well as their transcription activity.
II.2.1 Characterization of iMEF cell lines
The SUV39H1 or SUV39H2 single null (sn) cell lines were provided by Gunnar Schotta
(LMU Munich) and were generated by a lacZ knock-in using homologous recombination
as described in (Peters et al. 2001). An overview of the cell lines used for the respective
experiments is given in Table 3.
Table 3: Overview of iMEF cell lines used in the experiments described below.
name SUV39H1 SUV39H2 microscopy
western
blot
ChIP-seq RNA-seq
wt*) + + y y
wt1 (1487-1490)
wt1 (1740)
wt2 (1741)
wt2 (1491-1494)
wt3 (2192-2195)
E469-2 - + y y
1 (1301-1304)
(1736)
2 (2196-2199)
E469-3 - + y y
1 (1305-1308)
1 (1737)
2 (2200-2203)
E471-2 + - y y n n
E480-2 + - y y (1309-1313) (1738)
E480-6 + - y y (1314-1318) (1739)
dn*) - - y y
dn1 (1495-1498)
dn1 (1742)dn2 (1499-1502)
dn3 (2188-2191)
E124-1 - - n y (1624-1627) (1743)
E124-3 - - n y (1628-1631) (1744)
+ and  indicate whether or not the gene is present and expressed in each cell line. Yes (y) or no (n)
indicate whether or not the microscopy experiment (with immunoﬂuorescence staining for H3K9me3 and
HP1α), Western blot (detecting H3K9me3), ChIP-seq (using an H3K9me3-speciﬁc antibody) or RNA-seq
have been performed. The numbers in parentheses correspond to the Hi-seq database ID. Some ChIP-seq
samples were excluded due to quality issues (see below). *) original cell lines from (Peters et al. 2001).
**) This sample was included in the PCH analysis (Fig. 17), but excluded from all other analyses since
it did not have an IgG control for normalization.
The input samples of chromatin immunoprecipitation followed by DNA sequencing
(ChIP-seq) conﬁrmed the homologous recombination at SUV39H loci since no reads
mapped at the respective positions within the SUV39H1 and SUV39H2 genes (Fig. 13a).
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The number of reads that mapped to the respective SUV39H isoforms from strand-speciﬁc
RNA sequencing (RNA-seq) was signiﬁcantly reduced in the null cell lines conﬁrming the
functional knock-out (Fig. 13b). Note that the remaining low transcript levels might
stem from regions upstream of the knock in site or spurious transcription through the
lacZ gene, but are not expected to yield functional protein products.
Figure 13: Conﬁrmation of functional knock-out of SUV39H isoforms in iMEF
cell lines. (a) Integrative Genomics Viewer (IGV, (Robinson et al. 2011, Thorvaldsdottir
et al. 2013)) traces of ChIP-seq input samples. No reads mapped to a ∼1.4 kb region within
the Suv39h1 gene and a ∼3.0 kb region within the Suv39h2 gene in the respective cell lines
conﬁrming disruption of the gene loci by knock-in of lacZ. (b) SUV39H1 (NM_011514) and
SUV39H2 RNA (NM_022724) levels from strand-speciﬁc RNA-seq of the diﬀerent iMEF cell
lines. As expected, expression was signiﬁcantly reduced in the respective null cell lines.
II.2.2 Antibody validation and ChIP-seq quality control
A number of experiments conducted in this study, namely immunoﬂuorescence staining,
western blot and ChIP-seq, depend on the use of H3K9me3-speciﬁc antibodies. The
speciﬁcities of two diﬀerent antibodies (from Abcam and Active Motif, see Table 9 in
the Materials & Methods section) were tested using a modiﬁed histone peptide array
(Fig. 14a). The most relevant modiﬁcations are highlighted (Fig. 14) and listed in
Supplementary Table S1. Both antibodies bound H3K9me3 as expected (Fig S1b,c),
but also H4K20me3 (Abcam antibody) or H3K27me3 (Active Motif antibody). Both
antibodies did not recognize H3K9me3 in combination with serine 10 phosphorylation
(S10P) or threonine 11 phosphorylation (T11P).
As a quality control for ChIP-seq experiments, the similarity of the replicates was
evaluated by calculating the Pearson correlation of read counts within 10 kb windows
across the entire genome (Fig. 15a-e) using deepTools2 (Ramirez et al. 2016). If an input
sample did not correlate well with the others, the entire sample (i. e. all controls and the
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Figure 14: Modiﬁed histone peptide recognition by H3K9me3-speciﬁc antibodies.
(a) Modiﬁed histone peptide array setup and selected positions marked in the images below. The
modiﬁcations corresponding to the marked positions are listed in Supplementary Table S1.
(b) The Abcam antibody recognized various H3K9me3-modiﬁed peptides (black), but not in
combination with S10P or T11P (dashed). It also recognized some H3K27me3-modiﬁed peptides
(light grey) as well as H4K20me3 (dark grey). Shown are two replicates where the antibody was
tested on a new array (top) or on an array reused after stripping another antibody (bottom).
(c) The Active Motif antibody bound similar peptides as the Abcam antibody (b), but bound
weaker to H4K20me3-modiﬁed peptides and stronger to H3K27me3-modiﬁed peptides.
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speciﬁc IP) was excluded from the analysis (e. g. wt3, see Fig. 15a). The correlations
between controls and IP were very high for iMEF samples (e. g. for SUV39H2 cell lines,
Fig. 15d). In contrast, the IPs of mESC samples correlated well with one another, but not
with any of the controls (Fig. 15e), indicating that the IP signature was more dissimilar to
the background signal (i. e. speciﬁc and/or enriched) in this cell type. The same was seen
in the amplitude of the Pearson pseudo-autocorrelation at zero shift distance calculated
by MCORE (Molitor et al. 2017) that was much higher for the mESCs (Fig. 15f).
For the remaining ChIP-seq samples, ﬁngerprint plots were generated using deepTools2
(Ramirez et al. 2016) to check if the IP signal is enriched in a fraction of bins compared
to the controls. The ﬁngerprint plots (Fig. 16) are read as follows: 50% of the reads
(ﬁrst row, dashed horizontal line) fall into the ∼7% and ∼28% most covered bins (ﬁrst
row, right side of the dashed vertical line) for mESC and E469-2 ChIP, respectively. This
indicates that there were fewer regions harboring a greater fraction of reads in mESCs,
which points to a more peaked IP signature in mESCs and a much broader distribution
of IP signal across many bins in iMEFs. In addition, the SUV39H dn samples in the last
row did not show evenly distributed input patterns. In the most extreme case (E124-1),
the 50% most covered bins (right side of the dashed vertical line) harbored >92% of the
reads (above the dashed horizontal line), rendering the other 50% of the bins virtually
not covered at all. Subsequently, features with insuﬃcient input coverage were excluded
from the read counting analyses (see below).
II.2.3 H3K9me3 levels in PCH and genome-wide depended mostly on SUV39H2
The wt, SUV39H sn and dn cell lines described above were used to systematically char-
acterize diﬀerent contributions of SUV39H1 and SUV39H2 to H3K9me3 both at PCH
and elsewhere. Global levels of H3K9me3 were detected by western blot using the two
diﬀerent antibodies described above (Fig. 14). The SUV39H1 sn cell lines E469-2 and
E469-3 had global H3K9me3 levels similar to the wt iMEFs, whereas the SUV39H dn cell
lines E124-1 and E124-3 showed a strong overall reduction of H3K9me3 (Fig. 17a). This
reduction of H3K9me3 was less pronounced, but nonetheless detectable, in the original
dn cell line from (Peters et al. 2001) and in the SUV39H2 sn cell lines E471-2 and E480-6.
With the exception of the SUV39H2 sn cell line E480-2, loss of SUV39H2 correlated with
reduced global H3K9me3 levels.
To assess the role of the SUV39H enzymes at PCH, H3K9me3 and HP1α were stained
by immunoﬂuorescence and imaged by CLSM. PCH can be readily identiﬁed by intense
DAPI staining and showed accumulation of H3K9me3 and HP1α in wt and SUV39H1 sn,
but not in SUV39H dn iMEFs (Fig. 17b,c). SUV39H2 sn cells showed heterogeneous lev-
els of enrichment which also varied for the diﬀerent cell lines (Appendix, Supplementary
Fig. S1a). Notably, the E480-2 cell line, which showed no global reduction of H3K9me3,
did have reduced H3K9me3 levels in PCH compared to wild type cells, indicating that
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Figure 15: Pearson correlation as a quality control for ChIP-seq. In the heatmaps (a-
e), red boxes indicate pair-wise correlations between input samples. Red and grey samples were
excluded from the analyses. (a) Correlation of wt samples. The wt3 input did not correlate well
with wt1 and wt2 inputs and wt3 was thus excluded. (b) Correlation of SUV39H1 sn samples.
The E469-3_1 IgG control showed issues during sample preparation and was excluded. The
E469-2_2 input correlated less with the other input samples than those among each other.
E469-2_2 was thus excluded from the analyses. (c) Correlation of SUV39H dn samples. The
dn1 sample was excluded since the IP did not work. Notably, E124-1 and E124-3 showed quite
low pair-wise correlations with the dn cell line. In addition, the dn3 input did not correlate well
with the dn1 and dn2 input. However, to have a dn cell line replicate, it was not excluded. (d)
Correlation of SUV39H2 samples. (e) Correlation of two replicates of H3K9me3 ChIP-seq from
mESCs for comparison. (f) Pearson pseudo-autocorrelation between replicates calculated by
MCORE (Molitor et al. 2017). The amplitude at zero shift distance is a measure for replicate
similarity. The input and IgG control were used for normalization and background correction,
respectively. Top: iMEF cell lines. Bottom: wt iMEFs and mESCs.
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Figure 16: Fingerprint plots for all usable iMEF H3K9me3 ChIP-seq samples as
well as an exemplary mESC H3K9me3 ChIP-seq data set for comparison. Finger-
prints were generated using deepTools2 (Ramirez et al. 2016) based on (Diaz et al. 2012). The
cumulative read counts are plotted against the rank of the bins (500,000 bins of 500 bp length)
sorted according to reads that overlap with them. In iMEFs, most IP traces (red) were very
similar to the controls as expected for broad distributions or non-speciﬁc IP.
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H3K9me3 levels in PCH do not necessarily follow the global level. To verify the loss of
H3K9me3 at PCH and to assess whether other genomic regions were also aﬀected, ChIP-
seq was carried out as described in the Methods section. A larger fraction of reads from
ChIP-seq with an H3K9me3-speciﬁc antibody (Abcam) mapped to the consensus sequence
of mouse major satellite repeats (Lehnertz et al. 2003) compared to input, non-speciﬁc
ChIP with an IgG antibody or H3-speciﬁc ChIP (Fig. 17d). Similar to the microscopy
analyses, diﬀerent ChIP-seq read enrichments were observed among the various cell lines
with the same genotype (Appendix, Supplementary Fig. S1b). In summary, H3K9me3
levels in PCH were reduced in cell lines lacking SUV39H2. Loss of SUV39H1 alone had
little or no eﬀect, but resulted in complete loss of the modiﬁcation at PCH in combination
with loss of SUV39H2. Together, these results indicate that SUV39H enzymes have an
additive rather than an epistatic eﬀect and that SUV39H2 contributes more. In addition,
H3K9me3 levels in PCH did not always correlate with global levels, in particular among
the SUV39H dn and the SUV39H2 sn cell lines.
II.2.4 Loss of pericentromeric H3K9me3 did not always lead to increased
major satellite transcription
The eﬀect of reduction or loss of H3K9me3 at PCH on transcription output was assessed
by quantitative real-time PCR (qRT-PCR) and RNA-seq. In wild type and SUV39H1 sn
cell lines, gamma satellite (GSAT) transcript levels were low (Fig. 18) as expected based
on their high H3K9me3 levels at PCH (Fig. 17 & Supplementary Fig. S1). GSAT
transcription was upregulated in all SUV39H2 sn cell lines as well as in the original
SUV39H dn cell line. Surprisingly, transcription was not signiﬁcantly upregulated in the
other two SUV39H dn cell lines (E124-1 and E124-3, Fig. 18) although they showed sub-
stantial global reduction of H3K9me3 and loss of H3K9me3 at PCH according to ChIP-seq
(Fig. 17a&d). Conversely, the established MEF cell line NIH3T3, which is wild type
for SUV39H, showed a substantial upregulation of GSAT transcripts despite having in-
tact PCH in terms of H3K9me3, HP1, H4K20me3, MECP2, SUV39H and SUV4-20H
(Muller-Ott et al. 2014). Taken together, transcriptional output from PCH was generally
anticorrelated with H3K9me3, i. e. lower H3K9me3 resulted in higher RNA expression
values. The wild type NIH3T3 cell line and the SUV39H dn cell lines E124-1 & E124-3
behaved diﬀerently. In the former, intact H3K9me3 did not prevent transcription. In
the latter two cell lines, pronounced demethylation at H3K9 barely led to derepression
of transcription. Those results indicate that H3K9me3 is generally associated with tran-
scriptional repression, but other factors might interfere with this pathway.
II.2.5 SUV39H-dependent H3K9me3 outside of PCH
The enrichment of H3K9me3 at certain genomic features from ChIP-seq data was cal-
culated taking into account non-speciﬁc background and input coverage as described in
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Figure 17: Global and PCH-speciﬁc levels of H3K9me3 in iMEF cell lines. (a)
Western blots detecting H3K9me3 in histone extractions of iMEF cell lines. Two diﬀerent
H3K9me3-speciﬁc primary antibodies were used. Detection was based on chemoluminescence
using horseradish peroxidase (HRP). (b) CLSM images of iMEF cell lines with immunoﬂuo-
rescent detection of H3K9me3 and HP1α. PCH was identiﬁed by dense DAPI staining (left).
Scale bars: 5 µm. (c) Quantiﬁcation of H3K9me3 and HP1α enrichment at PCH. Fluorescence
intensity ratios were normalized to chromatin density. (d) Percentage of ChIP-seq reads map-
ping to the mouse major satellite consensus sequence. IP with an H3K9me3-speciﬁc antibody
(Abcam) led to an enrichment of reads compared to input or IP with a non-speciﬁc antibody
(IgG) or an H3 antibody. The corresponding single cell line plots for (c & d) are shown in the
appendix (Supplementary Fig. S1).
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Figure 18: Major satellite transcript levels in diﬀerent iMEF cell lines. (a) GSAT
RNA levels determined by qRT-PCR. For each of three independent experiments (except
NIH3T3 (n=1), E471-2 (n=2) and dn (n=5)), actin-normalized quantities were normalized
to average wt levels. Error bars represent the standard error of the mean (sem) of the biological
replicates. (b) Permillage of total reads from stranded RNA-seq that mapped to GSATs in
sense and antisense direction. Notably, the results corresponded well to the qRT-PCR results
shown in (a).
the Materials & Methods section (Fig. 47). As a reference, a mouse embryonic stem cell
(mESC) H3K9me3 ChIP-seq experiment was used, because mESCs have been described
to silence repetitive elements by SUV39H-dependent H3K9me3 (Bulut-Karslioglu et al.
2014). The reads mapping to the GSAT consensus sequence (Fig. 19d) were removed
before mapping to the mm9 assembly of the mouse reference genome (see Materials &
Methods, Fig. 45 for details). There are 42 intergenic GSATs (Bulut-Karslioglu et al.
2012), which have single nucleotide polymorphisms compared to the consensus sequence
and could thus be analyzed independently. 23 of the 42 intergenic repeats were mappable
and 22 of those were highly methylated (i. e. >3-fold enrichment above genomic aver-
age) in wt iMEFs. Intergenic GSAT methylation in cell lines lacking either one of the
SUV39H isoforms was reduced, although this eﬀect was more pronounced for cell lines
lacking SUV39H2 (Fig. 19a). The same analysis was done for 6387 repeat-rich (mainly
LINEs and LTRs) genomic regions (HET6387) that have been described to be enriched
for SUV39H-dependent H3K9me3 in mESCs (Bulut-Karslioglu et al. 2012). 5999 of those
regions were mappable and most (5221 or ∼87%) were in fact highly trimethylated at
H3K9 in mESCs. Only 319 (∼5%) of these were enriched for H3K9me3 in wt iMEFs
(Fig. 19b). In contrast to GSATs, loss of SUV39H1 had only a very small eﬀect, whereas
SUV39H2 had again a greater eﬀect on H3K9me3. The density plot for the H3K9me3
levels of these 319 regions (Fig. 19b, right) showed a single shifted peak for the SUV39H2
sn and SUV39H dn cell lines, indicating that the reduction of methylation was similar for
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all selected regions.
179 RefSeq genes were highly methylated in wt iMEFs and 119 (∼66%) of those were
protein-coding (NM IDs in the RefSeq annotation), whereas the other 60 encoded non-
coding RNAs (NR IDs in the RefSeq annotation). In contrast to the HET6387 regions
(Fig. 19b), methylation reduction in SUV39H sn/dn cell lines appeared to be bimodal
for the RefSeq genes (Fig. 19c). This observation suggests that one population of genes
is methylated by SUV39H and one population is not. As expected, nearly all genes that
were aﬀected by loss of one of the SUV39H isoforms were also aﬀected by loss of both
isoforms (Fig. 19d), and genes that were not aﬀected in SUV39H dn cells were also not
aﬀected in the sn cell lines (genes in the right peak of the density plot that is centered
close to 1). Separate analysis of protein-coding and non-coding RNA genes revealed that
the bimodality was much more pronounced in the protein-coding genes (Fig. 20). Among
the 119 H3K9-trimethylated protein-coding genes (Supplementary Table S3) were 26
genes coding for Zinc ﬁnger proteins (Zfp). Genes from this protein family have previously
been found to be enriched in a subgroup of genes bound by HP1β (Vogel et al. 2006).
However, all 26 Zfps were found in the population that did not change the H3K9me3
level (Fig. 19c) in all cell lines and were thus not strongly aﬀected by loss of SUV39H
enzymes.
Most repetitive sequences analyzed here showed average H3K9me3 levels slightly above
the genomic average, but only GSATs and a subset of other heterochromatic regions
showed high methylation levels (Fig. 19). Similar to PCH, those highly methylated
regions were more aﬀected by the loss of SUV39H2 than by the loss of SUV39H1. RefSeq
genes displayed average H3K9me3 levels below the genomic average, but a small subset
of genes was highly methylated in wt iMEFs and this high H3K9me3 level was SUV39H-
dependent in some of the genes. Notably, more genes were aﬀected by the loss of SUV39H2
than by the loss of SUV39H1 supporting the hypothesis that SUV39H2 plays a greater
role in controlling H3K9me3 levels.
II.2.6 Upregulation of transcription upon loss of SUV39H-dependent H3K9me3
was not a universal feature across the genome
To assess the impact of SUV39H-dependent loss of H3K9me3 at the features analyzed
above (Fig. 19), RNA was isolated and sequenced in wt, sn and dn iMEFs. Since the
RNA isolation protocol included a selection step for long RNAs (>200 nt, see Materials
& Methods section and Supplementary Fig. S2), GSATs shorter than 200 nt were
excluded from the analysis. In wt iMEFs, methylated GSATs showed generally very
low transcript levels (RPKM, Fig. 21a). In the SUV39H-deﬁcient cell lines, only a few
features showed slightly higher transcript levels and those appeared rather independent
of the methylation decrease. The same was true for the methylated HET6387 regions
(Fig. 21b). To evaluate the relationship of H3K9me3 and transcription at genes, the
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Figure 19: SUV39H dependency of H3K9 trimethylated features throughout the
genome. In the left column, all features of the respective group are shown. Dashed line:
genomic average. Dotted line: high methylation threshold (>3-fold enrichment above genomic
average). In the center column, the log2-fold change of the highly methylated features (selected
in wt iMEFs) normalized to wt iMEFs is shown. Dotted line: wt iMEF level. Where applicable,
density plots of the center column are shown on the right. (a) Intergenic GSATs. (b) Regions
displaying SUV39H-dependent H3K9me3 in mESCs (HET6387). (c) RefSeq genes. (d) Venn
diagrams of genes in the left and right peaks of the density plot. The circle sizes are proportional
to the number of genes in the respective peaks.
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Figure 20: H3K9me3 fold change at non-coding and coding genes. (a) Density plots
of H3K9me3 fold change of in wt iMEFs highly methylated non-coding (left) and protein-coding
(right) RefSeq genes. The bimodality in Figure 19c mostly originated from the protein-coding
genes (right, NM IDs in the RefSeq annotation). (b) Venn diagram of the 119 protein-coding
genes in the left and right peak (same as in Fig. 19d, but without the non-coding genes).
long non-coding RNAs were excluded from the analyses below, since half of them were
shorter than 200 nt and were thus eliminated during the RNA-seq library preparation.
In addition, they displayed no clear bimodality when analyzed separately (Fig. 20).
The 119 protein-coding genes that were highly methylated in wt iMEFs showed very
heterogeneous absolute transcript levels (Fig. 21c, orange dots). Some of the strongly
demethylated genes (i. e. log2-fold change of around -3) showed very high transcript
levels (Fig. 21c, upper left corner). To assess the change in transcript levels upon loss
of SUV39H, the log2-fold change of transcripts as calculated by DESeq2 (Love et al.
2014) was plotted against the change in H3K9me3 (Fig. 21d). In general, genes that
showed demethylation upon loss of SUV39H showed either upregulation or no change
in transcription (Supplementary TableS3), yielding a slight anticorrelation between
H3K9me3 and RNA changes. The 26 Zfp genes that were highly methylated in wt iMEFs
showed moderate expression levels in wt iMEFs (3.1±2.9 RPKM, mean & sd) indicating
that they were not silenced despite being heavily trimethylated at H3K9 (Fig. 21e).
Those expression levels were mostly unaﬀected by SUV39H loss (Fig. 21f) in agreement
with the result above that their methylation level is not strongly aﬀected by the loss of
SUV39H enzymes (Fig. 19c&d).
119 protein-coding genes were highly methylated in wt iMEFs (Fig. 19 and Fig. 20)
with the 2900026A02Rik gene (NM_172884) displaying the highest change in RNA ex-
pression (5.6 − 7.0 in the diﬀerent cell lines, see Fig 21d, dashed circle). Interestingly,
the high H3K9me3 level in wt iMEFs (∼4-fold enriched above genomic average) was re-
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Figure 21: Transcript levels of in wt iMEFs methylated genomic regions as deter-
mined by RNA-seq. Absolute read densities (reads per kilobase of exon per million mapped
reads, RPKM) were plotted against the log2-fold change in H3K9me3 (relative to wt iMEF
levels, a-c,e). Each dot represents one genomic region and the number of regions are given in
the legends. (a) Methylated intergenic GSATs. (b) Methylated HET6387 regions. (c) Methy-
lated protein-coding RefSeq genes. (d) The RNA log2-fold change (compared to wt iMEFs)
determined by DESeq2 was slightly anticorrelated with the H3K9me3 log2-fold change (the
Pearson correlation coeﬃcient r is given in the legend). Filled circles represent signiﬁcant RNA
changes (DESeq2 output padj < 0.05) and the points marked by the dashed ellipse correspond
to the 2900026A02Rik gene (NM_172884) shown in Figure 22a. (e&f) Same analyses as in
(c&d), but only for the subset of in wt iMEFs methylated Zfp genes.
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duced to ≤ 16% of the wt level in the functional knock out cell lines (Supplementary
Table S3). Visualizing the H3K9me3 signature revealed that this gene was located in
a large SUV39H-dependent H3K9me3 domain (Fig. 22a). However, loss or reduction of
this domain did not lead to an upregulation of all genes within this domain, suggesting
that demethylation of H3K9 is not suﬃcient to activate gene expression. Complementary
to the approach above (Fig. 21cf), where all genes with high at H3K9me3 levels in wt
iMEFs were analyzed with respect to their methylation and expression changes, all diﬀer-
entially expressed genes were also analyzed with respect to their H3K9me3 levels. Using
rather stringent parameters to partition the DESeq2 results (padj < 0.01 and log2-fold
change > 3 or < −3) resulted in a common set of 64 upregulated and 45 downregulated
genes (Fig. 22b, Supplementary Table S4). The upregulated genes showed no trend
for changing their H3K9me3 levels in any direction (Fig. 22c). Surprisingly, the strongly
downregulated genes tended to show slightly increased H3K9me3 levels (Fig. 22c) despite
having lost one or both isoforms of the SUV39H histone methyltransferase.
Figure 22: H3K9me3 at diﬀerentially expressed genes in diﬀerent SUV39H func-
tional knock out cell lines. (a) H3K9me3 ChIP- and RNA-seq signatures of a genomic
region on chromosome 5. ChIP-seq traces were normalized with MCORE (Molitor et al. 2017)
and single traces of cell lines with the same genotype were aggregated and visualized with IGV
(Robinson et al. 2011, Thorvaldsdottir et al. 2013). The RNA-seq trace was scaled to account
for the number of mapped reads in each sample. The right red box is an enlargement of the
left red box showing the 2900026A02Rik gene (NM_172884). (b) Diﬀerentially expressed genes
as determined by DESeq2 (Love et al. 2014). Gene expression with a log2-fold up- (left) or
down-regulation (left) >3 and an adjusted p-value <0.01 were considered to be signiﬁcant. (c)
H3K9me3 log2-fold change of the common set of diﬀerentially expressed genes (i. e. 64 up- and
45 downregulated genes). The dashed line represents the wild type methylation level and the
290026A02Rik gene shown in panel (a) is marked by a dashed circle.
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In summary, SUV39H-dependent loss of H3K9me3 had little to no eﬀect on the tran-
scription of intergenic GSATs and heterochromatic regions (Fig. 21a&b) that have pre-
viously been shown to be SUV39H-dependent in mESCs (Bulut-Karslioglu et al. 2012).
At PCH (Fig. 18) and at genes that are highly methylated in wt iMEFs (Fig. 21d),
transcription was either upregulated or did not change (compared to wt levels) indicat-
ing that SUV39H-dependent loss of H3K9me3 was not suﬃcient to activate transcription
in all cases, but rendered some loci more permissive towards activation. The fact that
some highly methylated genes in wt iMEFs and intact PCH in the NIH3T3 cell line dis-
played high levels of transcripts (Fig. 21c & Fig. 18a) indicates that H3K9me3 was not
suﬃcient to completely silence genomic loci.
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II.3 Activating transcription of a heterochromatic gene array with
light
Heterochromatic loci can transition from a repressed chromatin state to an activated one
when stimulated, e. g. by environmental cues. In addition, some active genes can be
located within heterochromatin domains indicating that repressed compartments might
not be completely silenced (Dimitri et al. 2005). Thus, understanding the activation of a
repressed locus might help to decipher the diﬀerent mechanisms guiding appropriate and
inappropriate transitions from silent to active chromatin states. To dissect the events at
a silenced locus upon activation of transcription, an optogenetic transcription activation
system was established. Therefore, the transcription reporter cell line U2OS 2-6-3 (Janicki
et al. 2004) was combined with the optogenetic CIB1/CRY2 system (Kennedy et al. 2010).
II.3.1 Eﬀector proteins were recruited to subnuclear compartments by blue
light
To quickly recruit eﬀector proteins such as transcription activators to subnuclear com-
partments, I developed an optogenetic system termed Blue Light-Induced Chromatin
Recruitment (BLInCR). To this end, eﬀectors were fused to a ﬂuorescent protein (FP)
and the PHR domain of the Arabidopsis thaliana protein CRY2 (Kennedy et al. 2010).
Its interacting partner, the CIBN domain of CIB1, was fused to an FP-tagged `localizer',
i. e. a protein with a speciﬁc subnuclear localization (Fig. 23a). PHR-mCherry was
used as a mock eﬀector to test the versatility of the system. Before illumination with blue
light, PHR-mCherry was rather evenly distributed throughout the cells and depleted from
nucleoli (Fig. 23, center column). The CIBN domain was fused to a variety of proteins
(see Table 6 in the Materials & Methods section) thereby targeting diﬀerent compart-
ments within the nucleus: a repetitive array stably integrated into the genome, nucleoli,
telomeres, nuclear lamina and PML nuclear bodies (Fig. 23b, left column and schematic
drawings from top to bottom). Upon blue light exposure, the PHR-tagged eﬀector relocal-
ized to sites of CIBN (Fig. 23b, right column). The BLInCR system could also be used
in other systems such as PCH foci in wt iMEFs. Here, murine SUV39H1, SUV4-20H1
and SUV4-20H2 were used as `localizers' and tagged with CIBN-YFP. PHR-mCherry-
NLS served as a mock eﬀector and could be recruited as expected (Fig. 24a). To verify
the localization of the `localizer' proteins when tagged with CIBN, cells transfected with
CIBN-mSUV39H1 and a PHR-mCherry-eﬀector construct were ﬁxed and counterstained
with DAPI after blue light exposure. As expected, the recruited constructs colocalized
with DAPI-dense foci (Fig. 24b) conﬁrming recruitment of the eﬀector to PCH. In sum-
mary, all `localizer' proteins tested thus far were compatible with the BLInCR system.
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Figure 23: Blue Light-Induced Recruitment to Chromatin (BLInCR) in U2OS 2-6-3
cells. (a) Principle of BLInCR: the CIBN domain is tethered to a `localizer' and a PHR-tagged
eﬀector protein relocalizes to the site of the `localizer' upon exposure to blue light. (b) Diﬀerent
`localizer' proteins were tagged with CIBN and tagBFP for visualization (left). PHR-mCherry
was evenly distributed throughout cell (center) and relocalized to sites of the `localizers' after
illumination with blue light. All constructs were transiently transfected. Scale bars: 5 µm.
Figure adapted and modiﬁed from (Rademacher et al. 2017).
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Figure 24: Adaptation of BLInCR to PCH in MEF cell lines. (a) Diﬀerent PCH
components were used as `localizers' and tagged with CIBN-YFP: murine SUV39H1, SUV4-
20H1 and SUV4-20H2 (from top to bottom). PHR-mCherry-NLS colocalized with the CIBN
counterparts after illumination with blue light (in wt iMEFs). Scale bars: 5 µm. (b) NIH3T3
cells were transfected with CIBN-mSUV39H1 (not visible) and exposed to blue light before
ﬁxation. PHR-mCherry-eﬀector constructs (NLS or VP16) colocalized with DAPI dense foci
indicating that recruitment via CIBN-mSUV39H1 worked as expected. Scale bars: 5 µm.
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II.3.2 BLInCR was rapid and reversible
The human osteosarcoma cell line U2OS 2-6-3 contains a stably integrated construct with
promoter-proximal binding sites for LacI and TetR and a reporter cassette comprising
a gene coding for peroxisome-localized CFP as well as MS2 loop sequences (Fig. 25a).
Around 200 copies of this construct are integrated near the telomere of the short arm of
chromosome 1 (Janicki et al. 2004). This cell line was used to characterize the binding
and dissociation kinetics of PHR-tagged eﬀectors to array-tethered CIBN.
For recruitment, the array was located without triggering the switching of the PHR do-
main (excitation with a wavelength of λ = 561 nm). Subsequently, the PHR-YFP-tagged
eﬀector was imaged, thereby inducing PHR switching and binding to CIBN (λ = 488 nm).
After <2 s, accumulation of ﬂuorescence intensity was already visible (Fig. 25b). For
the quantiﬁcation, a circular region around the array and a reference region were se-
lected in the maximum intensity projection of the time series (see Materials & Methods
section for details). PHR-YFP tagged eﬀectors accumulated rapidly at the array with
two characteristic rates and characteristic times to reach half-maximal levels in the order
of 10-23 s (Table 4). The PHR-YFP-fused nuclear localization signal (NLS) displayed
slightly slower accumulation compared to GCN5 and VP16 (Fig. 25c). This was not
an artifact of the NLS since PHR-YFP showed very similar recruitment kinetics and
the same was true for PHR-YFP-hGCN5 and PHR-YFP-hGCN5-NLS (Fig. 25d, left,
Fig. 25e). In addition, the recruitment kinetics to tetO or lacO were similar to each
other but slightly faster for lacO, as shown for PHR-YFP-VP16 and PHR-YFP-hGCN5
(Fig. 25d, right, Fig. 25e). The recruitment curves were ﬁtted to a model considering
two parallel ﬁrst-order reactions (E(t) = a−b ·exp(−k1 ·t)−c ·exp(−k2 ·t)). The two rates
could correspond to PHR-CIBN heterodimerization and the PHR-PHR oligomerization
that has previously been described (Bugaj et al. 2013). In this case, the rates should be
identical for all PHR and CIBN constructs and only diﬀer in their relative contribution to
the overall recruitment kinetics (i. e. the fast and slow fraction b and c. Accordingly, all
123 curves were ﬁtted with a single set of rates k1 and k2, but individual plateau values a
and contributions of the fast and slow reaction b and c to account for diﬀerent transfection
eﬃciencies and the properties of the fused eﬀectors. All curves and ﬁts were normalized
and averaged, resulting in the curves shown in Figure 25c&d. For comparison, single
curves were ﬁtted to the same model leaving all ﬁve parameters unconstrained. This was
diﬃcult because some of the recruitment curves had a low signal-to-noise ratio and the
ﬁt results frequently depended on the starting values. The normalization and averaging
was done as before and the average curves were reﬁtted. Results from both ﬁtting strate-
gies were similar (Table 4) and the characteristic recruitment times were heterogeneous
among cells, which was more pronounced for the single ﬁts (Fig. 25e). The ﬁt quality
was comparable for the two ﬁt methods (Fig. 25f) and the cumulative sum of squared
residuals from the global ﬁt were only 9% higher than those of the single ﬁts, indicating
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that global ﬁtting of the two characteristic rates was suitable as it described the data well
and was more robust to noise and individual outliers.
Table 4: Fit parameters for BLInCR kinetics.
PHR-YFP fused
to
VP16 hGCN5
hGCN5-
NLS
NLS -
recruited to tetO lacO tetO lacO tetO tetO tetO
number of cells n 18 10 18 11 32 19 15
global ﬁt of k1 and k2
k1 (s
−1), fast
reaction a)
0.127±0.002
b, fraction fast b) 0.41±0.17 0.47±0.19 0.40±0.23 0.53±0.26 0.36±0.17 0.19±0.21 0.23±0.24
k2 (s
−1), fast
reaction a)
0.0230±0.0004
c, fraction slow b) 0.48±0.18 0.32±0.18 0.46±0.26 0.34±0.26 0.44±0.21 0.73±0.22 0.67±0.32
τ1/2 (s)
b) 13.6±5.0 10.8±4.5 14.1±7.1 11.1±6.6 14.0±5.6 22.2±8.0 20.6±9.3
single curve ﬁts for normalization and reﬁtting of average curves
k1 (s
−1), fast
reaction a)
0.30±0.03 0.30±0.03 0.73±0.21 1.94±1.98 0.38±0.06 0.71±0.72 0.29±0.12
b, fraction fast b) 0.26±0.01 0.34±0.02 0.12±0.02 0.08±0.06 0.21±0.02 0.02±0.01 0.09±0.02
k2 (s
−1), fast
reaction a)
0.039 ±
0.001
0.041 ±
0.002
0.049 ±
0.001
0.066 ±
0.002
0.041 ±
0.001
0.034 ±
0.001
0.033 ±
0.001
c, fraction slow b) 0.64±0.01 0.48±0.02 0.71±0.01 0.76±0.01 0.61±0.01 0.78±0.004 0.73±0.01
τ1/2 (s)
*,b) 11.9±5.6 10.4±8.1 13.4±7.1 10.6±6.5 12.0±6.9 25.9±12.3 23.8±13.1
a) These ﬁt results are listed along with their standard ﬁt error. b) These ﬁt results correspond to the
average of the single ﬁt results and are listed with their standard deviations. *) τ1/2 is the characteristic
time to reach half-maximal levels.
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Figure 25: BLInCR kinetics. (a) Schematic representation of the array and recruitment
setup. Around 200 copies of this construct are incorporated in the U2OS 2-6-3 cell line (Janicki
et al. 2004). (b) Workﬂow for BLInCR kinetics measurements. See text for details. (c)
Measured BLInCR kinetics for diﬀerent eﬀectors recruited to the tetO sites. (d) BLInCR
kinetics of (mock) eﬀector with and without NLS to tetO sites (left) and eﬀector recruitment
to tetO compared to lacO (right). The black, blue and red curves are identical to those in
(c). (c&d) Averaged experimental data (transparent lines) with standard deviations (shaded
areas) and averaged global ﬁts (solid lines) are shown, ﬁt parameters are listed in Table 4.
(e) Characteristic recruitment times determined from the global (black) or the single curve
ﬁts (grey). (f) Coeﬃcients of determination for both ﬁt methods. Scaling of the y-axis is
logarithmic. Parts of the ﬁgure are adapted and modiﬁed from (Rademacher et al. 2017).
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To characterize the reversibility of BLInCR (Fig. 26a), the eﬀectors were tagged with
PHR-mCherry to allow for visualization without triggering recruitment (λ = 561 nm). Af-
ter recording a pre-recruitment stack, the GFP-marked array was visualized (λ = 488 nm),
thereby triggering light-induced PHR switching and recruitment of the eﬀectors. Subse-
quently, imaging of the eﬀector construct without recruiting anew allowed to track their
dissociation from the array. As for the BLInCR kinetics measurement, the ﬂuorescence
intensity at the array and a nuclear reference area were measured (Fig. 26b, see Materi-
als & Methods section for details). PHR-mCherry-fused eﬀectors readily dissociated from
the array (Fig. 26c) with a characteristic half-life time of ∼5 min (Fig. 26d, Table 5)
which was identical for both eﬀectors tested (VP16 and NLS). Importantly, the eﬀec-
tors completely dissociated from the array within 15-20 min. In addition, they could be
rapidly recruited again as shown for NLS BLInCR to PCH via CIBN-EYFP-SUV4-20H2
(Fig. 26e).
Table 5: Fit parameters for BLInCR dissociation kinetics.
PHR-mCherry fused to VP16 NLS
number of cells n 13 12
dissociation rate k (min-1) 0.07±0.04 0.08±0.03
m 1.53±0.20 1.47±0.22
half-life time t1/2 (min) 4.9±0.8 4.8±0.6
Single dissociation curves were ﬁtted to an exponential model with a time-
dependent rate (E = a · e−k·tm + c) similar to a previously proposed model
(Sing et al. 2014). The parameters correspond to the average of the single
ﬁt results and are listed with their respective standard deviations.
Taken together, BLInCR allows to accumulate eﬀector proteins at genomic loci on the
time scale of seconds after blue light illumination and those eﬀectors dissociate on the
time scale of minutes in the dark.
II.3.3 VP16 BLInCR activated the U2OS 2-6-3 transcription reporter system
and possibly GSAT transcription at mouse PCH
Eﬀector proteins such as the viral transactivator VP16 can be recruited to the vicinity of a
minimal CMV promoter in the U2OS 2-6-3 reporter cell line, thereby activating transcrip-
tion of the reporter. Active transcription can be tracked on the RNA level by transfecting
the cells with ﬂuorescently tagged MS2 coat proteins (MCP) that bind MS2 loop RNA
or on the protein level by observing peroxisomal CFP signal (Janicki et al. 2004). To
test if reporter transcription can eﬃciently be activated by VP16 BLInCR, the cells were
transfected with an array marker (CFP-LacI), an array `localizer' (CIBN-TetR), the PHR-
YFP-tagged eﬀector (VP16) as well as an RNA reader (mKate2-MCP) and illuminated
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Figure 26: BLInCR dissociation kinetics. (a) Schematic representation of recruitment and
dissociation. The array marker GFP-LacI was only imaged in the recruitment step and imaging
the eﬀectors did not lead to recruitment. (b) Workﬂow for BLInCR dissociation kinetics mea-
surements. See text for details. (c) Measured dissociation kinetics for two eﬀectors (VP16 and
NLS). Averaged experimental data (transparent lines) with standard deviations (shaded areas)
and averaged ﬁts (solid lines) are shown, ﬁt parameters are listed in Table 5. (d) Character-
istic half-life for the two eﬀectors. (e) Recruitment, dissociation and second recruitment of a
mock eﬀector (PHR-mCherry-NLS) to mouse PCH via CIBN-EYFP-mSUV4-20H2. BLInCR
was activated by imaging YFP ﬂuorescence in the localizer (not shown). Scale bar: 5 µm. Parts
of the ﬁgure are adapted from (Rademacher et al. 2017).
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with a blue LED over night (Fig. 27a). Fluorescently tagged MCP was enriched at the
array and peroxisomal CFP could also be detected (Fig. 27b). In addition, accumula-
tion of the largest subunit of pol II, RPB1, was visualized via a GFP-tagged construct
(Sugaya et al. 2000) and could be detected at the array alongside the recruited activator
(Fig. 27c). Transcription activation worked reliably with BLInCR as ∼90% of the cells
showed MCP enrichment at the array and peroxisomal CFP could be detected in ∼85%
of the cells, which was comparable to activation with FP-TetR-VP16 fusion constructs
and more eﬃcient compared to VP16 BLInCR to lacO (Fig. 27c). To adapt the system
to mouse PCH in iMEFs, the tightly bound PCH component SUV39H1 was used as a
`localizer' to tether VP16 upon blue light illumination (Fig. 27d). VP16 BLInCR worked
with this system (as shown in Figure 24c for NIH3T3 cells), but GSAT RNA cannot be
detected using a live cell reader domain. Thus, transiently transfected cells were lysed
after two hours of illumination with a blue LED and RNA levels were quantiﬁed using
qRT-PCR. Preliminary results of two biological replicates revealed a small and insignif-
icant increase of GSAT RNA compared to untransfected cells (Fig. 27e). However, the
transfection eﬃciency in a comparable control experiment (same transfection protocol,
constructs, cell line) where cells were ﬁxed and imaged was only about 6%. Analyzing the
bulk of transfected and untransfected cells might thus not be feasible under those non-
optimized conditions. Nonetheless, VP16 BLInCR at an endogenous heterochromatic
locus is technically possible and might overwrite the heterochromatic silencing and acti-
vate transcription of GSAT RNA. In the artiﬁcial reporter system of the U2OS 2-6-3 cell
line, VP16 BLInCR to tetO reliably activated transcription that can be detected in single
living cells.
II.3.4 Transcription output depended on the mode of activation and was
heterogeneous in U2OS 2-6-3 cells
Reporter transcripts were strongly enriched in cells transfected with the relevant BLInCR
constructs (CIBN-TetR, PHR-YFP-VP16 and mCherry-MCP) compared to mock-trans-
fected (TetR-mRFP and YFP) or untransfected U2OS2-6-3 cells after over night exposure
to blue light as determined by qRT-PCR (Fig. 28a). However, this bulk quantiﬁcation
does not oﬀer valuable clues about the activation hetero- or homogeneity among single
cells. Even though single cell microscopy can provide valuable insights on the hetero-
geneity of the response (Fig. 28b), exact quantiﬁcation of MS2 RNA at the array across
diﬀerent cells and diﬀerent constructs was not possible as the enrichment depends on
the transfection levels of the eﬀector constructs and mKate2-MCP. To account for those
experimental diﬀerences, the average radial ﬂuorescence intensity around the array was
quantiﬁed, normalized to the mean ﬂuorescence intensity of a nuclear reference area and
averaged. The resulting radial proﬁles (Fig. 28c) of the recruited eﬀector revealed that
RNA enrichment at the array was always higher when recruiting to tetO compared to lacO
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Figure 27: Transcription activation in U2OS2-6-3 cells and iMEFs. (a) Schematic
representation of reporter transcription activation in U2OS 2-6-3 cells using BLInCR. (b) Re-
porter transcription was activated with the system depicted in (a) by illumination with a blue
LED over night. RNA accumulation at the array (via mKate2-MCP) and peroxisomal CFP
were readily detected in live cell CLSM images. CFP-LacI was used as an array marker. (c)
CLSM images of pol II (GFP-RPB1) in cells activated as depicted in (a). Note that PHR con-
structs were labeled with iRFP713 and MCP with tagRFP to allow spectral separation of all
constructs. (d) Fraction of cells that show reporter signal (RNA/peroxisomal CFP) across all
experiments. (e) Schematic representation of VP16 BLInCR to activate GSAT transcription.
CIBN-SUV39H1 was used as a `localizer', but GSAT RNA cannot be detected by a ﬂuores-
cently tagged reader domain. Instead, qRT-PCR was used. (f) Relative RNA levels after VP16
BLInCR as depicted in (e). Relative GSAT RNA levels after VP16 BLInCR determined by
qRT-PCR. GSAT RNA levels were normalized using actin levels and untransfected controls.
The mean ± sem sem of two biological replicates with three technical replicates each are shown.
Parts of the ﬁgure were adapted and modiﬁed from (Rademacher et al. 2017).
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(Fig. 28c, bottom, Fig. 28b,d), even though VP16 was recruited equally well. This ef-
fect was more pronounced for the BLInCR recruitment, which only activated <50% of
the cells in the case of lacO (Fig. 27d). The integrated radial intensity from the array
center to the full width at half maximum (FWHM) of the recruited eﬀector was used
as a measure for the accumulated RNA from radial proﬁle plots (Fig. 28d). Some of
the control cells that were not transfected with a VP16 construct also showed increased
ﬂuorescent signal at the array (Fig. 27d). However, this occurred rarely and quantifying
the absolute ﬂuorescence accumulation at the array (Iarray − Iref) · Aarray in comparable
cells that were recorded on the same day with the same laser intensity revealed that it
was negligible compared to the MCP accumulation in the presence of VP16 (Fig. 29a,
top). This was validated by RNA ﬂuorescence in situ hybridization (FISH, Fig. 29a,b).
Direct RNA visualization by FISH also showed that the heterogeneous transcription re-
sponse to VP16 across diﬀerent cells was not a transfection artifact of MCP, but actual
cell-to-cell heterogeneity (Fig. 29a). In addition, the RNA level at the array (as detected
by RNA FISH) was rather uncorrelated with the PHR-YFP-VP16 accumulation at the
array (Fig. 28) suggesting that the array was saturated by VP16.
Lastly, the C-terminal domain (CTD) of pol II could be detected in cells activated
by VP16 BLInCR over night, but not in non-activated cells transfected with a mock
eﬀector. In particular, the serine 5-phosphorylated form that is associated with tran-
scription initiation (Stasevich et al. 2014) was strongly enriched (Fig. 30). Conversely,
the elongation-associated (Stasevich et al. 2014) serine 2-phosphorylated CTD was only
slightly enriched at the array (Fig. 30).
Characterization of the diﬀerent recruitment and activation strategies showed that
activation via recruitment to lacO was less eﬃcient compared to tetO in U2OS 2-6-3
cells. This eﬀect was more pronounced when using BLInCR compared to fusion constructs
which might be due to interference with CFP-LacI which was always co-transfected in
the BLInCR experiments (as an independent array marker). No additional array marker
was used in the experiments with fusion constructs. Taken together, transcription of the
reporter in the U2OS 2-6-3 cell line can be eﬃciently activated by VP16 BLInCR to tetO.
As expected, pol II was enriched as shown by IF staining using this activation strategy.
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Figure 28: RNA quantiﬁcation at the array after constitutive transcription acti-
vation. (a) qRT-PCR of untransfected and transfected U2OS 2-6-3 cells after constitutive
activation over night. The mock transfected samples were transfected with TetR-mRFP and
YFP and the sample was transfected with CIBN-TetR, PHR-YFP-VP16 and mCherry-MCP.
Notably, only 10-15% of the cells showed red and yellow ﬂuorescence (estimation by J. Tro-
janowski). Quantities were normalized using actin levels and the average value of untransfected
cells. Error bars correspond to sem of two biological replicates (each with three technical repli-
cates). (b) Live cell CLSM images of GFP-tagged fusion constructs (i. e. GFP-LacI-VP16,
GFP-TetR-VP16, TetR-GFP; from top to bottom) and RNA (mKate2-MCP) at the array.
Scale bars: 5 µm. (c) Average radial proﬁles of eﬀectors (top) and RNA (bottom, mKate2-
MCP reader) for recruitment via fusion constructs (left, as in (b)) or BLInCR (right, i. e.
PHR-YFP-VP16/CIBN-LacI, PHR-YFP-VP16/CIBN-TetR, PHR-YFP/CIBN-TetR). The ra-
dial intensity I(r) at distance r from the array center was normalized to the mean ﬂuorescence
intensity of a nuclear reference area Iref (dashed line): Inorm(r) = I(r)/Iref. The number of cells
for each condition is listed in panel (d). (d) Accumulated RNA at the array calculated from
the radial proﬁles in (c): Esum =
∑r=FWHM
r=0 2pirInorm.
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Figure 29: Diﬀerent RNA visualization techniques were compatible with BLInCR
and yielded comparable results. (a) RNA accumulation at the array after eﬀector BLInCR
over night. The RNA enrichment was calculated as (Iarray − Iref) ∗Aarray with Iarray being the
mean ﬂuorescence intensity of a circular region around the array and Aarray its area. Since
all images for each experiment were recorded on the same day with the same laser intensities,
this diﬀerence corresponds to the absolute mKate2-MCP or MS2 FISH probe accumulation at
the array, respectively. The two experiments are not directly comparable with one another
(diﬀerent ﬂuorescent probes). (b) Exemplary CLSM images of formaldehyde-ﬁxed cells with
MS2 RNA FISH using an Atto565-labeled probe after eﬀector BLInCR. PHR-eﬀector constructs
were YFP-tagged and detected by anti-GFP IF (with an Alexa488-labeled secondary antibody)
since YFP was destroyed during the FISH procedure. Scale bars: 5 µm. (c) Relationship
between RNA FISH signal (from panel (a), bottom) and VP16 signal calculated analogously.
Parts of the ﬁgure were adapted and modiﬁed from (Rademacher et al. 2017).
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Figure 30: Immunoﬂuorescence staining of DNA-directed RNA polymerase II after
constitutive VP16 BLInCR. U2OS 2-6-3 cells were transfected with CIBN-TetR, PHR-YFP
(mock) eﬀectors (NLS or VP16) and mKate2-MCP and illuminated with a blue LED over night.
(a) CLSM images of the PHR-eﬀector constructs (YFP-tagged), IF of pol II phosphorylated
at serine 5 or serine 2 (Alexa647-linked secondary antibody), merge of eﬀector (red) and pol II
(grey scale), RNA (mKate2-MCP) and DNA (DAPI) from top to bottom. Scale bars: 5 µm.
(b) DAPI-normalized radial proﬁles of the eﬀector and the modiﬁed pol II (mean and sd are
displayed). (c) Accumulated pol II at the array. Calculations for (b&c) were done as for RNA
described in Figure 28c&d.
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II.3.5 Histone modiﬁcations and chromatin structure changed after long-
term activation
Transcription activation in U2OS 2-6-3 cells has been reported to be accompanied by
chromatin decondensation and histone acetylation (Rafalska-Metcalf et al. 2010), whereas
non-activated cells displayed heterochromatic features such as binding of SUV39H1 and
HP1 proteins as well as increased H3K9me3 (Janicki et al. 2004). U2OS 2-6-3 cells
were transfected with the VP16 BLInCR system as depicted in Fig. 27a, constitutively
activated and stained for acetylation and trimethylation of H3K9 by immunoﬂuorescence
to analyze the above-mentioned features of the silent and activated state. In activated
cells, acetylation of H3K9 was rather evenly distributed across the array, but DAPI was
slightly depleted (Fig. 31a, left) resulting in a small net enrichment seen in the DAPI-
corrected proﬁles (Fig. 31a, right). In contrast, the negative control (no eﬀector, PHR-
YFP only) showed slight depletion of H3K9ac and homogeneous DAPI signal across the
array. In both activated and control cells, a moderate local enrichment of H3K9me3
was observed in most cells (Fig. 31b), indicating that H3K9me3 and transcription were
uncorrelated even though MS2 RNA production was not analyzed concomitantly.
Array decompaction was observed after long-term reporter transcription by expressing
TetR-VP16 fusion constructs (Fig. 28b) and was also detected in the width of the radial
array proﬁles (Fig. 28c, top left). However, assessing decompaction of the array upon
activation by VP16 BLInCR is not directly feasible since PHR constructs oligomerize
(Bugaj et al. 2013) possibly obscuring the actual array dimensions (Fig. 28c, top right).
Therefore, CFP-LacI was co-transfected as an independent marker and the array size
was determined in a threshold-based approach (see Materials & Methods for details).
Activated arrays were very heterogeneous in size and RNA signal was detected at both
small and large arrays (Fig. 32a). Recruitment of VP16-TetR fusion constructs led to
pronounced decompaction, whereas activation via BLInCR enlarged the array to a slightly
lesser extent (Fig. 32b). In summary, arrays tended to decompact upon constitutive
activation, but decondensation of the locus was not a prerequisite for activation.
II.3.6 Visualizing epigenetic signatures in live cells with ﬂuorescently tagged
reader domains
Immunoﬂuorescent staining of histone modiﬁcations (as in Fig. 31) is a standard tech-
nique to characterize the epigenetic signature of repetitive genomic loci, but it is inapt
to trace changes in histone marks over time in living cells. In contrast, naturally oc-
curring `reader' proteins or protein domains can be ﬂuorescently tagged and transfected
into living cells. One such `reader', namely murine bromodomain containing protein 2
(mBRD2), has been described to bind transcriptionally active arrays in the U2OS 2-6-
3 cell line (Rafalska-Metcalf et al. 2010). To test whether it is compatible with VP16
II RESULTS 59
Figure 31: Immunoﬂuorescence staining of histone modiﬁcations after constitutive
VP16 BLInCR to tetO. U2OS 2-6-3 cells were transfected with CIBN-TetR and PHR-
YFP-VP16 or PHR-YFP only. CLSM images of YFP ﬂuorescence from the recruited eﬀector
(left), immunoﬂuorescence staining of histone modiﬁcations (center, Alexa568-linked secondary
antibodies) and DAPI staining (right) of ﬁxed cells after blue light illumination over night are
displayed. (a) Acetylation of H3K9. (b) Trimethylation of H3K9. The proﬁles on the right were
normalized to a nuclear reference area as described above and the respective DAPI proﬁle. For
each condition, n = 10 cells were analyzed except for the negative control H3K9me3 staining
without VP16 (n = 11). Scale bars: 5 µm. Parts of the ﬁgure were adapted and modiﬁed from
(Rademacher et al. 2017).
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Figure 32: Array size after constitutive transcription activation. (a) CLSM images of
the independent array marker (CFP-LacI) and RNA (mKate2-MCP). Cells were either activated
with a VP16-TetR fusion construct or VP16 BLInCR and were heterogeneous in size. Scale
bars: 5 µm. (b) Array size quantiﬁed from CLSM images by a threshold-based approach. The
ﬁgure was adapted from (Rademacher et al. 2017).
BLInCR, it was cotransfected with the BLInCR components depicted in Figure 27. A
systematic analysis of recruitment to either lacO or tetO with fusion constructs or VP16
BLInCR revealed that recruiting VP16 fusion constructs to lacO resulted in more mBRD2
enrichment compared to tetO (Fig. 33). This indicates that mBRD2 recruitment might
be independent of transcription activation since recruitment to tetO generally resulted in
higher transcript levels (Fig. 28), bbut lower mBRD2 levels. BLInCR of VP16 or a mock
eﬀector to tetO showed no diﬀerential mBRD2 binding at the array, suggesting either
that mBRD2 did not eﬃciently bind acetylated histones in the given chromatin context
or that histones at the array were not acetylated despite transcription activation. Another
bromodomain containing protein, mBRD4, has been described to be co-recruited along
VP16 (Rafalska-Metcalf et al. 2010) and showed strong enrichment at the array when
cells were transfected with VP16 fusion constructs. As for mBRD2, activator recruitment
to tetO resulted in lower mBRD4 enrichment compared to lacO (Fig. 33).
The chromodomain of mouse HP1β (mCD) and the human ADD domain of the ATRX
protein bind H3K9me3 (Bannister et al. 2001, Dhayalan et al. 2011) and might also be
suitable to be used as reader domains in living cells as reported for the mCD (Muller-
Ott et al. 2014). Here, those two domains were tested as live cell readers to assess
the H3K9me3 status of the array under activated and silenced conditions. When no
activator is recruited, the reporter locus in the U2OS 2-6-3 cell line has been described
to be trimethylated at H3K9 and enriched with heterochromatin-associated proteins such
as the histone methyl transferases SUV39H1 and G9A as well as HP1 (Janicki et al.
2004). These ﬁndings were conﬁrmed by the immunostainings in Figure 31b above.
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Figure 33: Bromodomain-containing protein accumulation at the U2OS 2-6-3 re-
porter array for diﬀerent activation modes. (a) Live cell CLSM images of recruited
eﬀector (top), RNA reporter (mCherry-MCP, middle) and ﬂuorescently tagged mBRD2 (bot-
tom). The fusion eﬀectors were tagged with tagBFP, whereas the BLInCR eﬀectors were tagged
with iRFP713. Scale bars: 5 µm. (b) Quantiﬁcation of accumulated mBRDs at the array. The
quantiﬁcation of accumulated mBRD at the array was based on the radial proﬁles as in Fig-
ure 28d.
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The H3K9me3 reader domains were thus tested under the silenced conditions by marking
either the tetO or the lacO repeats with ﬂuorescently tagged TetR or LacI constructs,
respectively. The mCD was enriched at the array in most cells when marking the array at
the lacO sites, whereas enrichment of the hADD domain was observed less frequently and
at lower levels. In addition, reader enrichment was always lower when the array marker
was recruited to tetO compared to lacO (Fig. 34a). Notably, this eﬀect was observed
both with the mBRD proteins and the H3K9me3 reader domains, suggesting that it might
be related to the general chromatin landscape at the array. Transcription activation led
to a slight reduction of average H3K9me3 levels at the array (Fig. 34b), but nonetheless
cells with mCD enrichment at the array were observed even though they were activated
over night (Fig. 34b, top). This is consistent with the antibody staining of H3K9me3
after constitutive activation shown in Figure 31.
In summary, the localization of live cell readers of histone modiﬁcations did not only
depend on the activation state of the reporter array in the U2OS 2-6-3 cell line, but
also on the mode of activation (BLInCR vs. fusion constructs) and the site to which
the (mock) eﬀectors were recruited (lacO vs. tetO). VP16 BLInCR did not lead to
diﬀerential enrichment of mBRD2 at the array, but did lead to a slightly lower average
mCD enrichment compared to the mock control. Interestingly, activated cells with some
mCD accumulation at the array were observed, conﬁrming the ﬁnding that H3K9me3
alone cannot repress transcription as shown for PCH in NIH3T3 cells (Fig. 18a) and
some genes in wt iMEFs (Fig. 21c).
II.3.7 Transcription activation via VP16 BLInCR was rapid and accelerated
in cells with hyperacetylated histones
The VP16 BLInCR setup in the U2OS 2-6-3 reporter cell line depicted in Fig. 27a can
reliably activate transcription and detect RNA in cells. It is thus suited to follow re-
porter activation by time-lapse live cell imaging. To analyze the kinetics of transcription
activation in detail, VP16 was constantly re-recruited by simultaneous imaging the array
marker (CFP-LacI), the eﬀector (PHR-YFP-VP16) and the RNA reader (mKate2-MCP)
every 2-5 min. In addition, cells were cultured either with or without the histone deacety-
lase inhibitor SAHA prior to live cell imaging to assess the role of hyperacetylation in
transcription initiation. Treatment with 2 µM SAHA for 24 h led to an increase in his-
tone acetylation at H3K9, H3K27 and H4 as shown by western blot analysis (Fig. 35a).
Concordantly, constitutively activated cells (with/without SAHA treatment) stained for
H3K9ac by IF revealed that the accumulated ﬂuorescence signal in the entire nucleus
increased in SAHA-treated cells compared to untreated cells. Direct comparison of ﬂuo-
rescence intensities was feasible for this analysis, because cells were cultered in removable
4-well chambers and subsequently stained on the same slide and imaged with the same
parameters. Increased acetylation was also seen at the array (Fig. 35b). For this analy-
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Figure 34: Live cell H3K9me3 reader domains (a) The chromodomain of mouse HP1β
(mCD) and the human ATRX-Dnmt3-Dnmt3L (hADD) domain of the ATRX protein were en-
riched at the non-activated U2OS 2-6-3 reporter array albeit at diﬀerent amounts. The quan-
tiﬁcation below the CLSM images was based on the radial proﬁles as described for Figure 28d.
(b) Activation of the array via VP16 only led to a slight reduction of mCD accumulation at the
array compared to the controls without eﬀector. Note that CFP-MCP did not work well as an
RNA reader (top row, center), but all cells showed either a slight enrichment and/or CFP-SKL
conﬁrming activation. Scale bars: 5 µm.
64 II RESULTS
sis, the integrated intensity from the array center up to the FWHM was quantiﬁed (as in
Fig. 28d). Interestingly, array acetylation increased stronger in activated cells (VP16)
compared to control cells (NLS) suggesting that pre-existing hyperacetylation might fur-
ther enhance activation-associated acetylation that was only moderate in the absence of
SAHA (Fig. 31a).
Figure 35: Treatment with the histone deacetylase inhibitor SAHA led to histone
hyperacetylation in U2OS2-6-3 cells. (a) Western blot analysis of acetylation of H3K9,
H3K27 and H4 in the presence and absence of SAHA. After detecting the acetylation signals,
antibodies were stripped from the membrane and H3 was detected as a loading control. (b)
Quantiﬁcation of ﬂuorescence signal after IF staining for H3K9ac in transfected cells. Cells were
grown and stained on the same slide (with a removable 4-well chamber) and imaging was done
on the same day using the same imaging parameters, thereby allowing for direct comparison of
ﬂuorescence intensities. For the nuclei quantiﬁcation, the mean nucleus signal was multiplied
with the area of the nucleus. For the array quantiﬁcation, the signal was integrated from
the array center to the FWHM (as determined in the eﬀector channel). The array signal was
normalized to the DAPI ratio (array/whole cell) to correct for changes in chromatin structure
 i. e. decondensation of the array and associated DAPI decrease observed in some of the
activated cells. 12/6 treated and 12/8 untreated cells were analyzed (VP16/NLS). The ﬁgure
was adapted and modiﬁed from (Rademacher et al. 2017).
In some cells, RNA was already detected in the second frame, i. e. after 2 min
(Fig. 36a). Activation generally proceeded in two phases: a rapid ﬁrst activation lead-
ing to a plateau in RNA accumulation between 10-20 min after initial VP16 BLInCR
followed by a second increase of transcript accumulation after 20-40 minutes (Fig. 36b).
Hyperacetylation in cells pre-treated with SAHA resulted in a more pronounced ﬁrst ac-
tivation phase and a more rapid response to the activator in the sense that RNA was
detectable after less than ﬁve minutes in all cells compared to the broad distribution of
response times in untreated cells (Fig. 36c). In addition, the produced RNA was not
distributed homogeneously across the array (Fig. 36a, insets) indicating that some of the
∼200 promoters might be poised for transcription and activated more rapidly than others.
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During the ﬁrst 50 min of activation, the array structure did not change on the scale that
is accessible by light microscopy (Fig. 36a, middle, Fig. 36b, bottom). The average
array decondensation observed after constitutive activation over night (Fig. 32b) was
thus rather a downstream eﬀect of transcription activation. The biphasic activation ki-
netics ﬁtted a positive feedback model with a fraction of independent transcription units.
A sequential activation model with n steps and identical transition rates between those
steps also yielded a good, but slightly worse ﬁt (Fig. 36b). Importantly, simulation of
diﬀerent recruitment speeds showed that the fast BLInCR recruitment and detection of
RNA were necessary to resolve the biphasic activation kinetics (Rademacher et al. 2017).
Combining VP16 BLInCR and live cell RNA detection in the U2OS 2-6-3 reporter
system allowed to monitor the onset of transcription in single living cells at high spatial
and temporal resolution. The following results were obtained here from the application
of this system: i) the transcription activation kinetics of a gene cluster proved to be
biphasic; ii) the spatial organization of the array as accessible by confocal microscopy did
not change during the ﬁrst 50 min of activation; iii) RNA was produced heterogeneously
across the array; iv) the transcriptional response to a strong activator was heterogeneous
across diﬀerent cells and v) treatment with the histone deacetylase inhibitor SAHA led
to faster response times and a more pronounced ﬁrst activation phase.
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Figure 36: Transcription activation kinetics after VP16 BLInCR. (a) CLSM images
of the RNA reader (mKate2-MCP, top) and the VP16 eﬀector (PHR-YFP-VP16, middle) as
well as a merge (bottom). Scale bars: 5 µm. (b) Relative RNA levels during the ﬁrst 50 min of
activation (top, corrected for ﬂuorophore bleaching and normalized to the levels at t = 50 min).
Bottom: relative array size compared to the second time point (i. e. when VP16 was fully
recruited) during the activation. The RNA levels ﬁtted a model including positive (black/red)
or (slightly worse) a sequential activation model (yellow/blue). Modeling was done by F. Erdel.
(c) Response time and relative RNA levels at the ﬁrst plateau (i. e. at the point of inﬂection:
8.7 min for untreated and 11.8 min for treated cells) for the cells analyzed in (b). The ﬁgure
was adapted and modiﬁed from (Rademacher et al. 2017).
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II.3.8 The persistence of the activated state could be probed using BLInCR
BLInCR is a promising tool to study the reversibility of biological processes by taking
advantage of the dissociation kinetics in the dark (Fig. 26). To test this system for the
reversibility of transcription activation, the light trigger that targeted VP16 to the reporter
was removed after an initial recruitment phase. If the transcriptionally active state were
memorized even in the absence of the trigger (i. e. VP16), increased total reporter RNA
levels (Fig. 37a, top) and detectable array-associated RNA would be expected. In the
alternative case, transcriptional activity would not persist leading to a decrease in total
reporter RNA levels (Fig. 37b, bottom) and dissociation of ﬂuorescently tagged MCP
from the array. Both cases were detected in live cell experiments. In some cells, PHR-
iRFP713-tagged VP16 readily accumulated, activated transcription at the array after
minutes and dissociated in the dark, causing transcription to decrease (Fig. 37b&c,
cell 1). When recruiting VP16 anew, transcription increased again, possibly even faster
than after the ﬁrst BLInCR pulse. However, other cells were strongly activated with a
single VP16 BLInCR pulse (52 s), which resulted in a stably activated state that was
independent of light-induced VP16 tethering and irreversible on the time-scale considered
here (Fig. 37c, cell 2). Notably, VP16 did not completely dissociate from the array
in this case, which could be due to interactions with other proteins of the transcription
machinery or with RNA. A bulk experiment according to the scheme in Fig. 37a was
performed to assess which of those scenarios is more prevalent. Cells were transfected
with CIBN-TetR and PHR-YFP-VP16 and illuminated for the indicated amount of time
(tlight). Reporter RNA levels were measured by qRT-PCR at diﬀerent time points after
turning the light oﬀ (tdark) and displayed a decrease over time suggesting that the fully
activated state does not persist.
All in all, using BLInCR for transcription activation generated valuable insights on
the early steps of transcription activation and provides a tool to assess the memory of
the activated state. BLInCR was shown to be compatible with live cell detection of
RNA as well as qRT-PCR. In combination with epigenetically modifying drugs and live
cell monitoring of epigenetic readers and writers, BLInCR can be valuable in dissecting
mechanisms of epigenetic regulation.
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Figure 37: Reversible transcription activation by VP16 BLInCR and live cell imag-
ing of RNA production. (a) Schematic representation of experimentally testable scenarios
addressing the persistence of the transcriptionally active state. If the active state is memo-
rized, total reporter RNA should keep on increasing after the activator is lost from the array
(top). Alternatively, total reporter RNA levels would decrease if the activated state does not
persist (bottom). (b) CLSM images of the RNA reader (tagRFP-MCP, top) and the eﬀector
(PHR-iRFP713-VP16, bottom). The activation pattern is depicted in panel (c). Scale bars:
5 µm. (c) Quantiﬁcation of VP16 and RNA accumulation at the array. Enrichment values
were corrected for bleaching and normalized to the measured maximum. The shaded blue areas
represent the recruitment light pulses. Cell 1 is shown in panel (b). (d) Total reporter RNA
levels after activation for 50 min, 3 h or 7 h (tlight in (a)) determined by qRT-PCR. The time
after activation corresponds to tdark in (a). Actin-normalized quantities are depicted relative
to the average level before illumination (pre). The mock control corresponds to untransfected
cells. The qRT-PCR was performed by S. Schumacher. Parts of the ﬁgure were adapted and
modiﬁed from (Rademacher et al. 2017).
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III Discussion
III.1 PCH speciﬁcity and memory is governed by chromatin-
bound `bookmarking' factors and possibly DNA methyla-
tion rather than by PAX transcription factors
Although PCH in MEFs is a thoroughly studied model system for constitutive hete-
rochromatin, the question how PCH-speciﬁc stably bound complexes ﬁnd their sites of
action after DNA replication and cell division remains unresolved. The 234 bp major
satellite consensus repeat sequence harbors a sequence somewhat similar to the PAX3
transcription factor binding site. It has therefore been suggested that PAX3 is the DNA
sequence-speciﬁc factor that targets PCH and is necessary for eﬃcient repression of GSAT
transcription (Bulut-Karslioglu et al. 2012). PAX3-GFP showed a predominantly homo-
geneous distribution across the nucleus and was excluded from nucleoli (Fig. 10a,b).
The heterochromatic localization of PAX3-GFP in one cell was probably a transfection
artifact as this has only been observed in transfected cells and not when staining endoge-
nous PAX3 as described elsewhere (Corry et al. 2008). The observed inability of PAX3 to
tightly bind major satellite repeats in living cells might be explained by the mismatches
of the apparent binding site within the major satellite consensus sequence compared to
the Paired domain Recognition Site 1 (PRS-1) described for mouse PAX3 (Chalepakis
et al. 1994) (Fig. 38).
Figure 38: Alignment of published PAX3 binding motif and apparent Pax3 binding
site within major satellite repeats. Mutations in the upstream paired type homeodomain
(HD) or the paired domain (PD) binding motifs have been found to be suﬃcient to abolish
PAX3 binding (Chalepakis et al. 1994), whereas the spacer between the two domains can vary
in length. The absence of the correct HD or PD domain in the major satellite consensus
sequence could explain the inability of PAX3 to consistently localize to PCH.
In addition, PAX3-GFP showed high mobility both at PCH and in euchromatic re-
gions (Fig. 10c, Table 1), which is also consistent with previously published FRAP
data (Corry et al. 2008). Notably, the apparently longer time until complete recovery
observed by Corry and colleagues is likely due to the diﬀerence in bleach geometry (strip
vs. circle FRAP). Taken together, PAX3 cannot be considered a component of the stably
bound SUV39H-centered PCH-speciﬁc complex (Muller-Ott et al. 2014) since it is rather
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depleted from PCH when normalized to DNA density (Fig. 10b) and not immobilized.
However, PAX3 might contribute to induce GSAT transcription during some cell cycle
phase (e. g. during S-phase), thereby recruiting PCH factors such as SUMOylated HP1
or SUV39H2 for de novo PCH establishment as suggested elsewhere (Maison et al. 2011,
Velazquez Camacho et al. 2017).
An (epigenetic) factor upstream of SUV39H might also be responsible for targeting
SUV39H/HP1 speciﬁcally to PCH. The methyl-CpG-binding protein MECP2 as well as
5-methyl-cytosine (5mC) remains enriched at DAPI-dense foci in the absence of SUV39H
KMTs in iMEFs (Muller-Ott et al. 2014). Thus, the DNA methylation pathway harbors
intriguing candidates for such a factor. Indeed, MECP2 has been shown to direct KMT
activity speciﬁcally to H3K9 (Fuks et al. 2003b). Conversely, DNA methylation has been
reported to strongly depend on H3K9me3 in Neurospora crassa and Arabidopsis thaliana,
where loss of the respective KMT resembles the loss of DNA methyltransferase phenotype
(Jackson et al. 2002, Tamaru & Selker 2001). Similarly, DNA methylation was reduced
upon loss of SUV39H in mESCs (Lehnertz et al. 2003). In iMEFs, DNA methylation
appeared to be independent of SUV39H, since MECP2 localization and mobility was
unchanged in SUV39H dn compared to wt iMEFs (Fig. 11). MECP2 could therefore re-
cruit SUV39H to PCH. This notion is consistent with the observation that reintroducing
SUV39H dn iMEFs with SUV39H-GFP results in PCH enrichment of the GFP construct
(Muller-Ott et al. 2014). Krouwels and colleagues also showed that SUV39H1 reintro-
duction into SUV39H dn iMEFs resulted in a rescue of the PCH state in the sense that
H3K9me3 and HP1β enrichment were reestablished (Krouwels et al. 2005). The DNA
methylation pathway thus appears to be upstream of the H3K9me3/SUV39H pathway
at iMEF PCH rather than being part of a self-reinforcing cycle of repressed epigenetic
states as proposed elsewhere (Fuks 2005). However, this raises the question how MECP2
speciﬁcity for PCH comes about.
MECP2 has been found to bind cooperatively to methylated DNA (Ghosh et al. 2010)
and to have a slight preference for the non-methylated major satellite DNA sequence
compared to other non-methylated competitor DNA sequences (Lewis et al. 1992). Still,
the moderate 5mC enrichment at PCH compared to euchromatin (∼7-fold) alone cannot
explain the strong enrichment of immobilized MECP2 at PCH (∼80-fold) (Muller-Ott
et al. 2014). The strongly enriched immobilized MECP2 could be suﬃcient for SUV39H
immobilization (∼50/15-fold for SUV39H1/2, respectively). In addition, 2 out of 16
mappable interspersed major satellite repeats were reported to be active as judged by the
presence of H3K36me3 and did not show SUV39H/HP1/H3K9me3 enrichment (Muller-
Ott et al. 2014). Interestingly, those two repeats displayed a comparably high 5mC level
as the silenced repeats (Muller-Ott et al. 2014). Thus, another factor than 5mC must
contribute to MECP2 and  downstream  to SUV39H immobility. This hypothesis is
indirectly supported by the ﬁnding that SUV39H1 mobility increases only slightly upon
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DNA demethylation after treatment with 5-aza-C (Krouwels et al. 2005). Even though 5-
aza-C treatment leads to a pronounced reduction of 5mC and MECP2 at PCH, a fraction
of MECP2 remained rather immobilized (Ghosh et al. 2010) which might be indicative
of tethering through another factor or binding to unmethylated chromatin as shown for
human MECP2 in vitro (Georgel et al. 2003). To further explore the linkages between
the 5mC/MECP2 and the SUV39H/HP1/H3K9me3 pathway, it would be interesting to
explore if reintroduction of SUV39H into 5-aza-C-treated SUV39H dn iMEFs would also
rescue the PCH state.
Finally, the possibility that SUV39H1 remains chromatin-bound throughout all cell
cycle stages thereby acting as a `bookmark' to denote major satellite repeats as sites
to reestablish PCH after DNA replication and cell division was explored. These experi-
ments revealed that a fraction of SUV39H1 remained indeed chromatin-bound at all times
(Fig. 12). SUV39H1 was also detected at nascent chromatin right after DNA replication
along with the DNA methyltransferase DNMT1 and the HP1 proteins (Alabert et al.
2014), which is critical for a `bookmarking' factor. Notably, sparsely distributed tightly
bound PCH complexes (Fig. 39a) are suﬃcient to (re)establish PCH domains (Muller-
Ott et al. 2014). Thus, the high aﬃnity complexes might remain chromatin-bound at
major satellite repeats throughout the cell cycle and reestablish PCH after cell division,
whereas the fraction of loosely bound components dissociates (Fig. 39b).
Figure 39: PCH-speciﬁc, stably chromatin-bound complexes centered around
SUV39H/HP1/H3K9me3 and possibly 5mC/MECP2 remain chromatin-bound
throughout the cell cycle. (a) Stably bound PCH complexes (blue background) along-
side more transiently associated H3K9me3- and 5mC-binding proteins as observed during G1
phase. The gray non-histone protein next to MECP2 and 5mC could be an additional factor
that stabilizes MECP2 at PCH. (b) PCH during G2 phase and mitosis. Rather loosely bound
proteins dissociate and get diluted during cell division, whereas some stably bound PCH com-
plexes remain chromatin-bound. Figure adapted and modiﬁed from (Muller-Ott et al. 2014).
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III.2 Loss of SUV39H2 inﬂuenced global and local H3K9me3 lev-
els
The current view is that the two isoforms of the SUV39H KMT play redundant roles in
the establishment of H3K9me3 at least during embryonic development (O'Carroll et al.
2000, Peters et al. 2001). However, SUV39H2 had a greater inﬂuence on global H3K9me3
levels (western blot analysis, Fig.17a) and PCH H3K9me3 (microscopy and ChIP-seq,
Fig.17b-d). The SUV39H2 sn cell line E480-2 showed intact global H3K9me3, but re-
duced PCH H3K9me3 (Supplementary Fig. S1), indicating that the eﬀect on global
H3K9me3 levels might have been compensated by other KMTs. Some SUV39H2-deﬁcient
cells displayed wt levels of H3K9me3 and HP1 at chromocenters (e. g. the upper right cell
depicted in Fig.17b, row 3). Thus, SUV39H1 can in principle maintain intact PCH in
the absence of SUV39H2, but might not always be targeted to pericentromers leading to
a loss of H3K9me3 at PCH in some cells (e. g. the lower left cell depicted in Fig.17b, row
3). This is consistent with the previous ﬁnding that transfected SUV39H1 can reestablish
PCH H3K9me3 in SUV39H dn iMEFs (Krouwels et al. 2005). Furthermore, a contribution
of SUV39H1/2 to targeting other PCH components to pericentromeres has recently been
proposed (Johnson et al. 2017, Velazquez Camacho et al. 2017). Taken together, both
SUV39H1 and SUV39H2 seem to be able to set H3K9me3 in living cells. SUV39H2, how-
ever, might have a more prominent role in targeting pericentromers, thereby guiding other
PCH components. A detailed analysis of reintroduced SUV39H constructs into SUV39H
dn cells and their eﬃciency in correctly localizing to PCH and reestablishing H3K9me3
might be a starting point to uncover the cause of the heterogeneity observed even within
one cell line (as shown in Fig.17b, row 3). All but one of the 23 mappable, interspersed
GSATs analyzed here displayed high levels of H3K9me3 (>3-fold above genomic aver-
age) in wt iMEFs and even higher levels in mESCs. All normalized GSAT H3K9me3
levels were in the range of 2.5- to 4.5-fold above genomic average (Fig. 19a). Hence, the
substantial diﬀerences in H3K9me3 that depended on the presence of TF binding sites
within the interspersed repeats (Bulut-Karslioglu et al. 2012) was not observed here. Im-
portantly, only 23 of the 42 described intergenic GSATs have been considered here, since
the other 19 showed insuﬃcient input coverage (i. e. <30% of the genome average input
coverage) and were thus considered unmappable. Loss of either one of the SUV39H
isoforms led to a substantial decrease of H3K9me3, which was also observed for the 319
heterochromatic regions and the 179 genes that were mappable and highly methylated in
wt iMEFs (Fig. 19). In all cases  i. e. interspersed GSATs, heterochromatic regions and
genes  SUV39H2 had a greater inﬂuence on H3K9me3 compared to SUV39H1, which
mirrors the eﬀect of SUV39H2 on global and PCH H3K9me3 levels. Whereas the methy-
lated heterochromatin regions (Fig. 19b) display a uniformly lower H3K9me3 level in
SUV39H-deﬁcient cells compared to wt iMEFs, the highly methylated genes showed a
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bimodal distribution with a group of genes being aﬀected by loss of SUV39H and a group
of genes being SUV39H-independently trimethylated at H3K9 (Fig. 19c). As described
elsewhere, the latter group might be regulated by G9A (Ogawa et al. 2002, Roopra et al.
2004) or SETDB1 (Ayyanathan et al. 2003, Schultz et al. 2002). The overall H3K9me3
levels of genes in iMEFs were rather low compared to the genomic average or repetitive
sequences. This ﬁnding is consistent with the notion that terminal silencing in diﬀerenti-
ated cells is governed by DNA methylation rather than histone modiﬁcations (Bird 2002,
Bulut-Karslioglu et al. 2014).
III.3 Loss of SUV39H/H3K9me3-dependent heterochromatin is
neither necessary nor suﬃcient for transcription activation
Despite being generally considered a silencing histone modiﬁcation, the exact interplay of
H3K9me3, particularly SUV39H-dependent H3K9me3, and transcription remains obscure.
Here, four types of SUV39H-dependent H3K9me3 target loci were considered: PCH,
interspersed GSATs, other repeat-rich interspersed heterochromatic regions (HET6387)
and genes. Although H3K9me3 levels and produced RNA were mostly anticorrelated
at PCH (wt, SUV39H1 sn and SUV39H2 sn cell lines, original dn cell line), PCH with
high H3K9me3 in NIH3T3 cells was transcribed nonetheless. In addition, loss of PCH
H3K9me3 in two SUV39H dn cell lines (E124-1 & E124-3) did not activate transcription.
Similar patterns were observed at other loci. In particular, demethylated interspersed
GSATs or heterochromatic regions did not get activated with the exception of two to three
out of 23 GSATs (Fig. 21a). Interestingly, some of the regions showed basal transcription
(>1 RPKM) even if highly H3K9 trimethylated in wt iMEFs (Fig. 21a,b) indicating that
the silencing marks can be overruled by some activating signals. This was even more pro-
nounced for the highly methylated protein-coding RefSeq genes, where 54 out of 119 genes
(∼45%) had RNA expression values >1 RPKM. In addition, the group of genes that was
demethylated in SUV39H-deﬁcient cells (genes in the left peak in Fig. 19c) was not gen-
erally derepressed, but if their RNA expression changed, it mostly increased (Fig. 21d).
Those results are consistent with the notion that SUV39H-dependent H3K9me3 stabi-
lizes a silenced state and protects genomic loci against sporadic activation. Nevertheless,
it can be overruled by strong and/or targeted activation (Fig. 40). The latter could
be the case in the presence of a strong exogenous factor such as a viral activator (see
below) or the activation of a signaling cascade due to extracellular signals, such as stim-
ulation of immune response genes upon interferone signaling (Platanias 2005). One of
the few genes that was strongly derepressed upon loss of one or both of the SUV39H iso-
forms is located within a larger (∼1 Mb) H3K9me3 domain that was SUV39H-dependent
(Fig. 22a). Disruption of this heterochromatin domain did not signiﬁcantly derepress
any of the neighboring genes, suggesting again that loss of H3K9me3 was not suﬃcient
74 III DISCUSSION
to activate transcription, but that an additional activating factor was required. Finally,
changes in H3K9me3 levels within the gene body might not change total transcript levels.
Instead, diﬀerential H3K9me3 could aﬀect splicing as suggested elsewhere (Saint-Andre
et al. 2011, Yearim et al. 2015).
Figure 40: The role of SUV39H-dependent H3K9me3 domains in the regulation
of transcription. Intact heterochromatin (left) stabilizes a transcriptionally silent state (top)
by suppressing sporadic activation of genomic elements such as repeats or genes, but can be
overruled by a strong activating signal (bottom). Loss of SUV39H2 or both SUV39H enzymes
leads to partial or complete loss of SUV39H-dependent heterochromatin (right) resulting in
transcriptional derepression or compensation possibly by SUV39H1 and DNA methylation or
other silencing machineries (e. g. Polycomb/H3K27me3 (Saksouk et al. 2014)). It seems likely
that impaired heterochromatin would also be readily activated in the presence of a strong or
targeted activator independently of compensatory mechanisms (bottom, right). Light blue area:
H3K9me3 domain; grey area: other silencing domain (e. g. H3K27me3); grey ellipses: other
heterochromatin proteins (e. g. MBDs); wavy black lines: RNA transcripts.
Last, a common set of 109 genes was diﬀerentially expressed in the respective SUV39H1/2
sn and SUV39H dn cell lines as determined by DESeq2 (log2-fold change >3, padj < 0.01).
However, only two of those genes were highly methylated at H3K9 in the ﬁrst place and
then demethylated upon loss of SUV39H. Thus, the observed expression changes did not
directly depend on H3K9me3. Interestingly, PAX3 and PAX9 that have been implicated in
targeting SUV39H-dependent heterochromatin (Bulut-Karslioglu et al. 2012) were among
the common diﬀerentially expressed genes. Although they have been described as redun-
dant regulators of heterochromatin, expression of PAX3 was downregulated >10-fold and
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PAX9 expression was upregulated >10-fold, indicating that they are regulated diﬀerently
in the context of SUV39H loss and might therefore also have unique functions.
The H3K9me3 level of the 45 commonly downregulated genes (Fig. 22b) tended
to be higher. This is consistent with H3K9me3 being a silencing mark, but appears
counterintuitive as one or two KMTs are missing in those cell lines. This could, however,
be explained by overcompensation of the loss of SUV39H through other H3K9 KMTs.
Contrarily, the 64 commonly upregulated genes showed no clear trend regarding their
change in H3K9me3. Taken together, the diﬀerential gene expression in the diﬀerent
SUV39H knock-out cell lines is probably not directly related to gene body H3K9me3.
A detailed analysis of H3K9me3 changes at regulatory elements  i. e. promoters and
enhancers  and their relation to transcriptional activation or silencing might elucidate
the functional links between loss of SUV39H and diﬀerential gene expression.
III.4 BLInCR is a rapid and reversible tool to target a variety of
subnuclear structures
To test if a bona ﬁde heterochromatic locus can be activated by a strong activator as
suggested above (Fig. 40) and to analyze the kinetics of this activation, the versatile light-
inducible recruitment system BLInCR was devised. Therefore, CIBN was recruited to
various nuclear subcompartments, e. g. telomeres or nucleoli in the human osteosarcoma
cell line U2OS 2-6-3, via fusions with compartment-speciﬁc proteins (in this case TRF1/2
or nucleolin, respectively). This led to a relocalization of PHR-tagged eﬀectors to those
CIBN-tagged compartments upon illumination with blue light (Fig. 23). The BLInCR
system was also functional in a MEF cell line for targeting PCH foci (Fig. 24). So far,
all proteins could be tagged with CIBN without compromising their nuclear localization,
which was also reported in another study that used CIB1-TRF1 fusion constructs in HeLa
cells (Choudhury et al. 2016). In principle, switching the optogenetic tags, i. e. tethering
PHR to localizer proteins and recruiting CIBN-tagged eﬀectors would be an intriguing
modiﬁcation of BLInCR, because PHR is the component that changes its conﬁrmation
upon light exposure and it would be rather immobilized. Thus, one could illuminate only
part of a cell, e. g. half of the nuclear lamina, which would only target a CIBN-tagged
eﬀector to that part of the cell and create an intrinsic negative control (the unilluminated
part of the cell). Unfortunately, a CIBN-tagged ﬂuorophore could not be targeted to
the nuclear lamina when cotransfecting the cells with PHR-tagged hLaminB1 fusions,
irrespective whether the tag was N- or C-terminal (data not shown). This is, however,
probably a lamina-speciﬁc eﬀect, since CIB1-tagged activators have been successfully
recruited to DNA-tethered CRY2 (Konermann et al. 2013, Pathak et al. 2017, Taslimi
et al. 2016). As the lamina is a complex protein network with tight interactions between
copolymerized lamin proteins (as reviewed in (Herrmann & Aebi 2004)), hLaminB1-fused
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PHR might be sterically blocked which could prevent its conformational change upon
illumination. In any case, the suitability of BLInCR or its modiﬁed version with switched
tags would need to be assessed in the respective cell line with the respective constructs.
This is facilitated by the large collection of human and mouse CIBN and PHR constructs
described in this work (Table 6).
The recruitment kinetics of a number of eﬀector constructs were analyzed and the
characteristic time to reach half-maximal levels was in the range of 10-23 s (Fig. 25),
which is faster than conventional inducible systems based on chemically induced dimer-
ization. Importantly, the recruitment kinetics depend on the number of binding sites and
on the concentration of the recruited molecule (Normanno et al. 2015). In the experi-
ments presented here, cells expressing rather low amounts of the transfected constructs
were chosen to avoid pre-recruitment of the eﬀector in the dark. Doxycycline-induced
binding of ﬂuorescently tagged reverse TetR constructs at low concentrations has charac-
teristic recruitment times in the order of 100 s, i. e. about an order of magnitude slower
than BLInCR (Normanno et al. 2015). Tamoxifen- or LINuS-induced nuclear import
and subsequent binding of a DBD to a reporter promoter is another order of magnitude
slower with characteristic recruitment times in the order of 10-20 min (Niopek et al. 2014,
Rafalska-Metcalf et al. 2010). It should be noted that LINuS and BLInCR also depend
on the illumination pattern and light intensities, which were not comparable, but this is
not expected to make a 100-fold diﬀerence. Recruitment of constructs containing either
VP16 or hGCN5 were recruited faster than PHR-YFP control constructs. Assuming that
the two globally ﬁtted rates k1 and k2 correspond to the PHR-CIBN and the PHR-PHR
association, VP16 and hGCN5 might limit PHR-PHR oligomerization due to their high
concentration of negative charge and size, respectively. To test this hypothesis, eﬀector
concentrations could be measured to assess if the steady state amount of recruited PHR
was lower for VP16- and hGCN5-containing constructs. Alternatively, an oligomerization-
deﬁcient PHR version such as CRY2 [1-507] (F507D) (Park et al. 2017) could be used to
check if PHR-YFP control constructs would reach steady state levels faster and/or recruit-
ment curves could be ﬁtted with a single rate. For the purpose of transcription activation
described below, the details of recruitment were rather unimportant as long as signiﬁcant
amounts of VP16 accumulated around the promoter within seconds, which was the case
(Fig. 25). It should be noted that a new optogenetic system, magnets, has been shown
to achieve accumulation with characteristic recruitment times as low as 1.5 s (Kawano
et al. 2015). Last, the system was reversible on the time scale of minutes (t1/2 =∼5 min)
with no eﬀector detectable after 15-20 min (Fig. 26). This is an intermediate half-life
time compared to other optogenetic systems such as magnets (t1/2 =∼7 s, (Kawano et al.
2015)) or PHYB that remains in its active conﬁrmation for hours after induction if not
reversed by illumination with a far-red light pulse (Ni et al. 1999). For analyzing the
activation kinetics of a reporter locus as conducted here, the time scale of reversibility in
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the order of minutes was suitable as constant presence of signiﬁcant amounts of activator
at the array could be achieved with imaging every 2 to 5 minutes, which was acceptable
with respect to laser-induced phototoxicity and photobleaching.
The main limitations of BLInCR are (i) the use of fusion constructs that might impair
localizer or eﬀector function, (ii) the level of transfected PHR-eﬀector constructs, which
can cause leakiness in the dark if too high and, (iii) the transfected eﬀector constructs
that are present (and possibly active) before illumination. The ﬁrst is an issue of fusion
constructs in general and thus has to be tested for each BLInCR design. The second
is not problematic for single live cell experiments, because cells with appropriate trans-
fection levels can be selected. For bulk experiments, the generation of stable cell lines
with low expression values should be considered. The third point strongly depends on
the eﬀector: VP16 has been described to only activate genes to whose promoter it is
speciﬁcally targeted to (Polstein et al. 2015). In other cases such as targeting the FokI
DNA endonuclease to telomeres (as in (Tang et al. 2013) via fusion to TRF1), this might
be more problematic since freely available PHR-FokI would cut in the proximity of any
GGATG sequence in the genome (Sugisaki & Kanazawa 1981). This limitation might
be overcome by using an additional blue light-dependent optogenetic approach that in-
activates the eﬀector, e. g. by caging a functional peptide using LOV domain-dependent
TULIPs (Strickland et al. 2012). In summary, BLInCR is a versatile, rapid and reversible
tool to increase local eﬀector concentrations that has some inherent limitations due to
the PHR/CIBN system used. However, those limitations can be measured and controlled
for and possibly also improved by implementing recently published modiﬁcations of the
optogenetic components (Taslimi et al. 2016).
III.5 BLInCR is a suitable tool to monitor transcription in living
cells
BLInCR of the viral transcription activator VP16 to the promoter-proximal tetO ar-
ray in the U2OS 2-6-3 reporter cell line (Fig. 27a) eﬃciently activated transcription
(Fig. 27d). Light-dependent nuclear clearance of optogenetic constructs as reported for
PHR-DBD constructs in another reporter system (Pathak et al. 2017) was not observed
here. Activation by VP16 BLInCR worked robustly, but resulted in lower accumulated
RNA levels (Fig. 28d) and in less pronounced decondensation of the reporter array af-
ter constitutive activation (Fig. 32) compared to VP16 recruitment via TetR fusions.
Since light-dependent activation has been shown to depend on the integrated blue light
dose (Kennedy et al. 2010), BLInCR-dependent transcription activation as well as the
associated chromatin structure changes could probably be tuned to mimic endogenous
decondensation (Boettiger et al. 2016). One could speculate that the observed diﬀerence
between activation with BLInCR or fusion constructs might be related to the VP16-DNA
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distance. This distance is probably smaller in the case of fusion constructs. In addi-
tion, it would be interesting to see if the transcriptional output can be modulated by the
light intensity as described for the number of light pulses (Kennedy et al. 2010) or for
two diﬀerent light intensities for yeast (Pathak et al. 2014). Apart from the diﬀerence
in transcriptional output that was due to the recruitment method (BLInCR vs. fusion),
less MS2 RNA was detected when targeting VP16 to lacO compared to tetO. This was
probably due to the distance of lacO to the minimal promoter (∼4,000-13,000 bp), since
all eﬀects of VP16  i. e. recruiting activating factors (Hirai et al. 2010) or perturbing
local nucleosome structure (Erkina & Erkine 2016)  are rather short-distance eﬀects.
Upon recruitment of VP16, GFP-tagged labeled pol II readily accumulated at the
reporter array (Fig. 27c) and IF staining for active pol II marks, i. e. phosphorylation of
serines 2 & 5, was also observed albeit at diﬀerent levels. The initiation-associated pSer5
mark was heavily enriched in all activated cells. In contrast, the elongation-associated
pSer2 mark was far less enriched and not detectable in most cells (Fig. 30). Hence, the
pSer2 mark was not necessary for the release of paused pol II or the pSer2 levels were
below the detection limit. The latter scenario also seems plausible since pSer2 is generally
much more enriched towards the 3' end of transcribed genes (Heidemann et al. 2013). A
single reporter gene might be too short (∼3,000 bp) compared to most human genes with
an average size >10,000 bp (Grishkevich & Yanai 2014) for detectable pSer2 enrichment.
To address this question in more detail, the speciﬁc CTD kinases including CDK7 (pSer5)
as well as CDK9 and CDK12 (pSer2) could in principle also be detected in cells activated
by VP16 BLInCR.
Detection of MS2 RNA via ﬂuorescently labeled MCP is a widely used tool to visualize
on-going transcription in living cells (Darzacq et al. 2009, Larson et al. 2013) and was also
compatible with BLInCR (Fig. 27b). Even though the enrichment of MCP at the array is
not suitable to detect absolute RNA levels, it does represent the cell-to-cell heterogeneity
of RNA accumulation measured by RNA FISH (Fig. 29a,b). For more comparability
between cells, a stable cell line with more homogeneous MCP expression levels would
be helpful. In addition, one could calibrate the measured intensity to absolute reader
particle numbers using ﬂuorescence correlation spectroscopy (FCS) similar to previous
studies characterizing MCP binding (Wu et al. 2012). However, to analyze the kinetics of
transcription activation in single cells, the relative enrichment of MCP over time is also an
informative measure. To read out endogenous RNA species such as GSATs (Fig. 27d,e),
more elaborate detection methods such as molecular beacons (Tyagi & Kramer 1996) or
sticky-ﬂares (Briley et al. 2015) are required. For proof-of-concept experiments, RNA
quantiﬁcation by qRT-PCR is, however, also suitable when high transfection eﬃciencies
are reached. In summary, recruiting a strong viral transcription activator such as VP16
to the proximity of a target promoter via BLInCR allows robust induction of pol II-
dependent transcription. RNA detection via MCP is also suitable for MS2 loop-containing
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transcripts, but can also be realized by PCR-based methods (Fig. 27e,28a). In addition,
coinciding recruitment of other ﬂuorescently tagged eﬀectors such as pol II and RNA
accumulation can also be monitored in living cells.
III.5.1 Transcription-associated changes of the local chromatin environment
can be traced by ﬂuorescently tagged reader domains
After constitutive activation of transcription, changes in the modiﬁcation state of H3K9
were minor, with H3K9ac levels increasing slightly and H3K9me3 levels remaining virtu-
ally unchanged (Fig. 31). Particularly the subtle changes in H3K9ac are in contrast to
the strong hyperacetylation at many histone tail residues observed by others (Rafalska-
Metcalf et al. 2010, Tumbar et al. 1999). Interestingly, Tumbar and colleagues did not
see any hyperacetylation of H3K9 in ∼30% of the cells and only a weak eﬀect in another
∼35%, indicating that strong hyperacetylation of H3K9 is not a universal feature. Since
BLInCR is particularly useful to monitor the consequences of targeting an eﬀector to a
speciﬁc locus in living cells over time, ﬂuorescently tagged reader proteins or protein do-
mains are of particular interest as they can also be used in live cell experiments, e. g. in
addition to the RNA read out. The bromodomain-containing proteins 2 and 4 (BRD2/4)
are particularly interesting candidates as their bromodomains can bind acetylated histones
(LeRoy et al. 2008, Vollmuth & Geyer 2010) and BRD4 is also involved in facilitating the
transition of paused pol II to productive elongation (Jonkers & Lis 2015). They could
therefore serve as live cell readers for acetylated histones and possibly as markers for on-
going transcription. However, both were not recruited to the reporter array activated by
VP16 BLInCR in U2OS 2-6-3 cells (Fig. 33). BRD4 has been shown to be dispensable in
some cases of transcription initiation via a viral activator (Yang et al. 2005), although it
is essential for the activation of stimulus-dependent endogenous genes (Patel et al. 2013).
If the observed absence of BRDs from activated arrays is related to the viral nature of
activation used in this system, it remains confusing why the BRDs are recruited when ac-
tivating transcription using TetR/LacI-VP16 fusion constructs (Fig. 33), which has also
been previously described elsewhere (Rafalska-Metcalf et al. 2010). How independent
acetylation binding and necessary coactivation functions of BRDs at the array are inter-
related is currently an open question. It would be interesting to see if arrays activated by
fusion constructs are enriched for histone acetylation and if they could also be activated
in the absence of BRDs. However, for the advancement of the BLInCR methodology
for live cell monitoring of processes associated with transcription activation, it might be
more feasible to consider ﬂuorescently tagged CDK7 and/or CDK9. The latter factors set
the possibly indispensable phosphorylation marks on the pol II CTD, and could be used
as tracers of actively ongoing transcription as used for live cell imaging of transcription
factories (Ghamari et al. 2013).
H3K9me3 levels at the reporter array were not aﬀected by transcription activation
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as determined from IF staining (Fig. 31). Nevertheless, live cell reader domains for
H3K9me3, namely the mouse chromodomain of HP1β (mCD) and the human ADD do-
main (hADD), were tested on inactive arrays (Fig. 34a). Accumulation of mCD was
more pronounced than hADD accumulation, indicating that the mCD might be a more
suitable H3K9me3 reader domain. Notably, both mCD and hADD showed less accumu-
lation at the array when an array marker (i. e. ﬂuorescently tagged TetR or LacI) was
tethered to the tetO repeats compared to the lacO repeats. DNA binding of TetR and/or
LacI could interfere with H3K9me3 recognition by reader domains. In that case, the ob-
servation would indicate that histones methylated at H3K9me3 are predominantly found
at the tetO repeats close to the promoter. ChIP of H3K9me3 and subsequent qPCR or
DNA sequencing could shed light on the distribution of H3K9me3 within this silenced
locus and might explain the interdependencies of array labeling and histone modiﬁcation
read out. Importantly, some cells with activated arrays as judged by CFP-SKL expres-
sion and/or MCP accumulation showed enrichment of the mCD, although the average
H3K9me3 level was lower in activated cells compared to inactivated ones (Fig. 34). This
is consistent with the notion that H3K9me3 is generally a silencing mark, but cannot
prevent transcription in the presence of a strong, targeted activator (as in Fig. 40c, left).
The H3K9 modiﬁcations monitored here displayed only subtle changes after 24 h of activa-
tion. Hence, tracing those changes at the array in real-time experiments during activation
would not be very insightful here. However, it is in principle possible and recruitment of
diﬀerent (non-viral) activators (e. g. STAT transcription factors) or use of other reader
domains might provide useful to dissect the timing of histone modiﬁcation changes in the
context of transcription activation.
III.5.2 BLInCR adds fast reversibility to the toolbox of live cell transcription
activation methods
Targeting VP16 to tetO in U2OS 2-6-3 cells via BLInCR resulted in RNA accumulation
within minutes after ﬁrst exposure to blue light and dispersion of the signal after dissoci-
ation of the eﬀector in the dark (Fig. 37b,c). A second VP16 recruitment by blue light
resulted in another increase of RNA accumulation, showing that BLInCR can be used to
reversibly trigger eﬀector relocalization within minutes. Light-dependent reversibility is
easier to use than wash-out of e. g. doxycycline and can be controlled more precisely. The
use of far-red ﬂuorescent proteins such as iRFP713 (Filonov et al. 2011) in combination
with established red ﬂuorophores such as tagRFP allowed to quantify both eﬀector and
reader accumulation while avoiding renewed recruitment. Thus, BLInCR can be used
to apply tailored illumination patterns resulting in well-controlled eﬀector accumulation
and dissociation. Combining this methodology with live cell readers for RNA and histone
modiﬁcations, BLInCR is a valuable tool to study epigenetic memory of transcription
states.
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III.6 The time course of transcription activation resolved by BLInCR
reveals a biphasic activation kinetics
First transcripts accumulated rapidly after triggering VP16 accumulation at the array
by BLInCR and reached detectable amounts in less than two minutes in some cells
(Fig. 36a,b). The subsequent lag phase that displayed rather unchanged amounts of
accumulated RNA at the array was followed by another rapid RNA accumulation phase.
The rapid response to the activator of at least some cells in the untreated case and all
cells in SAHA-treated cells is consistent with the idea of a fraction of poised reporter
genes that can be rapidly activated. Histone hyperacetylation after SAHA treatment
could therefore increase this fraction of reporter copies that is poised or primed for ac-
tivation, which seems plausible as H4ac is increased upon SAHA treatment (Fig. 35a)
and might recruit some of the PIC components such as TFIID that has been shown to
interact with acetylated lysine residues on the H4 tail (Jacobson et al. 2000). During
the lag phase, another  inactive or weakly active  fraction of reporters might undergo
a maturation process allowing its delayed activation and consequently increasing levels
of RNA at the array after twenty to forty minutes (Fig. 36a,b). Processes occurring
during this maturation can be diverse. They range from delayed recruitment of coacti-
vators or nucleosome remodeling (Nocetti & Whitehouse 2016, Venkatesh & Workman
2015) to interaction with neighboring actively transcribing reporter genes (Li et al. 2012,
Papantonis & Cook 2013) or relocalization (Therizols et al. 2014) within the array. The
array size did not change during this initial activation phase (Fig. 36b). Thus, massive
decondensation on the scale observable by light microscopy plays no role during this ini-
tial activation phase, but might rather be a downstream eﬀect of transcription. Similarly,
extensive changes in histone modiﬁcations would also not be expected, since they were not
observed after constitutive activation over night (Fig. 31, 34b). Transcription was not
initiated homogeneously across the reporter array (Fig. 36a). Accordingly, the notion
that spatially distinct compartments within the array exist and need to contact or spread
to other loci also seems reasonable. Promoters functioning as speciﬁc enhancers for other
genes (Dao et al. 2017, Diao et al. 2017) as well as promoter-promoter interactions within
a gene cluster have been described recently (Corrales et al. 2017). These could contribute
to enhanced activation of repressed genes. As for the corecruitment of eﬀectors, BLInCR
is well-suited tool to monitor the recruitment kinetics of components that are not directly
recruited by BLInCR (e. g. GFP-RPB1 as in Fig. 36c). Notably, simulations revealed
that rapid recruitment as achieved by BLInCR and time-resolved detection of RNA as
realized by RNA detection in living cells is required to resolve the biphasic kinetics of
transcription activation (Rademacher et al. 2017).
Assessing the persistence of the actively transcribing state proved diﬃcult in live cells
due to extensive bleaching of iRFP713 and heterogeneous responses across single cells
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(Fig. 37b,c). However, an initial experiment using qRT-PCR as a read out showed that
RNA levels decayed after removing the light trigger (Fig. 37d). This ﬁnding indicates
that the actively transcribing state cannot be maintained in the absence of the activating
eﬀector. Other studies that have probed the persistence of the transcriptionally silent
state reported varying results. In some cases, silencing modiﬁcations depended directly
on the presence of an eﬀector (Kungulovski et al. 2015) or no memory was observed after
mitotic division (Brueckner et al. 2016). This is in contrast to induced silent states that
can display prolonged persistence for hours or days without the initial trigger (Bintu et al.
2016, Hathaway et al. 2012).
Taken together, even a strong activator such as VP16 cannot activate a gene array in
a single step, but requires some maturation or rearrangement to result in enhanced acti-
vation (Fig. 41). In addition, rapid initial activation was modulated by hyperacetylation
of histones after treatment with the histone deacetylase inhibitor SAHA. Finally, tran-
scription activity was decreased or shut down when the eﬀector was no longer recruited
to the reporter.
Figure 41: Biphasic activation model of a gene array. In the initial rapid activa-
tion phase, a fraction of poised or primed reporters gets activated producing detectable RNA
amounts within ∼2 min. During the maturation phase, repressed promoters get activated lead-
ing to enhanced transcription after 20-40 min. Upon loss of the activating eﬀector in the dark,
transcription activity ceases leading to a gradual decrease of total RNA. Figure adapted from
(Rademacher et al. 2017).
III.7 Conclusion and perspectives
The mechanisms by which the genome compartmentalizes into distinct functional units
within the nucleus after cell division are diﬃcult to dissect experimentally and might vary
for diﬀerent compartments. In this study, the speciﬁcity and memory of the SUV39H/H3K9me3-
dependent heterochromatic state was analyzed. The results obtained here showed: i) that
the H3K9me3 `writer' enzyme SUV39H1 remains chromatin-bound throughout the cell cy-
cle and ii) that the mobility of the methyl-DNA-binding protein MECP2 was independent
of SUV39H. Therefore, SUV39H1 might `bookmark' heterochromatic sites throughout cell
division and contribute to targeting other heterochromatin factors to those sites after mi-
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tosis. In addition, MECP2 could also be a factor that actively guides SUV39H enzymes to
their sites of action. In this case, the pressing questions are, how MECP2 speciﬁcity can
be explained and if MECP2 is another bookmarking factor that might also contribute to
SUV39H binding to chromatin during mitosis. In established SUV39H-centered domains
such as PCH, both isoforms of the histone methyltransferase are enriched, which might
confer stability to the heterochromatic state of the domain. Analysis of SUV39H1/2 sin-
gle null iMEFs revealed that the function of both isoforms is not completely redundant
and that SUV39H2 contributes more to H3K9me3 at PCH. The same trend was also
observed in a genome-wide analysis of interspersed heterochromatic repeats and genes.
However, SUV39H-dependent H3K9me3 did not always repress transcription and its loss
only sporadically led to derepression of the respective regions. This raised the question
how the activation of a heterochromatic locus proceeds. Therefore, the activation of
a bona ﬁde heterochromatic reporter locus in the U2OS 2-6-3 cell line was dissected in
single living cells. To be able to precisely trigger activation, the Blue Light-Induced Chro-
matin Recruitment (BLInCR) tool was devised. It allowed to trigger the relocalization
of the strong viral activator VP16 to the reporter locus by light. Using this technique,
transcription was rapidly activated, showing that the heterochromatic state can be over-
written by a strong activator and that activation was upstream of histone modiﬁcations
or large-scale chromatin rearrangements. VP16 targeting by BLInCR also revealed that
activation of a heterochromatic gene cluster was biphasic and that histone acetylation
inﬂuenced the shape of the activation curve. BLInCR can also be used to disturb the epi-
genetic landscape at genomic loci by targeting epigenetic modiﬁers such as demethylases
or acetyltransferases to further elucidate the role of histone modiﬁcations in silencing and
activation.
In summary, mechanistic details on speciﬁcity and memory of endogenous SUV39H-
dependent silencing and the contribution of the diﬀerent SUV39H isoforms were dissected
here. In combination with the analysis of the light-induced activation kinetics of a hete-
rochromatic locus, those results provide insight into the establishment and maintenance
as well as on the stability of this chromatin state. I envision that understanding the un-
derlying principles of silencing and activating heterochromatin will be instrumental in the
identiﬁcation of drug targets and the development of epigenetic drugs, because epigenetic
deregulation and aberrant transcription of repetitive sequences are frequently observed in
cancer and other diseases.
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IV Materials & Methods
IV.1 Materials
Table 6: Plasmids constructed within my thesis work.
construct name
CloneX
ID
construct name
CloneX
ID
CIBN constructs PHR constructs
CIBN-tagBFP-hLaminB1 776 PHR-EYFP 835
CIBN-EYFP-hLaminB1 816 PHR-EYFP-NLS 986
CIBN-tagBFP-hLaminB1-IRES2 821 PHR-mCherry-NLS 1006
CIBN-tagBFP-hLaminB1-IRES2-mCherry 825 PHR-EYFP-VP16 836
CIBN-tagBFP-hLaminB1-IRES2-GBP-PHR 831 PHR-mCherry-VP16 948
CIBN-tagBFP-TetR 929 PHR-EYFP-hPMLIII 937
CIBN-EYFP-TetR 930 PHR-mCherry-hPMLIII 942
CIBN-TetR 865 PHR-EYFP-CDK1AF 962
CIBN-TetR-tagRFP-T 875 PHR-mCherry-CDK1AF 963
CIBN-tagBFP-hTRF1 943 PHR-EYFP-hGCN5 1003
CIBN-EYFP-hTRF1 944 PHR-EYFP-hGCN5mut 1004
CIBN-hTRF1-tagRFP-T 945 PHR-EYFP-hGCN5-NLS 1005
CIBN-tagBFP-hTRF2 931 PHR-EYFP-NBS1 1007
CIBN-EYFP-hTRF2 932 PHR-mCherry-NBS1 1008
CIBN-hTRF2-tagRFP-T 946 PHR-EYFP-hHP1β 1011
CIBN-tagBFP-hNCL 933 PHR-mCherry-hHP1β 1010
CIBN-EYFP-hNCL 934 hLaminB1-PHRa) 797
CIBN-tagBFP-hPMLIII 935 PHR-tagBFP-hLaminB1a) 817
CIBN-EYFP-hPMLIII 936
CIBN-EYFP-mHP1β 1013 reader domains
CIBN-mSUV39H1 1089 mCherry-mBrd2 964
CIBN-EYFP-mSUV39H1 1086 mKate2-mBrd2 869
CIBN-EYFP-mSUV4-20H2 1087 mCherry-MS2 876
CIBN-mCherry 815 CFP-MS2 947
tagBFP-MS2 941
ﬂuorescently tagged eﬀectors hADD-mKate2 926
EGFP-mSUV39H1-∆N89 698 hADD-CFP 927
mSUV39H1-∆N89-EGFP 699 hADD-tagBFP 928
mSUV39H1-∆N89-tagRFP 700 mCD-CFP 883
Flag-mSUV39H1-∆N89 701 mCD-tagBFP 882
EGFP-mSUV39H2 789 mCherry-mB2BDb) 866
EGFP-CDK1AF 961 mKate2-mB2BDb) 870
EGFP-CyclinB∆aa1-166 1009 mCherry-mBRD4b) 867
EYFP-hLaminB1 790 mKate2-mBRD4b) 871
mCherry-mB4BDb) 868
other LacI/TetR fusion proteins
hNCL-EGFP-LacI 949
hNCL-CFP-LacI 950
tagBFP-LacI-VP16 775
tagBFP-TetR-VP16 873
GFP-TetR-VP16 874
a) These constructs did not work as they did not lead to CIBN-mKate2-NLS accumulation upon illumi-
nation with blue light. b) These constructs did not work in the sense that they did not accumulate when
co-transfected with any VP16 construct.
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Table 7: Other plasmids used.
construct name
CloneX
ID
source/comment
PAX3-GFP 645 (Bulut-Karslioglu et al. 2012)
PAX5-GFP 646 (Bulut-Karslioglu et al. 2012)
PAX7-GFP 647 (Bulut-Karslioglu et al. 2012)
PAX9-GFP 648 (Bulut-Karslioglu et al. 2012)
pCIBN(deltaNLS)-
pmGFP
795 Addgene #26867 (Kennedy et al. 2010), cloning of CIBN
pCRY2PHR-mCherry-N1 796 Addgene #26866 (Kennedy et al. 2010), cloning of PHR
pGEX-GP-2-ATRX ADD 851 Addgene #59698/A. Jeltsch lab, cloning of hADD
pAdEasy Flag GCN5 854
Addgene #14106 (Lerin et al. 2006), cloning of human GCN5
constructs
pAd-Track Flag GCN5
Y621A/P622/A
855
Addgene #14425 (Lerin et al. 2006), cloning of human
GCN5mut
GFP-RPB1 1242
largest pol II subunit for live cell imaging (Sugaya et al.
2000), from Jan Ellenberg (EMBL)
YFP-mBRD2 862
as a reader and for cloning of other Brd2 constructs
(Rafalska-Metcalf et al. 2010)
YFP-mBRD4 863
as a reader and for cloning of other Brd4 constructs
(Rafalska-Metcalf et al. 2010)
GFP-MECP2 597 (Schmiedeberg et al. 2009)
pEGFP-MS2_coat 547 J.-Philipp Mallm; cloning of MS2
GBP-TetR 809 F. Erdel; cloning of TetR
GBP-PHR 830 F. Erdel; cloning of GBP-PHR IRES2 constructs
PHR-hLaminB1 777 F. Erdel; cloning of PHR-hLaminB1 constructs
CIBN-EYFP-hLaminB1 816 F. Erdel; cloning of hLaminB1
CIBN-EYFP-hSUV39H1 1085 F. Erdel
CIBN-LacI 828 F. Erdel
CIBN-mKate2-NLS 791 F. Erdel
mCD-mKate2 628
F. Erdel; chromodomain of mouse HP1β, H3K9me3 reader
(Muller-Ott et al. 2014) and cloning of other mCD constructs
CIBN-LacI-tagRFP-T 853
K. Mueller-Ott/Ronja Rappold; cloning of
CIBN-. . . -tagRFP-T
PHR-iRFP713 991 J. Trojanowski
PHR-iRFP713-VP16 994 J. Trojanowski
GFP-LacI-VP16 264 I. Chung; cloning of VP16 and LacI
EGFP-N1 mSUV39H1 527 K. Mueller-Ott/C. Bauer; cloning of mSuv39h1-∆N89
SUV39H2-EGFP 440 Schotta lab/ K. Mueller-Ott; cloning of SUV39H2
CMeGFP-mSUV39H1 432 C. Bauer, cloning of mSUV39H1
CMeGFP-mouseHP1β 420 C. Bauer, cloning of mHP1β
pTRE3G-ZsGreen 718 K. Deeg; cloning of IRES2
EGFP-C1-TRF2 231 T. Jegou (Jegou et al. 2009); cloning of hTRF2
EGFP-C1-PMLIII 273 T. Jegou (Jegou et al. 2009); cloning of hPMIII
CFP-LacI 239 T. Jegou
RFP-NCL 897
M. Caudron-Herger (Caudron-Herger et al. 2015); cloning of
hNCL
pEGFP-N1_TRF1 837 D. Braun/I. Chung (Chung et al. 2011); cloning of hTRF1
p2GFP-NBS1 576 I. Chung/(Lukas et al. 2003), cloning of NBS1
ECFP-HP1β 558 I. Chung, cloning of hHP1β
CDK1AF-containing
plasmid
- from Pierre Wehler (Barbara Diventura group)
tagBFP-containing
plasmid
- from Ashish Goyal (Sven Diederichs devision)
ENTR221-CyclinB 1012 DKFZ core facility (clone 14754003)
SUV4-20H2-GFP 505
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Table 8: Cell lines used within this thesis.
cell line
CloneX
ID
source/comment
NIH3T3 370 commercial (DSMZ)
NIH3T3 675 (Muller et al. 2009)
iMEF wild type 669 (Peters et al. 2001)
iMEF SUV39H double
null
668 (Peters et al. 2001)
NIH3T3 SUV39H1-GFP 369
Thomas Jenuwein (MPI Freiburg), doxycyline-inducible
SUV39H1-GFP expression
iMEF E469-2 706 Gunnar Schotta (LMU Munich), SUV39H1 single null
iMEF E469-3 707 Gunnar Schotta (LMU Munich), SUV39H1 single null
iMEF E471-2 708 Gunnar Schotta (LMU Munich), SUV39H2 single null
iMEF E480-2 710 Gunnar Schotta (LMU Munich), SUV39H2 single null
iMEF E480-6 709 Gunnar Schotta (LMU Munich), SUV39H2 single null
iMEF E124-1 807 Gunnar Schotta (LMU Munich), SUV39H double null
iMEF E124-3 808 Gunnar Schotta (LMU Munich), SUV39H double null
mESC wt26 804
Gunnar Schotta (LMU Munich), ESC wild type control
(original, with FBS)
U2OS 2-6-3 809 David Spector & Susan Janicki (Janicki et al. 2004)
Table 9: Antibodies used within this thesis.
antigen/speciﬁcation host
dilution/
amount
source/comment
H3K9me3 rabbit
1:500 (IF)
1:1000 (WB)
4 µg (ChIP)
Abcam #8898
H3 rabbit 4 µg (ChIP) Abcam #1791
normal IgG rabbit 4 µg (ChIP) R&D Systems #AB-105-C
H3K9me3 rabbit 1:1000 (WB) ActiveMotif #39161
H3K9ac rabbit 1:1000 (WB) ActiveMotif #39137
H3K27ac rabbit 1:1000 (WB) Abcam #4729
H4ac rabbit 1:2000 (WB) Millipore #06-866
H3 mouse 1:1000 (WB) Cell Signaling Technology #14269
rabbit IgG, HRP-linked goat 1:2000 (WB) Cell Signaling Technology #7074
mouse IgG, HRP-linked horse 1:2000 (WB) Cell Signaling Technology #7076
HP1α mouse 1:300 (IF) Euromedex (2HP-1H5-AS)
H3K9ac rabbit 1:500 (IF) ActiveMotif #39917
GFP rabbit 1:500 (IF) Abcam #290
RNA pol II CTD phospho Ser2 rat 1:100 (IF) clone 3E10, ActiveMotif #61083
RNA pol II CTD phospho Ser5 rat 1:100 (IF) clone 3E8, ActiveMotif #61085
mouse IgG, Alexa Fluor
488-linked
goat 1:500 (IF) Life Technologies #A11029
rabbit IgG, Alexa Fluor
568-linked
goat 1:500 (IF) Life Technologies #A11036
rat IgG, Alexa Fluor 647-linked goat 1:500 (IF) Life Technologies #A21247
IF: immunoﬂuorescence, WB: western blot, ChIP: chromatin immunoprecipitation.
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Table 10: Buﬀer composition.
buﬀer application composition pH
phosphate buﬀered saline (PBS) universal
1.7 mM KH2PO4, 137 mM NaCl,
10 mM Na2HPO4, 2.7 mM KCl
7.2
Tris EDTA (TE) universal 10 mM Tris, 1 mM EDTA 8.0
Tris base, acetic acid, EDTA
(TAE)
cloning
40 mM Tris, 13.8 mM C2H4O2, 1 mM
EDTA, pH 8.0
Tris buﬀered saline (TBS) WB 50 mM Tris-HCl, 150 mM NaCl 7.5
SDS running buﬀer WB
25 mM Tris, 192 mM glycine, 0.1% w/v
sodium dodecyl sulfate (SDS)
transfer buﬀer WB
25 mM Tris, 192 mM glycine, 0.5% w/v
SDS, 20% v/v methanol (added before
use)
CSK buﬀer RNA-FISH
100 mM NaCl, 300 mM sucrose, 3 mM
MgCl2, 10 mM
piperazine-N,N'-bis(2-ethanesulfonic
acid) (PIPES), 0.5% Triton X-100
saline-sodium citrate (SSC) RNA-FISH
150 mM NaCl, 15 mM Na3C6H5O7
(trisodium citrate)
7.0
hybridization buﬀer (2×) RNA-FISH 4× SSC, 20% dextrane sulfate, 2 mg/ml
bovine serum albumin (BSA)
swelling buﬀer ChIP-seq
25 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (Hepes)
pH7.8, 1 mM MgCl2, 10 mM KCl, 0.1%
NP-40, 1 mM Dithiothreitol (DTT),
COMPLETE protease inhibitor (Roche,
Germany), 0.5 mM
phenylmethylsulfonyl ﬂuoride (PMSF)
7.8
MNase buﬀer ChIP-seq
25 mM KCl, 4 mM MgCl2, 1 mM
CaCl2, 1× protease inhibitor (Cell
Signalling, UK), 50 mM Tris/HCl pH7.4
7.4
sonication buﬀer (1×) ChIP-seq
10 mM Tris pH8.0, 200 mM NaCl,
1 mM EDTA, 0.5% N-lauroylsarcosine,
0.1% Na-deoxycholate
8.0
elution buﬀer ChIP-seq
50 mM Tris pH8.0, 1 mM EDTA, 1%
SDS, 50 mM NaHCO3
8.0
high-salt buﬀer ChIP-seq
50 mM Hepes pH7.9, 500 mM NaCl,
1 mM EDTA, 1% Triton X-100, 0.1%
Na-deoxycholate, 0.1% SDS
7.9
Li buﬀer ChIP-seq
20 mM Tris pH8.0, 1 mM EDTA,
250 mM LiCl, 0.5% NP-40, 0.5%
Na-deoxycholate
8.0
iT buﬀer RNA-seq
25 mM Tris-HCl, 137 mM NaCl, 5 mM
KCl, 0.3 mM Na2HPO4, 0.5 mM
MgCl2, 0.7 mM CaCl2
7.5
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Table 11: Primers and probes used in this thesis.
probe/primer application remarks sequence
Atto565-labeled
MS2 probea)
RNA-FISH 5'-label
5'-GTC GAC CTG CAG ACA TGG GTG ATC
CTC ATG TTT TCT AGG CAA TTA-3'
(Goodier et al. 2010)
human actin
primer
qRT-PCR
length of main
fragment: 194 bp
fw: 5'-TCC CTG GAG AAG AGC TAC GA-3'
rv: 5'-AGC ACT GTG TTG GCG TAC AG-3'
CFP/SKL
primerb)
qRT-PCR
length of main
fragment: 104 bp
fw: 5'-GTC CGG ACT CAG ATC TCG A-3'
rv: 5'-TTC AAA GCT TGG ACT GCA GG-3'
mouse GSAT
primer
qRT-PCR
length of main
fragment: 126 bp
fw: 5'-TGG CGA GAA AAC TGA AAA TCA
CG-3'
rv: 5'-TCT TGC CAT ATT CCA CGT CCT
AC-3'
mouse actin
primer
qRT-PCR
length of main
fragment: 133 bp
fw: 5'-TAT CCT GAC CCT GAA GTA CC-3'
rv: 5'-CTC GGT GAG CAG CAC AGG G-3'
mouse GAPDH
primer
qRT-PCR
length of main
fragment: 125 bp
fw: 5'-TAT GTC GTG GAG TCT ACT GG-3'
rv: 5'-ACA CCC ATC ACA AAC ATG GG-3'
a) from T. Pankert; b) designed by J. Trojanowski.
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IV.2 Methods
IV.2.1 Molecular cloning
Within this thesis, I cloned 42 optogenetic constructs, 15 ﬂuorescently tagged reader do-
mains and 13 other ﬂuorescently tagged eﬀector constructs. All of those plasmids are listed
in Table 6. Details on the cloning strategy for each construct as well as plasmid maps can
be found in the AG Rippe CloneX database with the associated reference number provided
in Table 6. In principle, appropriate inserts were ampliﬁed from the plasmids listed in
Table 7 by gradient polymerase chain reaction (PCR) with the following general program:
3 min at 98°C (step 1, initialization), 10 s at 98°C (step 2, denaturation), 30 s at 50-65°C
(step 3, annealing, temperature gradient was generally used), 30-150 s at 72°C (step 4,
elongation, time depended on the insert size), 2 min at 72°C (step 5, ﬁnal elongation) and
going from step 4 to step 2 34× for a total of 35 cycles. For one reaction, ∼40-200 ng of
template were mixed with 0.5 µM forward primer, 0.5 µM reverse primer, 25 mM deoxynu-
cleoside triphosphate (dNTPs) mixture (ThermoFisher Scientiﬁc, USA), Q5 polymerase
reaction buﬀer (5x) and 2 U Q5 polymerase (New England Biolabs, USA). PCR products
were puriﬁed using the Wizard PCR cleanup system (Promega, USA) and their sizes were
veriﬁed by electrophoresis using 1% agarose (LE agarose, Biozym, Germany)/TAE gels.
Inserts and backbones were cut with the appropriate restriction enzymes (see database
entries for details) according to the manufacturer's protocols (ThermoFisher Scientiﬁc
or New England Biolabs, USA). Fragments were separated on 1% cloning agarose (LE
genetic pure agarose, Biozym, Germany)/TAE gels, bands were cut out and DNA frag-
ments were isolated using the Nucleospin gel cleanup system (Macherey Nagel, Germany)
or DNA gel extraction spin columns (Freeze 'n squeeze, Bio-Rad Laboratories, USA).
Fragments were ligated using T4 ligase (ThermoFisher Scientiﬁc, USA) or Quick ligase
(New England Biolabs, USA) and competent bacteria (XL10 or dam-/-/dcm-/- JM110,
Agilent Technologies, USA) were transformed with the plasmids, cultured in LB medium
(1% w/v tryptone, 0.5% w/v yeast extract, 86 mM NaCl, pH7.0) at 37°C on a shaker over
night and plasmid DNA was isolated using the Nucleospin plasmid puriﬁcation system
(Macherey Nagel, Germany). Isolated DNA was test digested with appropriate restriction
enzymes and the inserts of promising clones were sequenced.
IV.2.2 Cell culture and transfection
Cell lines used within this thesis are listed in Table 8. NIH3T3 and iMEF cells were
cultured in high glucose (4.5 g/l) Dulbecco's Modiﬁed Eagle Medium (DMEM, #31053,
ThermoFisher Scientiﬁc Inc., USA) supplemented with 10% fetal bovine serum (FBS, PAN
Biotech GmbH, Germany), 2 mM stable glutamine (PAN Biotech GmbH, Germany), 1x
Penicillin/Streptomycin (PAN Biotech GmbH, Germany) at 37°C and 5% CO2. To induce
stable expression of SUV39H1-GFP in the respective cell line (Table 8), 3 µg/ml doxycy-
IV MATERIALS & METHODS 91
cline (Sigma-Aldrich, USA) were added to the culture medium. U2OS 2-6-3 were cultured
in low glucose (1.0 g/l) DMEM (#11880, ThermoFisher Scientiﬁc Inc., USA) with the
same supplements as above except for the FBS, which was guaranteed doxycycline-free
(PAN Biotech GmbH, Germany). MESCs were cultured in high glucose DMEM medium
supplemented with 4 mM L-Glutamine (PAA M11-006), 1x Penicillin/Streptomycin, 1
mM sodium pyruvate solution, 1x non-essential amino acids (ThermoFisher Scientiﬁc,
USA), 100 µM sterile-ﬁltered β-mercaptoethanol (in water), 0.41% v/v LIF (self-made,
supernatant from LIF-producing cells, batch: 26.7.14 from Dennis Sadic, Schotta lab,
LMU Munich) and 15% FBS (Sigma F7524, lot: 091M3398) in 0.2% gelatin/PBS-coated
dishes. To passage, collect or seed cells, they were washed brieﬂy with phosphate-buﬀered
saline (PBS) and detached from the culture dish by incubation with 0.05% Trypsin/0.02%
ethylenediaminetetraacetic acid (EDTA) in PBS (PAN Biotech GmbH, Germany) for 2-
5 min at 37°C. For immunoﬂuorescence and/or RNA ﬂuorescence in situ hybridization
(FISH) staining, cells were seeded on 12 mm diameter glass slides. For live cell exper-
iments, they were seeded either in 8-well Lab-Tek chambers (#154534, ThermoFisher
Scientiﬁc Inc., USA) or 10-well CELLview slides (#543079, Greiner Bio-One GmbH, Ger-
many) that were coated with 1% Matrigel in serum-free DMEM beforehand to allow for
better cell attachment and limit cell movement during image acquisition. U2OS 2-6-3 cells
were transfected with Eﬀectene (Qiagen, Netherlands) whereas NIH3T3 and iMEFs were
transfected with Lipofectamine (LTX or 3000, ThermoFisher Scientiﬁc, USA) according
to the manufacturer's protocols. For qRT-PCR of transfected U2OS 2-6-3 cells, Xtreme
gene 9 (Roche, Germany) was used for transfection. For some experiments, cells were
pre-treated with the histone deacetylase (HDAC) inhibitor suberanilohydroxamic acid
(SAHA). In that case, fresh medium containing 2 µM SAHA (Millipore) in ethanol was
added 4-5 h after transfection (if applicable) and ∼24 h before the respective experiment
(microscopy, western blot or immunoﬂuorescence staining).
IV.2.3 Cell ﬁxation and immunoﬂuorescence staining
Cells on coverslips were brieﬂy washed with PBS, incubated with 4% paraformaldehyde
(PFA) in PBS (Santa Cruz, Germany) for 7-12 min at room temperature (RT) and washed
again with PBS (three times). For immunoﬂuorescence staining, cells were permeabilized
with 0.1% TritonX-100 (Merck, Germany) in PBS for 5 min and washed twice with PBS.
Fixed cells were then incubated 30-60 min with 10% goat serum (Sigma-Aldrich, USA)
in PBS to block unspeciﬁc antibody binding sites. The appropriate primary antibodies
(Table 9) were diluted as indicated in 5% goat serum. Incubation was either 60-120 min
at RT or over night at 4°C. After washing thrice with PBS/0.002% NP-40 (Sigma-Aldrich,
USA), the cells were incubated with ﬂuorophore-coupled secondary antibodies (Table 9)
diluted in PBS for 45-90 min at RT. After washing another three times with PBS and
rinsing the coverslips brieﬂy with water to desalt and 70% followed by 100% ethanol to
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dry, cells were mounted on a microscopy slide with a drop of Prolong Gold Antifade
mountant containing DAPI (ThermoFisher Scientiﬁc Inc., USA).
IV.2.4 RNA ﬂuorescence in situ hybridization
RNA FISH was performed on cells seeded (and transfected/treated) on glass coverslips.
After washing the cells once with PBS, they were incubated with CSK buﬀer with 10 mM
vanadyl ribonucleoside complex (VRC) for RNase inhibition or 50 µg/ml RNase A (nega-
tive control, ThermoFisher Scientiﬁc, USA) on ice for 5 min. Another washing with PBS
was followed by ﬁxation with 4% PFA for 12 min. The cells were washed again with PBS
and dried with an ethanol series (70%→ 85%→ 100%; 3 min each). Meanwhile, 50 ng of
the Atto565-labeled MS2 probe (Table 11) were mixed with 10 µg salmon sperm DNA
and 5 µl formamide (all quantities are per slide) and incubated ﬁrst at 37°C for 10 min
and then at 74°C for 7 min. Last, the probe mix was diluted 1:1 with 2× hybridization
buﬀer and supplemented with 10 mM VRC or 50 µg/ml RNase A (ThermoFisher Scien-
tiﬁc, USA). Cells were incubated with the probes in a wet chamber at 37°C over night.
On the next day, they were washed twice with 2× SSC buﬀer/50% v/v formamide at RT
for 15 min, once with 0.2× SSC/0.1% v/v Tween-20 at 40°C for 10 min, twice with 2×
SSC at RT for 5 min and once with PBS. This protocol destroyed ﬂuorescent proteins,
so that it was generally followed by an immunoﬂuorescence staining using a speciﬁc anti-
body against GFP (to detect GFP and/or YFP). Therefore, cells were permeabilized with
ice-cold 0.1% v/v Triton X100/PBS for 5 min and then the immunoﬂuorescence protocol
described above was followed.
IV.2.5 Confocal ﬂuorescence microscopy
All ﬂuorescence microscopy data was acquired using microscopes from the DKFZ light
microscopy core facility. FRAP and BLInCR experiments were carried out on a Leica SP5
microscope equipped with a HCX PL APO lambda blue 63.0×1.40 OIL UV objective, a
UV diode (405 nm), a multiline argon laser (458 nm, 476 nm, 488 nm, 496 nm, 514 nm)
and three HeNe lasers for excitation at 561 nm, 594 nm and 633 nm. This setup was
also used for imaging except for H3K9me3/HP1 imaging in diﬀerent iMEF cell lines
and Pax imaging in NIH3T3 cells. Those experiments were done using the Zeiss LSM 710
microscope equipped with a 63x/1.4 NA oil DIC III objective and an avalanche photodiode
(APD). A summary of the microscope settings used for the respective experiments is
given in Table 12. Fluorescent proteins and dyes with their excitation and emission
wavelengths used in this study are listed in Table 13. When imaging more than one
ﬂuorescent protein, imaging was done sequentially.
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Table 12: Microscopy settings for diﬀerent acquisitions.
experiment microscope
image
size (px)
scan speed
line
average
z stacks
Imaging Leica SP5 512×512 400 Hz 4× ∆z=0.5 µm
APD imaging Zeiss LSM710 512×512 speed 3 or 5 4× no
FRAP Leica SP5 128×128 1400 Hz 1× no
BLInCR
recruitment
Leica SP5
256×256 1400 Hz 1× no
reversibility 512×512 400 Hz 2× ∆z=0.5 µm, #z=7
txn activation 512×512 400 Hz 4× ∆z=0.5 µm, #z=4-5
More speciﬁc parameters are listed in the respective sections.
Table 13: Excitation & emission settings for imaging ﬂuorescent proteins and dyes.
ﬂuorescent protein/dye excitation wavelength (nm) detected emission range (nm)
tagBFP, CFP, DAPI 405 415-475
GFP, Alexa488 488 500-550
YFP 488 (or 514) 500-550/75 (or 525-575)
tagRFP, tagRFP-T, Alexa568 561 575-630
mCherry, mKate2 *) 561 or 594 575/605-750 or 570-615 **)
iRFP713, Alexa647 633 645-780
*) Excitation at 561 nm resulted in a better signal (higher signal-to-noise ratio), but also caused more
photobleaching. Therefore, mKate2 was excited at 594 nm for time lapse experiments. **) When the
sample was stained with an Alexa647-linked antibody also, this emission range was used to avoid bleed-
through as Alexa647 can also be excited at 561 nm.
IV.2.6 PCH enrichment analysis
To quantify the enrichment of factors at PCH from CLSM images, the DAPI image was
used for threshold-based selection of PCH using ImageJ (Schneider et al. 2012). The
entire nucleus apart from the PCH foci was considered bona ﬁde euchromatin (Fig. 42).
The resulting masks were then used to measure the intensity of the factor of interest
(e. g. H3K9me3). The PCH enrichment d of any factor was calculated from the mean
PCH and euchromatin intensities IPCH and IEu: d = IPCH/IEu. This enrichment was
normalized to the chromatin density c which can be calculated from the measured DAPI
enrichment d(DAPI) as c = dref(H2A) · d(DAPI)/dref(DAPI). Here, the reference H2A
and DAPI enrichments were dref(H2A) = 1.80.1 and dref(DAPI) = 2.7± 0.1. Those values
were obtained from imaging DAPI and mRFP in an NIH3T3 cell line stably expressing
H2A-mRFP (Muller-Ott et al. 2014). The corrected enrichment was thus calculated as
dcorr = d/c.
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Figure 42: Quantiﬁcation of PCH enrichment. PCH foci were identiﬁed in the DAPI
image (left) by using a threshold-based approach. The detected foci (center) were despeckled
(Process  Noise  Despeckle) and used as a mask to quantify the ﬂuorescence intensity of
a factor of interest (right). Figure adapted from (Muller-Ott et al. 2014).
IV.2.7 Fluorescence recovery after photobleaching
For ﬂuorescence recovery after photobleaching (FRAP), ﬂuorescent proteins in a circular
region of interest (ROI) within the nucleus were bleached and recovery of ﬂuorescence
intensity at the bleach area was recorded as depicted for an exemplary cell in Figure 43
(top). From the recovery curve (Fig. 43, bottom), protein mobility parameters such
as the (eﬀective) diﬀusion coeﬃcient and chromatin binding/dissociation rates can be
derived ((Mueller et al. 2010, Vivante et al. 2017)).
Data acquisition. Cells were transfected with the GFP-tagged protein of interest
(i. e. Pax3-GFP or GFP-MeCP2) and the FRAP Wizard included in the Leica imaging
software (LAS AF) was used with the general parameters listed in Table 12 resulting in a
frame time of 0.115 s. Photobleaching was done in an area of 1.5 µm in diameter either at
PCH foci or in euchromatic regions. The Argon laser was set to 80% in the conﬁguration
and the laser lines at 458 nm, 476 nm, 488 nm and 496 nm were used at 100% in the
acquisition setup for two bleaching frames. Pre- and post-bleach imaging was done using
an appropriate laser power depending on the expression level of the ﬂuorescently tagged
protein. The number of pre- and post-bleach frames was 50 and 700, respectively, for
Pax3-GFP. For GFP-MeCP2, 70 pre-bleach frames were acquired and the number of
post-bleach frames was 600 for euchromatin and 1200 for PCH.
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Figure 43: Principle of FRAP. Fluorescent proteins in the ROI (dashed pink) were pho-
tobleached using high laser intensity. The recovery of ﬂuorescence intensity at the ROI was
recorded and the FRAP curve was ﬁtted using FREDIS ((Muller et al. 2009)). In this example,
GFP-MeCP2 at a PCH focus was bleached in a wt iMEF. Scale bar: 5 µm, gray: experimental
data, black: reaction-diﬀusion ﬁt.
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Image analysis. To account for cell movement during the acquisition, images were
registered using the TurboReg plugin ((Thevenaz et al. 1998)) in the Fiji distribution
((Schindelin et al. 2012)) of ImageJ ((Schneider et al. 2012)). The maximum projection
of the pre-bleach frames was used as target. In addition, the bleach proﬁle was analyzed
since it is taken into account in a newer version of the FREDIS software ((Muller et al.
2009)). Due to surrounding heterochromatin foci, bleach proﬁle analysis based on the
ﬁrst post-bleach frame as suggested by Mueller and colleagues ((Mueller et al. 2008)) was
not feasible for PCH FRAP. Therefore, the ﬁrst post-bleach image was subtracted from
the last pre-bleach image using ImageJ (Process  Image Calculator...) and the
radial proﬁle was calculated from this diﬀerence image (Fig. 44a) with a radius of 15 px
(Plugins  Radial Profile). For euchromatin FRAP, this analysis was done on the
ﬁrst post-bleach image. All proﬁles from one condition (i. e. PCH or euchromatin in the
same cell type) were normalized to the average intensity of a distant region (Fig. 44a),
averaged (Fig. 44b) and ﬁtted with the following constant function with Gaussian edges
based on ((Mueller et al. 2008)) using R:
I(r) =
b for r ≤ rcθ (1− exp(−(r−rc)2
2σ2
))
for r > rc
(1)
Here, θ − b is the bleach depth, rc the radius of the constant and σ the width of the
Gaussian. The latter two parameters were used as input parameters for FREDIS and are
listed in Table 14. Note that the average proﬁle was subtracted from 1 to yield the curve
as in Figure 44b when the image diﬀerence was used (i. e. for PCH FRAP).
Table 14: Bleach proﬁle parameters.
construct sample σ (µm) rc (µm)
GFP-MeCP2
PCH
wt 0.39 0.15
dn 0.38 0.16
euchromatin
wt 0.59 0.18
dn 0.88 0
Pax3-GFP
PCH 0.80 0.07
euchromatin 1.01 0
The proﬁle analysis was done using either the ﬁrst post-bleach
image (euchromatin) or the diﬀerence of the last pre- and the
ﬁrst post-bleach image (PCH). The parameters were subse-
quently used for FRAP analysis with FREDIS.
Data analysis. Registered time series were analyzed using the FREDIS software ((Muller
et al. 2009)) that is based on the theoretical framework previously described ((Sprague
et al. 2004)). Based on more recent advances in FRAP data analysis ((Mueller et al.
2008)), the newest FREDIS version used here also takes the shape of the initial bleach
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Figure 44: Bleach proﬁle analysis for FRAP. (a) First post-bleach image subtracted
from last pre-bleach image (same cell as in Fig. 43) to analyze the average radial proﬁle (solid
circle) using ImageJ. The mean intensity in the reference area (dashed circle) was used for
normalization. This example shows GFP-MeCP2 FRAP at a PCH focus. Scale bar: 5 µm.
(b) Average of the GFP-MeCP2 PCH FRAP proﬁles in wt iMEFs. The curve was ﬁtted with
a constant function with Gaussian edges yielding the radius of the constant rc and the width
of the Gaussian σ that were used as input parameters for subsequent ﬁtting of FRAP curves
using FREDIS. The dashed line represents the actual bleach radius (0.75 µm).
proﬁle into account. All curves were ﬁtted with the three models implemented in FREDIS,
namely a binding model, a diﬀusion model and a combined reaction-diﬀusion model.
To determine if the more complex model (i. e. the reaction-diﬀusion model) yielded a
signiﬁcantly better ﬁt, a ratio F and the resulting P value were calculated as in ((Muller
et al. 2009)):
F =
χ2s − χ2rd
χ2rd
· frd
fs − frd =
χ2s − χ2rd
χ2rd
· n− prd
prd − ps (2)
P = 1− cdf(F, fs − frd, frd) (3)
Here, χ2 was the sum of the residuals as calculated by FREDIS for the simple model
(s, i. e. the reaction or diﬀusion model) and the complex model (rd, i. e. the reaction-
diﬀusion model), respectively. The degrees of freedom f can be expressed in terms of
the number of data points n and the number of ﬁt parameters p (ps = 1, prd = 3).
To calculate the P value, the cumulative distribution function cdf (implemented in R as
pf()) was used. If P ≤ 0.05, the reaction-diﬀusion model was considered to ﬁt the data
signiﬁcantly better than the respective simple model. To calculated average curves for the
FRAP experiments, the FREDIS output curves (Fig. 43) were normalized to the average
pre-bleach intensity. The mean of the thus normalized curves was reﬁtted using FREDIS
and the best ﬁt is displayed in all average curves (Fig. 10c & Fig. 11b).
IV.2.8 Blue Light-Induced Chromatin Recruitment (BLInCR)
BLInCR is a tool devised in this thesis to rapidly increase the local concentration of
eﬀector proteins at subnuclear loci upon illumination with blue light (Rademacher et al.
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2017).
Data acquisition. U2OS 2-6-3 cells or MEF cell lines (wt iMEFs or NIH3T3) were
transfected with the appropriate BLInCR constructs from Table 6 and Table 7 and
treated with the histone deacetylase inhibitor SAHA if needed. To avoid pre-recruitment
of PHR-tagged eﬀectors, light exposure of transfected cells had to be avoided. In particu-
lar, cells were kept in a dark box after transfection and mounted on the microscope using
a red ﬂashlight. BLInCR images were recorded with the parameters given in Table 12
and Table 13. Generally, a zoom factor of 9 corresponding to 53.39 nm/px was used.
Excitation of ﬂuorophores with wavelengths ≥561 nm did not cause PHR switching and
was thus suited to follow eﬀector and/or reader dissociation from the array. For longer
time series experiments (BLInCR dissociation kinetics and transcription activation), z
stacks were recorded and the focus was adjusted if necessary.
Image analysis. Image processing and intensity quantiﬁcations were done using the
Fiji distribution (Schindelin et al. 2012) of ImageJ (Schneider et al. 2012). When z stacks
were recorded, they were registered using the StackReg plugin for single channel stacks
(reversibility kinetics) or the TurboReg plugin for multi channel stacks (Thevenaz et al.
1998). For intensity quantiﬁcations, a maximum projection of the z stacks was used
(Image  Stacks  Z Project...). The mean ﬂuorescence intensity was measured
(Analyze  Measure) at a nuclear reference region (30/60 px for 256×256/512×512 px
images, respectively) and the array (15/20-40 px for 256×256/512×512 px images, respec-
tively). The nuclear reference region was selected to be in a homogeneously stained region
(e. g. not at nucleoli) and close to the array to minimize possible intensity diﬀerences due
to inhomogeneous illumination of the cell. For time-lapse experiments, the enrichment
(of the eﬀector or reader) at the array E(t) was calculated as the diﬀerence of the mean
ﬂuorescence intensities at the array region Iarray and the reference region Iref. The mean
intensity at the nuclear reference region Iref and at a background region Iback outside of
the cell were used to account for bleaching by ﬁtting their diﬀerence to an exponential
decay (Iref − Iback = a · e−k·t). The bleach-corrected enrichment was thus calculated as
E(t) = (Iarray − Iref)/e−k·t.
BLInCR kinetics. The array was marked with CIBN-TetR-tagRFP-T and could
thus be localized without triggering PHR switching as depicted in Figure 25b (Results
section). Subsequently, a YFP time series of 400 frames with 204.3 ms frame time was
acquired (see parameters in Table 12 and Table 13) thereby triggering and recording
PHR-YFP-eﬀector switching and recruitment. The enrichment of PHR-YFP-labeled ef-
fectors at the array E(t) at time t after the ﬁrst blue light exposure was calculated as
described above, but without bleach correction since the measurement time was rather
short and YFP rather bleach-resistant (see Results section, Fig. 25b). A maximum pro-
jection of the time series was used to select array and reference region. The enrichment
at the array E after time t (E(t) = (Iarray − Iref) was ﬁtted to a model considering two
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parallel ﬁrst-order reactions:
E(t) = a− b · ek1·t − c · ek2·t (4)
Each single curve was ﬁtted using a non-linear generalized least squares method (gnls)
implemented in the nlme package in R (Pinheiro et al. 2017). In an alternative approach,
the two characteristic rates k1 and k2 were kept constant for all cells and all constructs
under the assumption that they correspond to the PHR-CIBN heterodimerization and
the PHR oligomerization and are therefore identical for all eﬀector constructs. Using the
global ﬁtter (by F. Erdel), all 123 single recruitment curves were ﬁtted with individual
constants a, b and c to account for expression and eﬀector diﬀerences, but with global
rates k1 and k2. To assess the goodness of ﬁt, the cumulative sum of squared residuals
of the global ﬁt were devided by the cumulative sum of squared residuals of the single
ﬁts. In addition, the coeﬃcient of determination R2 was calculated for each single curve
and the distribution of those coeﬃcients is shown in Figure 25f. For both ﬁt strategies,
the characteristic time to reach half maximal levels τ1/2 was calculated from the model
(Eq. 4) and the half-maximal level E(τ1/2):
E(τ1/2) = E(0) +
E(∞)− E(0)
2
(5)
With the oﬀset E(0) = a − b − c and the plateau value E(∞) = a, τ1/2 was determined
using the uniroot function in R to solve
0 = b · (1− 2e−k1·τ1/2) + c · (1− 2e−k2·τ1/2) (6)
Single curves were normalized to the plateau value a (Enorm(t) = E(t)/a) to account
for diﬀerent transfection eﬃciencies before averaging. Cells that moved during image
acquisition or had a very low signal-to-noise ratio were removed from the analysis.
BLInCR dissociation kinetics. To characterize the BLInCR dissociation kinetics,
PHR-mCherry-eﬀector constructs were used to avoid triggering re-recruitment during
imaging of those constructs. They were co-transfected with CIBN-TetR (`localizer') and
an GFP-LacI (array marker) and imaged with the appropriate parameters (Table 12 &
Table 13). A pre recruitment z stack was recorded before triggering relocalization of
PHR-mCherry-tagged eﬀectors by imaging the array marker (excitation at 488 nm, two
sequential stacks with a total of 38 s exposure to blue light). The ﬁrst post recruitment
stack in the mCherry channel was recorded right after the two recruitment stacks and
constitutes the time point t = 0. Subsequent stacks were recorded every ∼30 s for the
ﬁrst 5 min and then at longer time intervals for a total of ∼30 min. Image analysis
was done as described above. The array and reference region were selected manually for
each time point since the cell shape changed considerably during the acquisition period
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rendering registration of the time series impractical. Importantly, the size of the array
measurement area was large enough to include the entire array and was always the same
for a single cell time trace. The bleach-corrected enrichment E(t) of single cells was ﬁtted
with a model considering a single exponential with a time-dependent (i. e. concentration-
dependent) rate similar to a previously proposed model (Sing et al. 2014):
E(t) = a · e−k·tm + c (7)
The characteristic half-life time t1/2 was calculated from the model ﬁt (Eq. 7) and the
half-maximal level E(t1/2) (as Eq. 5). With the initial enrichment at E(0) = a + c and
the oﬀset E(∞) = c, t1/2 was determined using the uniroot function in R to solve
0 = a ·
(
e−k·t
m
1/2 − 1
2
)
(8)
Cells were normalized to account for diﬀerent transfection eﬃciencies (Enorm(t) = (E(t)−
c)/a) and points at regular intervals were interpolated (linear interpolation between neigh-
boring points) to allow for averaging of single traces.
Transcription activation with VP16 BLInCR. Cells were transfected with the
`localizer' CIBN-TetR, the eﬀector construct PHR-YFP-VP16, the array marker CFP-
LacI and the RNA reader domain mKate2-MCP. A z stack of the latter construct was
recorded before the initial recruitment of the eﬀector by imaging of YFP and CFP (be-
tween stacks sequential scan mode). Subsequently, stacks in all three channels (between
lines sequential scan mode) were recorded every 2-4 min thereby consistently re-recruiting
VP16 to the reporter array. Reader enrichment was quantiﬁed as described above and
normalized to the level before the ﬁrst recruitment and after 50 min. For normalization
and averaging, time points every 2.5 min were interpolated linearly between neighboring
time points. The averaged time traces were ﬁtted to three diﬀerent models: a two-state
model, a model including positive feedback and a sequential activation model (ﬁtting by
Fabian Erdel, see (Rademacher et al. 2017) for details). The inﬂection points (Fig. 36c)
were calculated from the feedback model ﬁt (by Fabian Erdel). To determine the array
size (Fig. 36b), a local area around the array was selected (60 px/3.2 µm in diameter)
either in the YFP or CFP channel and converted to a binary image using Otsu's method
(Otsu 1979) for thresholding (Image Adjust Threshold...). The size was measured
(Analyze  Measure) and normalized to the value at 2.5 min to ensure that recruitment
was complete at the ﬁrst measurement time point (which was critical when using the
PHR-YFP-VP16 images).
Constitutive BLInCR with LED illumination over night. Control experiments
for VP16 BLInCR were conducted with the same constructs as the time-resolved VP16
BLInCR, but the cells were illuminated over night with a blue LED. To test reader do-
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mains such as ﬂuorescently tagged hADD or mCD (see Results section and Table 6 for
details), cells were seeded, transfected and imaged in 8-well chambers suited for CLSM
(Labtek, ThermoFisher Scientiﬁc, USA). Cells that were subsequentially stained for his-
tone PTMs or pol II phosphorylation were seeded on 12 mm glass coverslips and treated
for IF as described above. Cells were seeded in a removable 4-well chamber (ibidi, Ger-
many) for direct comparison of H3K9ac levels by IF (Fig. 35). The chamber was removed
after washing once with PBS before adding PFA. After over night activation, ﬁxation and
IF (when applicable), images were recorded as speciﬁed in Table 12, processed and the
mean ﬂuorescence intensity at a nuclear reference area Iref was measured as described
above. To analyze the enrichment of the reader or histone modiﬁcations compared to the
local chromatin environment, radial proﬁles around the array were calculated (diameter:
70 px/3.7 µm) yielding the intensity I(r) at distance r from the array center which was
normalized to Iref (Inorm(r) = I(r)/Iref). For ﬁxed samples the reader proﬁle was devided
by the normalized DAPI proﬁle to account for chromatin density. To quantify the accu-
mulation of the reader proteins at the array, the enrichment over the reference Inorm(r)
was integrated from the array center to the FWHM yielding the accumulated enrichment
Esum:
Esum =
r=FWHM∑
r=0
2pirInorm (9)
The FWHM was calculated from the eﬀector protein proﬁle to account for diﬀerent array
sizes resulting from recruitment of diﬀerent eﬀectors.
IV.2.9 Quantitative real-time polymerase chain reaction (qRT-PCR)
Experimental procedure. Total RNA was isolated from 0.5− 1.5× 106 cells using the
Nucleospin RNA plus kit (Macherey Nagel, Germany) according to the manufacturer's
protocols. Alternatively, long RNA (>200 nt) isolated for RNA-seq (see below) was
used. Complementary DNA (cDNA) was synthesized from 650 ng  1 µg RNA using the
SuperScript III or IV reverse transcriptases (ThermoFisher Scientiﬁc, USA) with random
hexamer primers according to the manufacturer's protocols. Samples without reverse
transcriptase were prepared as controls. For the calibration standard, 2-2.5 µg RNA from
SUV39H dn iMEFs was used. After digestion of the RNA templates with 2.5 U RNase
H (New England Biolabs, USA), the standard was diluted sequentially (1:3), resulting in
a total of ﬁve to eight standards. qRT-PCR was performed using the SYBR green PCR
master mix (Roche, Germany or Applied Biosystems, USA) and the primers for GSATs,
Actin, GAPDH and the CFP-SKL reporter gene in the U2OS 2-6-3 cell line are listed
in Table 11 with the following PCR program on a step one plus real-time PCR light
cycler (Applied Biosystems, USA): 95°C/10 min (step 1), 95°C/10 s (step 2), 60°C/10 s
(step 3), 72°C/10 s (step 4) with cycling from step 4 to step 2 for a total of 28 (GSAT)
or 35 (Actin, GAPDH) cycles. All samples and the standard were analyzed in triplicates
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and the controls without reverse transcriptase were analyzed in duplicates or as single
controls.
Data analysis. The raw data analysis was done with the step one software (Applied
Biosystems, USA) and the normalization was done in Excel. Brieﬂy, the standard curves
were used to determine quantities from the measured CT values. Mean GSAT or CFP-
SKL quantities from the three technical replicates were normalized to the respective actin
or GAPDH quantities. The fold change of those normalized quantities compared to the
average of the biological replicates of wild type iMEFs (Fig. 18a), untransfected cells
(Fig. 27f, Fig. 28a) or non-activated values ("pre" in Fig. 37) are shown, respectively.
The error bars reﬂect the sem of the biological replicates.
IV.2.10 Histone extraction and western blot
Acid extraction of histones. For western blot protein analysis of modiﬁed histones, the
latter were isolated by an acid extraction protocol based on published protocols ((Shechter
et al. 2007, Villar-Garea et al. 2008)). Brieﬂy, 106-107 cells were washed with PBS and
resuspended in 0.25 M HCl (100 µl/106 cells) and rotated over night at 4°C. After cen-
trifugation at 20, 800 × g at 4°C in a table-top centrifuge for 7-10 min, the supernatant
was set aside (4°C or on ice) and the pellet was redissolved in the half the volume HCl
and rotated at 4°C for another 3-4 h. The supernatants were combined and histones were
precipitated for ∼2 h on ice (or at 4°C) by adding trichloroacetic acid (TCA) to a ﬁnal
concentration of 33% v/v. After centrifuging for 20-60 min at 4°C and 13000 rpm, the
supernatant was discarded and the pellet washed twice with 170 µl and 150 µl tert-butyl
methyl ether (TBME)/ethanol (1:1). The pellet was dried (∼20 min at RT), dissolved in
1× Laemmli buﬀer (Alfa Aesar, USA) to a ﬁnal cell concentration of 104 cells/µl and
heated to 100°C for 10 min.
Protein separation and western blot. Acid-extracted proteins were separated on
a stainfree gel (4-20%, Bio-Rad Laboratories Inc., USA) for 45 min at 160 V and semi-
dryly blotted onto a nitrocellulose membrane (Bio-Rad Laboratories Inc., USA) for 1 h
at 200 mA. After transfer, unspeciﬁc binding sites were blocked with 5% milk in TBS for
1 h at RT. The primary antibodies against H3K9me3 (see Table 9) were diluted in 1%
bovine serum albumin (BSA) in TBS with 0.02% sodium azide and incubated with the
membrane at 4°C over night. After washing thrice with 0.1% Tween in TBS, the mem-
brane was incubated with a secondary antibody coupled to HRP in 5% milk/TBS for 1 h
at RT. After washing again, the secondary antibody was detected by chemoluminescence
(Clarity Western ECL, #170-5060, Bio-Rad Laboratories Inc., USA) using a ChemiDoc
MP Imaging System (Bio-Rad Laboratories Inc., USA). To check protein loading, anti-
bodies were stripped from the membrane (30 min at 56°C, Roti-free stripping buﬀer, Carl
Roth GmbH & Co. KG, Germany). Subsequently, the membrane was blocked again and
incubated with a primary antibody against H3 following the same protocol as described
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above.
Histone tail modiﬁcation antibody tests on the modiﬁed peptide array. The
speciﬁcity of primary antibodies against H3K9me3 (Table 9) was tested on a modiﬁed
histone peptide array (#13005, ActiveMotif) by following the same procedure as described
in the previous section for protein detection on the membrane after western blotting.
Notably, antibodies could also be stripped from the peptide array so that the latter could
be reused at least three times.
IV.2.11 Chromatin immunoprecipitation followed by DNA sequencing
ChIP. 3 − 10 × 106 cells were pelleted, dissolved in 1% formaldehyde (#28906, Ther-
moFisher Scientiﬁc Inc., USA) in PBS and incubated on a rotating mixer for 10 min
at RT. The ﬁxation reaction was stopped by addition of glycine to a ﬁnal concentra-
tion of 125 mM. After washing the cells twice with PBS/0.5 mM phenylmethylsulfonyl
ﬂuoride (PMSF), they were dissolved in swelling buﬀer (Table 10) and incubated on
ice for 10 min. The cells were pelleted, dissolved in MNase buﬀer (Table 10) and in-
cubated with 4 U MNase (ThermoFisher Scientiﬁc, USA) at 37°C for 15 min. Samples
were stored on ice and diluted with the appropriate amount of 10× sonication buﬀer (to
yield 1×Table 10). The samples were transferred to glass tubes (Covaris Inc., USA) and
sonicated in a Covaris S2 sonicator (parameters: 900s, burst 200, cycle 20%, intensity 8).
After centrifugation at 13000 rpm and 4°C for 15 min to pellet cell debris, the supernatant
was used for immunoprecipitation. ChIP-grade protein G magnetic beads (25 µl/sample,
#9006S, Cell Signalling, UK) were washed twice and dissolved in sonication buﬀer with
1× protease inhibitor. The cell supernatant and 4 µg normal rabbit IgG (lot: ER1212071)
were added to the beads and the mixture was rotated at 4°C for ∼2 h (pre-clearance).
About 1/20 of the supernatant was used as input sample and the remainder was split
equally for three ChIP reactions using 4 µg of the respective antibody (IgG, H3 and
H3K9me3) and incubating at 4°C for 2 h while rotating. Meanwhile, protein G magnetic
beads were prepared as described above and then added to each IP sample. The pre-
cleared sample, antibody and bead mixture was incubated on a rotator at 4°C over night.
Meanwhile, the input samples were ﬁlled up to 500 µl with elution buﬀer (Fig. 10) and
RNaseA (ThermoFisher Scientiﬁc, USA) was added to a ﬁnal concentration of 10 µg/ml.
After one hour at 37°C, Proteinase K (M3037, Genaxxon bioscience, Germany) and NaCl
were added to ﬁnal concentrations of 80 µg/ml and 200 mM, respectively and the input
samples were incubated over night at 65°C (protein digestion and reverse crosslink). On
the next day, the IPs were washed once with sonication buﬀer, once with high-salt buﬀer,
once with Li buﬀer and twice with TE buﬀer (see Table 10 for buﬀer compositions).
For each washing step, the samples were rotated and incubated for 5 min at RT and
then placed on a magnetic rack. Subsequently, the DNA-antibody complexes were eluted
twice with elution buﬀer (50 mM Tris pH8.0, 1 mM EDTA, 1% SDS, 50 mM NaHCO3)
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at 37°C (15 min) on a shaker to avoid bead sedimentation. The IP samples were treated
with RNaseA and Proteinase K as described above for the input samples. Meanwhile, the
input DNA was precipitated by adding 0.1 volume 7.5 M ammonium acetate, 1 volume
isopropanol and 1.5 µl Glycoblue and storing the samples at -20°C for ∼75 min. The
precipitated DNA was pelleted by centrifugation at 4°C and full speed for 40 min and the
pellet was washed once with ice-cold 75% Ethanol before dissolving it in water. The input
samples were used to assess the fragment size by gel electrophoresis on a 2% agarose E-Gel
(ThermoFisher Scientiﬁc, USA) and on a DNA1000 bioanalyzer chip (Agilent Technolo-
gies Inc., USA). On the next day, the IP samples were precipitated as the input samples
on the previous day and their concentrations were measured by Qubit (dsDNA or dsDNA
high sensitivity, ThermoFisher Scientiﬁc, USA).
Library preparation. The libraries were prepared using ∼50-800 ng of precipitated
DNA (or all if the concentration could not be measured by Qubit (dsDNA or dsDNA high
sensitivity, ThermoFisher Scientiﬁc, USA)) using the NEBNext Ultra DNA Library Prep
Kit for Illumina (#E7370, New England Biolabs Inc., USA) following the manufacturers'
protocols. Notably, diluted adapters (1.5 µM) were used for the adapter ligation and
insert fragments of 150 bp (i. e. mononucleosomes) corresponding to 270 bp total library
size (including insert and adaptors) were selected in the size selection step. For library
ampliﬁcation, 13 PCR cycles were carried out. Lastly, the library size and quality were
checked on DNA1000 bioanalyzer chips. Libraries were sequenced and demultiplexed by
the DKFZ core facility on a HiSeq 2000 machine (Illumina, USA).
Initial data processing. All samples were mapped with Bowtie ((Langmead et al.
2009)) according to the mapping scheme depicted in Figure 45. Brieﬂy, reads were
mapped to the mouse major satellite consensus sequence ((Lehnertz et al. 2003)) without
mismatches. All unmapped reads were then mapped to the mm9 assembly of the refer-
ence genome with random assignment of multiple mapping reads and without mismatches.
Lastly, unmapped reads were remapped allowing up to two mismatches. The raw read
numbers and resulting read distributions are shown below (Fig. 46) and are listed in
the Appendix (Supplementary Table S2). Files containing mapped reads (with or
without mismatches) were sorted by genomic coordinate, merged and indexed using sam-
tools ((Li et al. 2009)). For quality control, the Pearson correlation of read counts within
10 kb windows across the entire genome were calculated using the multiBamSummary
and plotCorrelation functions of deepTools2 (Ramirez et al. 2016). As another qual-
ity control measure, ﬁngerprints were calculated using the plotFingerprint function of
deepTools2.
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Figure 45: Mapping strategy for reads from ChIP-seq. All samples (i. e. input, IgG
control, H3 ChIP and H3K9me3 ChIP of all cell lines) were mapped according to the scheme
depicted here using Bowtie. An overview of the mapped reads (unique/multiple, with/without
mismatches) is given in Fig 46.
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Figure 46: Mapping results of all samples left after QC. Total read numbers and
coverage are listed in Supplementary Table S2. Notably, H3K9me3 ChIP samples from
wild type (iMEFs and mESCs) and most SUV39H1 sn cell lines have an increased fraction of
major satellite mapping reads (grey), multiple mapping reads (yellow and light green) as well
as unaligned reads (blue) compared to controls.
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ChIP-seq data analyses. The data was analyzed according to the overview below
(Fig. 47). The coverage was calculated using a Perl script and all other calculations
were done using R. Brieﬂy, reads that overlap with feature i were counted using samtools
(multiBamCov) and normalized to the average sample coverage c and the feature length
ki.
Figure 47: Calculation of sample coverage and normalized read counts per feature.
The coverage of each sample was determined from the eﬀective chromosome length and the total
number of mapped reads (multiple mapping allowing up to two mismatches). Reads overlapping
with features were counted using multiBamCov (samtools). Feature lengths were taken from
annotation bed ﬁles.
The resulting normalized read counts nnorm,i and the background contribution b deter-
mined with MCORE ((Molitor et al. 2017)) were then used to calculate the enrichment of
a feature. To be able to compare diﬀerent samples, the enrichment was normalized with
(1− b) yielding a genomic average of enrichment E = 1 for all samples:
Ei =
nnorm,i(IP)− b · nnorm,i(IgG)
nnorm,i(input)
· 1
1− b (10)
Features with nnorm,i < 0.3 (i. e. feature input covered less than 30% of the average
genome-wide input coverage) were considered unmappable and excluded. For all anal-
yses, the average of cell lines with the same genotype was analyzed (see Supplemen-
tary Table S2 for a summary). Features with Ei > 3 (i. e. threefold enrichment
over genomic background) were considered to be highly methylated. To analyze the
methylated subset, features with Ei(iMEFwt) > 3 were selected and the fold enrichment
Ei,fold(sample) = Ei(sample)/Ei(iMEFwt) was calculated for the SUV39H sn, dn and
mESC wt samples. For the RefSeq genes, genes with identical genomic start and end
positions (i. e. splice variants) were only kept once as they are the same on the DNA
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level.
IV.2.12 RNA sequencing
All RNA-seq results described in this study were deduced from sequencing strand-speciﬁc
libraries of long (>200 nt) total RNA libraries. An overview of the workﬂow is given in
the Appendix (Supplementary Fig. S2).
RNA isolation. 3 × 105 − 1.5 × 106 cells were dissolved in a 1:1 mixture of iT
buﬀer (Table 10) and glycerol and stored at -80°C until all samples were collected and
processed together. After thawing the cells, they were washed twice with ice-cold PBS
before RNA isolation using the miRNeasy Mini kit (#217004, Qiagen, Netherlands).
RNA isolation was carried out according to the manufacturer's protocol and both the
miRNA-enriched fraction and the total RNA fraction (>200 nt) were puriﬁed separately.
Subsequently, residual genomic DNA was removed by DNaseI. Therefore, the RNA (in
RNase-free water) was mixed with RQ1 DNase reaction buﬀer (1×), 1 U/µl ribolock
(ThermoFisher Scientiﬁc, USA) and 1 U RQ1 DNase (Promega, USA) per µg of RNA
and incubated at 37°C for 30 min. Subsequently, the RNA was precipitated by adding
sodium acetate to a ﬁnal concentration of 100 mM, 0.4 mg/ml glycogen and three volumes
of 100% ethanol. After incubation at -20°C for at least 15 min, RNA was pelleted by
centrifugation in a benchtop centrifuge at full speed and 4°C. After washing the pellet
once with 70% ethanol, the RNA was dissolved in RNase-free water, the concentration was
determined by Qubit (RNA high sensitivity, ThermoFisher Scientiﬁc, USA) and the RNA
integrity (long RNAs) was checked on a 2% w/v agarose E-gel (ThermoFisher Scientiﬁc,
USA). Therefor, ∼200 ng RNA were diluted in 10 µl water and mixed 1:1 with formamid.
After heating to 65°C for 5 min, the samples were immediately stored on ice, then loaded
onto the gel and separated for 10 min (program 7).
Library preparation. Libraries were only prepared for the long RNA fraction. First,
ribosomal RNA was removed using the Ribo-Zero Magnetic Gold Kit (Epicentre Biotech-
nologies, USA) with 2 µg RNA input according to the manufacturer's protocol. After
measuring the concentration with Qubit (RNA high sensitivity, ThermoFisher Scientiﬁc,
USA), 20-40 ng RNA were used for the strand-speciﬁc library preparation with the NEB-
Next RNA library prep kit for Illumina (#E7420, New England Biolabs, USA) following
the provided protocol. The PCR library enrichment was done with 13 cycles. Last, library
size and quality were checked on a bioanalyzer chip (DNA1000 and High sensitivity, Ag-
ilent Technologies, USA). The libraries were sequenced and demultiplexed by the DKFZ
core facility on a HiSeq 2000 machine (Illumina, USA).
Initial data processing. All samples were mapped to the mouse major satellite
consensus sequence (Lehnertz et al. 2003) without mismatches using Bowtie (Langmead
et al. 2009). All unmapped reads were then mapped to the mm9 assembly of the refer-
ence genome with random assignment of multiple mapping reads and allowing up to two
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mismatches using the spliced read aligner STAR (Dobin et al. 2013). A STAR index ﬁle
for the mm9 assembly of the reference genome was generated beforehand with an mm9
fasta ﬁle and a gene annotation ﬁle (gtf) that was also used for the mapping (providing
annotated intron/exon boundaries). The gene annotation ﬁle contained the mm9 annota-
tion of the RefSeq genes (whole genes) and was downloaded from the UCSC table browser
(Karolchik et al. 2004). The sorted output bam ﬁles were indexed using samtools (Li &
Durbin 2009).
RNA-seq data analyses. Reads overlapping with certain features (i. e. GSATs,
HET6387 regions or genes) were counted using multiBamCov (samtools) with the options
considering split reads and using the strand information. Features that were excluded from
the ChIP-seq analyses due to limited mappability (see above) were also excluded from the
RNA-seq analyses for consistency. Despite its limitations (Wagner et al. 2012), the RPKM
measure of read density (Mortazavi et al. 2008) was calculated for the features listed above
and used as an estimate of transcript abundance. For a more accurate quantiﬁcation of
log2-fold changes of RNA-seq samples from SUV39H sn or dn cell lines compared to wt
iMEFs, the R tool DESeq2 (Love et al. 2014) was used. Importantly, the DESeq2 analysis
was done for the full set of (mappable) RefSeq genes (n = 26, 036) to ensure accurate
normalization. The partitioning in diﬀerent subsets of genes was done in the downstream
analysis.
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V.1 Supplementary Tables
Table S1: Speciﬁcation of selected modiﬁed histone peptides.
peptide
loca-
tion
peptide sequence name Mod1 Mod2 Mod3 Mod4
N
terminus
A15
ARTKQTARKSTGGK
APRKQ
H3 1-19
K9me3
free
C1 R8me2s K9me3
C7 R8me2a K9me3
C13 R8Citr K9me3
C23 K9me3 S10P
C24 K9me3 T11P
D1 K9me3 K14ac
D10 R8me2s K9me3 S10P
D14 R8me2s K9me3 T11P
D18 R8me2a K9me3 S10P
D22 R8me2a K9me3 T11P
E2 R8me2a K9me3 S10P T11P
E20 R2me2s K4me1 K9me3
E21 R2me2s K4me2 K9me3
E22 R2me2s K4me3 K9me3
E23 R2me2s K4ac K9me3
F20 K4me1 R8me2s K9me3
F21 K4me2 R8me2s K9me3
F22 K4me3 R8me2s K9me3
F23 K4ac R8me2s K9me3
F24 K4me1 R8me2a K9me3
G1 K4me2 R8me2a K9me3
G2 K4me3 R8me2a K9me3
G3 K4ac R8me2a K9me3
H4 R2me2s K4me1 R8me2s K9me3
H5 R2me2s K4me2 R8me2s K9me3
H6 R2me2s K4me3 R8me2s K9me3
H7 R2me2s K4ac R8me2s K9me3
H8 R2me2a K4me1 R8me2s K9me3
H9 R2me2a K4me2 R8me2s K9me3
H10 R2me2a K4me3 R8me2s K9me3
H11 R2me2a K4ac R8me2s K9me3
I12 R2me2s K4me1 R8me2a K9me3
I13 R2me2s K4me2 R8me2a K9me3
I14 R2me2s K4me3 R8me2a K9me3
I15 R2me2s K4ac R8me2a K9me3
I16 R2me2a K4me1 R8me2a K9me3
I17 R2me2a K4me2 R8me2a K9me3
I18 R2me2a K4me3 R8me2a K9me3
I19 R2me2a K4ac R8me2a K9me3
K2
PRKQLATKAARKSA
PATG
H3 16-35
K27me3
acetylated
K7 R26me2s K27me3
K12 R26me2a K27me3
K17 R26Citr K27me3
N3
GKGGAKRHRKVLR
DNIQGIT
H4 11-30
K20me3
acetylated
N14 K16ac K20me3
N18 K12ac K16ac K20me3
N22 R19me2a K20me3
O2 R19me2s K20me3
O6 R24me2a K20me3
O10 R24me2s K20me3
The positions listed here are the ones encircled in Figure 14.
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Table S2: ChIP-Seq samples and basic speciﬁcations.
HiSeq
ID
raw reads IP coverage genotype sample
background
contribution
1487 126238704 input 2.31
wild type
wt1 0.62
1488 114686342 IgG 2.09
1489 109344739 H3 1.99
1490 113601462 H3K9me3 1.98
1491 118669205 input 2.17
wt2 0.65
1492 129958570 IgG 2.36
1493 82126699 H3 1.50
1494 110258311 H3K9me3 1.90
1301 115835411 input 2.11
SUV31H1 sn
E469-2 0.62
1302 122707297 IgG 2.21
1303 121785813 H3 2.19
1304 117870903 H3K9me3 1.9
1305 151919655 input 2.78
E469-3_1
-1307 105351171 H3 1.94
1309 120396586 H3K9me3 2.10
2200 117683344 input 2.14
E469-3_2 0.55
2201 90115380 IgG 1.67
2202 79580116 H3 1.46
2203 88390142 H3K9me3 1.59
1309 116178090 input 2.15
SUV39H2 sn
E480-2 0.64
1310 122110572 IgG 2.25
1311 118605873 H3 2.19
1312 117322103 H3K9me3 2.14
1313 120467720 input 2.22
E480-6 0.54
1314 96396546 IgG 1.80
1315 91525182 H3 1.71
1316 87757090 H3K9me3 1.63
1499 114271340 input 2.10
SUV39H dn
dn2 0.60
1500 122879266 IgG 2.25
1501 90311619 H3 1.67
1502 91572300 H3K9me3 1.69
2188 82647573 input 1.51
dn3 0.60
2189 74936236 IgG 1.38
2190 89700084 H3 1.64
2191 98388112 H3K9me3 1.81
1624 82243808 input 1.56
E124-1 0.70
1625 95447144 IgG 1.79
1626 87137900 H3 1.63
1627 100862106 H3K9me3 1.89
1628 114172526 input 2.12
E124-3 0.75
1629 110705642 IgG 2.04
1630 82019725 H3 1.52
1631 102203517 H3K9me3 1.89
1809 124657774 input 2.17
wild type
(mESC)
wt26, rep1 0.61
1810 99032939 IgG 1.79
1811 118095580 H3 2.11
1812 90097243 H3K9me3 1.42
1813 109316591 input 1.88
wt26, rep2 0.50
1814 65533816 IgG 1.18
1815 104532754 H3 1.88
1816 79378787 H3K9me3 1.27
The coverage was calculated from bedgraph ﬁles as shown in Figure 47 using a Perl script.
The background contribution corresponds to the parameter b yielded by MCORE (Molitor et al.
2017).
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Table S3: H3K9me3 and expression changes of in wt iMFEs methylated genes.
H3K9me3 fold
change
RNA
H1sn H2sn dn
gene ID chr start end RefSeq ID H1sn H2sn dn
base
mean
log2-fold
change
padj
base
mean
log2-fold
change
padj
base
mean
log2-fold
change
padj
D1Pas1 chr1 188791294 188794506 NM_033077 0.76 0.78 0.41 1.02 -0.01 NA 1.28 0.12 NA 1.02 -0.03 NA
Gm996 chr2 25430935 25435619 NM_001005424 0.83 0.33 0.36 4.32 0.46 0.823 3.11 0.14 NA 2.28 -0.23 NA
Sp5 chr2 70312979 70315783 NM_022435 0.77 0.06 0.17 4.52 0.23 0.921 2.53 -0.41 NA 2.02 -0.91 NA
Zfp120 chr2 149940142 149962414 NM_023266 0.58 0.58 0.78 188.12 -0.14 0.907 210.38 0.12 0.895 266.32 0.6 0.294
Gm14139 chr2 150007490 150019015 NM_001145863 0.83 0.63 0.82 35.7 -3.21 1.25e-05 36.25 -3.39 1.76e-06 47.69 -0.91 0.351
Zfp937 chr2 150043834 150070610 NM_001142411 0.71 0.63 1.06 200.03 -0.21 0.848 242.53 0.27 0.689 237.86 0.19 0.758
Gm14124 chr2 150083252 150096036 NM_001142410 0.86 0.65 0.9 25.6 -2.34 0.00551 31.19 -1.28 0.158 57.56 0.42 0.676
3300002I08Rik chr2 150136672 150188501 NM_027017 0.74 0.6 0.95 12.37 -0.2 0.932 15.19 0.17 0.918 14.7 0.11 0.941
Zfp345 chr2 150296726 150310799 NM_001034900 0.78 0.7 0.82 53.73 -3.24 2.01e-06 67.34 -1.47 0.0455 73.44 -0.87 0.241
Blcap chr2 157382097 157392097 NM_016916 0.92 0.51 0.78 246.88 -0.3 0.724 302.02 0.21 0.747 244.87 -0.3 0.714
Nnat chr2 157385845 157388255 NM_010923 0.77 0.47 0.57 1.77 0.32 NA 2.53 0.59 NA 1.22 0.14 NA
1700028P15Rik chr2 171782378 171788299 NR_040509 1.19 0.72 0.39 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Cbln4 chr2 171861835 171868966 NM_175631 0.99 0.47 0.19 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Gnas chr2 174123359 174126303 NM_201617 1.06 0.5 0.43 1.52 0.22 NA 1.78 0.33 NA 3.41 1.12 NA
4930591A17Rik chr2 179149640 179151585 NM_026596 1.29 0.72 0.22 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Rprl2 chr3 22150291 22150529 NR_004439 2.84 0.82 0.38 2234.83 -4 1.68e-06 4005.86 -0.36 0.428 4854.63 0.08 0.969
Sox2 chr3 34548926 34551382 NM_011443 0.46 0.08 0.11 1.02 -0.01 NA 27.53 2.78 0.004 1.22 0.14 NA
Flg2 chr3 93001194 93025298 NM_001013804 1.16 0.89 0.27 1.02 -0.01 NA 1.03 -0.01 NA 1.21 0.14 NA
Foxe1 chr4 46357065 46358181 NM_183298 1.56 0.15 0.13 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Zfp37 chr4 61850570 61869236 NM_001290353 0.77 0.67 0.92 76.01 0 1 129.24 1.15 0.0224 119.67 0.69 0.636
Zfp37 chr4 61850570 61869580 NM_001290351 0.77 0.67 0.83 76.51 0.02 0.993 129.24 1.15 0.0222 120.67 0.7 0.629
Foxd3 chr4 99322989 99325362 NM_010425 0.82 0.18 0.13 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Pou3f1 chr4 124334888 124337899 NM_011141 0.31 -0.01 0.15 1.28 -0.14 NA 1.8 0.09 NA 1.44 -0.12 NA
Hmgb4 chr4 127937455 127938139 NM_027036 1.3 0.67 0.38 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Gm13238 chr4 145427121 145427895 NR_033612 0.95 0.57 0.28 4.3 0.06 0.983 3.08 -0.4 NA 7.41 0.89 0.515
Zfp992 chr4 145728598 145749009 NM_001085522 1.23 0.69 0.58 183.57 -0.27 0.858 133.96 -1.63 0.000664 299.09 0.76 0.274
Gm13034 chr4 146034924 146036119 NR_030771 0.77 0.65 0.31 115.66 0.3 0.788 119.98 0.36 0.631 135.28 0.56 0.413
4933438K21Rik chr4 146437474 146442545 NR_045446 1.29 0.82 0.35 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Znf41-ps chr4 146514185 146556724 NR_040355 1.26 0.72 0.7 131.84 -0.15 0.924 101.05 -1.15 0.0361 204.11 0.74 0.303
Rps19-ps3 chr4 147195885 147196311 NR_033639 0.78 0.74 0.35 82.11 -0.19 0.899 82.75 -0.22 0.826 100.52 0.26 0.756
Gm833 chr4 152071648 152075031 NR_033138 1.27 0.87 0.16 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Ajap1 chr4 152747329 152856939 NM_001099299 1.1 0.61 0.12 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Arhgef16 chr4 153652578 153674004 NM_001112744 0.28 0.52 0.13 1.02 -0.01 NA 1.28 0.12 NA 1.61 0.42 NA
AI506816 chr5 23198078 23218485 NR_015554 1.51 0.82 0.58 19.66 -0.45 0.81 22.39 -0.19 0.896 13.66 -1.57 0.109
Nkx3-2 chr5 42152721 42155459 NM_007524 0.52 0.18 0.16 4.07 -0.81 0.614 3.86 -1.07 NA 4.87 -0.57 0.729
Gm15446 chr5 110362581 110370729 NR_040366 0.72 0.66 0.77 16.69 -1.01 0.447 19.7 -0.6 0.631 21.25 -0.35 0.746
Myo18b chr5 113117895 113325382 NM_028901 0.3 0.64 0.23 1.02 -0.01 NA 1.03 -0.01 NA 1.81 0.54 NA
1700095B10Rik chr5 113222311 113230721 NR_040676 0.34 0.71 0.28 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Grk3 chr5 113339497 113444558 NM_177078 0.3 0.53 0.22 3.77 0.64 NA 1.28 -0.14 NA 37.01 2.85 0.018
Crybb3 chr5 113504858 113510604 NM_001159650 0.32 0.22 0.11 1.02 -0.01 NA 2.53 0.63 NA 1.42 0.29 NA
2900026A02Rik chr5 113515342 113592333 NM_172884 0.16 0.1 0.09 147.53 5.6 8.19e-19 300.55 6.99 2.78e-35 264.91 6.54 2.19e-19
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Tmem211 chr5 113655928 113668283 NM_001033428 0.37 0.31 0.22 1.02 -0.01 NA 1.03 -0.01 NA 1.6 0.4 NA
NA chr5 113672239 113709621 NR_027934 0.33 0.36 0.17 8.77 1.89 0.0852 6.28 1.56 0.176 27.71 2.57 NA
Sgsm1 chr5 113672239 113739806 NM_172718 0.36 0.38 0.18 8.52 1.86 0.0935 6.03 1.52 0.193 26.73 2.55 NA
Sgsm1 chr5 113686493 113739806 NM_001162965 0.37 0.39 0.18 7.53 1.5 0.223 4.3 0.89 0.521 17.33 1.99 NA
NA chr5 113686493 113709621 NR_027936 0.32 0.38 0.16 7.78 1.53 0.207 4.55 0.94 0.487 18.31 2.02 NA
5930412G12Rik chr5 129085004 129106562 NR_015517 1.36 0.64 0.16 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Fzd10 chr5 129106980 129109968 NM_175284 1.04 0.35 0.08 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Piwil1 chr5 129242120 129261349 NM_021311 1.35 0.82 0.16 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Zfp68 chr5 139044879 139060971 NM_013844 1.01 0.73 0.99 463.64 0.42 0.577 460.86 0.37 0.504 660.28 1.04 0.0124
Zfp12 chr5 143996841 144010513 NM_001289589 1.04 0.48 0.63 286.24 0.17 0.877 262.91 -0.1 0.898 368.85 0.65 0.165
Zfp316 chr5 144011373 144031701 NM_017467 1.09 0.5 0.52 203.68 0.12 0.933 181.84 -0.23 0.773 249.76 0.51 0.401
Smo chr6 29685496 29711366 NM_176996 1.69 0.79 0.29 1258.55 0.78 0.112 1260.32 0.77 0.0395 1580.08 1.11 0.00242
Klf14 chr6 30906020 30908990 NM_001135093 1.02 0.81 0.73 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Repin1 chr6 48543881 48549081 NM_001079905 1.03 0.38 0.4 36.44 1.4 0.234 119.3 3.56 1.89e-10 41.19 1.63 0.16
AI854703 chr6 48578165 48583687 NR_027236 0.59 0.33 0.29 2.52 0.53 NA 2.28 0.51 NA 2.41 0.86 NA
Nap1l5 chr6 58855226 58857120 NM_021432 0.78 0.6 0.74 1.02 -0.01 NA 1.03 -0.01 NA 1.22 0.14 NA
Zfp606 chr7 13063653 13081584 NM_026112 0.82 0.64 0.8 198.69 0.3 0.804 187.24 0.12 0.893 240.7 0.64 0.216
Zfp110 chr7 13420158 13435933 NM_022981 0.86 0.66 0.53 246.92 -0.36 0.708 310.05 0.22 0.787 233.33 -0.47 0.552
Zfp180 chr7 24866915 24892727 NM_001045486 1.01 0.81 0.53 316.29 -0.16 0.897 295.77 -0.41 0.538 343.55 0.03 0.973
Zfp146 chr7 30946286 30954746 NM_011980 1.22 0.79 0.97 555.17 -0.31 0.748 582.39 -0.21 0.79 791.94 0.51 0.34
Scgb1b3 chr7 32160610 32161935 NM_001256073 1.86 0.71 0.34 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Scgb1b30 chr7 34880449 34885856 NM_001099330 0.59 0.53 0.46 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
AW146154 chr7 48734243 48755260 NM_001033530 0.72 0.59 0.73 32.07 0.21 0.912 45.51 0.91 0.271 62.84 1.43 0.0204
Dbx1 chr7 56886868 56892205 NM_001005232 0.88 0.33 0.3 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Klhl35 chr7 106614513 106622530 NM_028145 1.13 0.26 0.63 1.27 0.11 NA 1.03 -0.01 NA 1.02 -0.03 NA
Rbmxl2 chr7 114352958 114354430 NM_029660 0.92 0.49 0.19 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Zfp629 chr7 134750548 134757947 NM_177226 1.31 0.59 0.58 229.56 -0.17 0.901 228.61 -0.23 0.817 303.13 0.44 0.444
Nkx6-2 chr7 146765274 146768696 NR_027857 0.9 0.21 0.26 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Nkx6-2 chr7 146767118 146768696 NM_183248 0.97 0.15 0.22 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
6430531B16Rik chr7 147158201 147164654 NM_001033465 0.78 0.39 0.47 1.27 0.11 NA 1.28 0.12 NA 1.22 0.14 NA
Cdkn1c chr7 150644243 150646955 NM_009876 1.46 0.33 0.23 1.27 0.11 NA 3.03 0.74 NA 65.8 4.07 9.21e-05
Rprl3 chr8 3803124 3803361 NR_024198 0.49 0.2 0.17 3019.22 -6.29 1.83e-28 5369.85 -0.38 0.371 6724.22 0.1 0.96
Zfp958 chr8 4613169 4630231 NM_145591 0.7 0.58 0.9 171.78 -0.24 0.847 177.75 -0.19 0.828 202.57 0.15 0.859
Sox1 chr8 12395518 12399555 NM_009233 0.85 0.21 0.13 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
NA chr8 22083372 22084427 NM_001012640 1.43 0.45 0.34 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Zfp930 chr8 71732944 71754438 NM_001013379 0.78 0.57 0.7 179.57 0 0.999 194.21 0.16 0.836 143.08 -0.49 0.74
Gm10033 chr8 71894923 71919443 NR_038043 0.75 0.73 0.91 63.42 -0.35 0.817 83.85 0.32 0.705 82.44 0.25 0.807
Isyna1 chr8 73118379 73121189 NM_023627 2.1 0.43 0.87 12.69 0.43 0.831 34.8 2.04 0.0107 17.76 0.91 0.496
Zfp599 chr9 22051873 22064339 NM_181419 0.97 0.62 0.74 110.28 0.18 0.885 98.92 -0.15 0.876 117.61 0.26 0.783
Rfpl4b chr10 38540346 38541585 NM_001177783 0.33 0.66 0.62 1.27 -0.13 NA 1.28 -0.14 NA 1.62 0.04 NA
Polrmt chr10 79198869 79209326 NM_172551 1.4 0.65 0.72 279.97 -0.28 0.76 302.41 -0.1 0.896 281.6 -0.25 0.759
NA chr10 81167569 81184721 NM_001243067 0.84 0.7 0.73 77.56 0.93 0.295 69.14 0.72 0.352 87.27 1.07 0.125
NA chr10 81205565 81233887 NM_199062 0.79 0.6 0.88 42.73 0.66 0.564 42.75 0.64 0.484 43.46 0.61 0.515
NA chr10 81326678 81343831 NM_001243067 0.72 0.56 0.67 72.16 0.9 0.292 59.05 0.48 0.579 70.14 0.76 0.315
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NA chr10 81364655 81393225 NM_199062 0.8 0.61 0.89 299.72 0.63 0.335 306.32 0.65 0.164 278.74 0.38 0.588
Zfp873 chr10 81510871 81524331 NM_001024626 0.82 0.6 0.7 95.01 -0.71 0.42 110.39 -0.29 0.756 109.56 -0.26 0.739
AU041133 chr10 81590757 81615810 NM_001163064 0.81 0.69 0.87 122.43 0.3 0.798 126.51 0.35 0.635 133.58 0.43 0.515
Zfp938 chr10 81687601 81704020 NM_001105557 0.69 0.67 0.87 114.66 0.13 0.929 134.48 0.48 0.474 162.02 0.79 0.215
Washc4 chr10 83006685 83059218 NM_001033375 0.07 0.08 0.17 1464.6 0.5 0.393 1644.3 0.74 0.0615 1864.45 0.89 0.0704
Appl2 chr10 83062778 83111409 NM_145220 0.11 0.07 0.08 262.17 0.8 0.204 245.72 0.65 0.192 1150.26 2.57 0.00872
1500009L16Rik chr10 83185609 83225507 NM_001145198 0.16 0.13 0.1 8.55 0.73 0.675 14.08 1.53 0.153 27.51 2.76 0.000335
Nuak1 chr10 83834063 83903216 NM_001004363 0.19 0.15 0.12 1050.72 0.42 0.706 1074.08 0.44 0.586 4458.75 2.46 0.00544
Platr7 chr10 84010161 84016083 NR_040658 0.2 0.2 0.14 1.02 -0.01 NA 1.03 -0.01 NA 35.95 2.6 NA
Tcp11l2 chr10 84039691 84077100 NM_146008 0.15 0.14 0.14 135.08 1.05 0.235 143.82 1.22 0.0418 390.62 2.31 0.0184
Polr3b chr10 84085181 84189923 NM_027423 0.15 0.16 0.17 424.96 -0.2 0.841 466.3 0.01 0.988 1260.78 1.56 0.155
Rfx4 chr10 84218792 84369281 NM_001024918 0.26 0.24 0.2 1.27 0.11 NA 1.03 -0.01 NA 1.02 -0.03 NA
Rfx4 chr10 84300892 84369283 NM_027689 0.25 0.21 0.18 1.27 0.11 NA 1.03 -0.01 NA 1.02 -0.03 NA
4933416C03Rik chr10 115548719 115550973 NM_001161855 0.24 0.2 0.13 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Kcnmb4 chr10 115854923 115910579 NM_021452 0.28 0.31 0.21 4.27 0.78 0.632 9.03 1.89 0.0761 46.18 3.69 0.000373
Kcnmb4os1 chr10 115855176 115858291 NR_028107 0.26 0.25 0.16 1.02 -0.01 NA 1.03 -0.01 NA 1.21 0.14 NA
1700030O20Rik chr10 116160122 116166233 NR_045345 0.32 0.34 0.26 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Myrﬂ chr10 116213600 116333935 NM_001033333 0.22 0.21 0.21 1.27 0.11 NA 1.53 0.23 NA 4.94 1.38 0.353
4933412E12Rik chr10 116387617 116400335 NR_038025 0.36 0.3 0.24 50.6 -0.47 0.712 54.84 -0.3 0.774 109.26 0.96 0.445
D630029K05Rik chr10 116401795 116406163 NR_027847 0.22 0.26 0.17 1.27 0.11 NA 1.53 0.23 NA 4.55 1.32 0.381
D630029K05Rik chr10 116403329 116406163 NR_027846 0.26 0.24 0.17 1.27 0.11 NA 1.53 0.23 NA 4.55 1.32 0.381
Yeats4 chr10 116652196 116661563 NM_026570 0.15 0.09 0.07 272.93 0.49 0.529 298.12 0.67 0.171 1284.58 1.86 NA
9530003J23Rik chr10 116670808 116675737 NM_029906 0.16 0.11 0.14 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Lyz2 chr10 116714596 116719328 NM_017372 0.19 0.19 0.14 15.09 -1.1 0.389 15.54 -1.12 0.308 20.78 -0.15 0.939
Lyz1 chr10 116724850 116729924 NM_013590 0.15 0.11 0.15 2.05 -0.44 NA 2.33 -0.35 NA 3.23 0.03 NA
Cpsf6 chr10 116781723 116814029 NM_001013391 0.13 0.08 0.16 1885.01 0.12 0.901 1922.62 0.13 0.837 3788.21 1.23 0.249
Cpm chr10 117066555 117124408 NM_027468 0.12 0.14 0.1 3.03 0.47 NA 2.3 0.28 NA 35.77 2.45 NA
Mdm2 chr10 117125930 117147814 NM_001288586 0.08 0.09 0.08 1704.3 1.39 0.00402 2016.09 1.68 9.24e-05 4169.45 1.66 0.225
Slc35e3 chr10 117170733 117183414 NM_029875 0.13 0.12 0.08 231.64 -0.04 0.978 289.59 0.49 0.349 849.59 1.9 NA
Nup107 chr10 117187698 117229761 NM_134010 0.13 0.1 0.13 1134.86 -0.43 0.508 1140.44 -0.47 0.308 1273.56 -0.1 0.923
Gdf7 chr12 8304723 8308760 NM_013527 0.85 0.13 0.22 37.27 2.44 0.0138 5.28 0.9 0.516 5.59 1.31 0.336
5730507C01Rik chr12 18521315 18542060 NM_001201330 1.11 0.63 0.61 42.24 -1.36 0.104 45.56 -1.16 0.115 67.84 0.09 0.937
1700030C10Rik chr12 20810252 20821640 NR_015521 1.04 0.78 0.32 11.14 0.36 0.871 10.21 0.31 0.861 46.07 2.58 0.00289
2410018L13Rik chr12 22990696 23046943 NR_015504 1.12 0.7 0.59 16.46 -1.13 0.363 21.22 -0.46 0.729 27.87 0.2 0.873
9030624G23Rik chr12 24728066 24782134 NM_001256489 1.22 0.68 0.53 34.88 -0.63 0.647 41.49 -0.21 0.862 55.74 0.46 0.547
Insm2 chr12 56699903 56703004 NM_020287 1.44 0.13 0.27 1.27 0.11 NA 1.03 -0.01 NA 1.02 -0.03 NA
NA chr12 57632923 57636093 NM_001146198 1.53 0.23 0.19 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
1700121N20Rik chr12 107680861 107685876 NR_036593 1.19 0.79 0.22 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
Dio3 chr12 111517439 111519307 NM_172119 1.24 0.15 0.13 55.77 3.54 2.49e-05 24.28 3.08 0.000492 33.8 3.26 0.00297
2210016F16Rik chr13 58481406 58486586 NM_027335 0.72 0.64 0.77 134.62 0.08 0.958 181.7 0.74 0.23 184.94 0.59 0.661
Zfp808 chr13 62231249 62275296 NM_001039239 0.66 0.6 0.8 105.13 -1.08 0.122 112.01 -0.93 0.118 121.61 -0.49 0.522
Gm3604 chr13 62469075 62484534 NM_001162910 1.03 0.68 0.93 43.32 -1 0.321 49.54 -0.62 0.512 49.3 -0.49 0.674
Zfp935 chr13 62554375 62568172 NM_178875 0.69 0.64 1.03 137.21 -0.11 0.936 146.09 0.02 0.987 148.3 0.05 0.942
Gm5141 chr13 62873559 62887168 NM_001256065 0.96 0.71 1.23 84.07 -0.9 0.228 84.62 -0.95 0.176 96.85 -0.38 0.688
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Zfp369 chr13 65380161 65399103 NM_178364 0.76 0.78 0.67 235.25 -0.21 0.852 241.21 -0.2 0.781 237.7 -0.19 0.783
Gm10324 chr13 66214388 66223772 NM_001177832 1.09 0.63 0.69 1.52 -0.01 NA 1.78 0.1 NA 2.8 0.66 NA
2410141K09Rik chr13 66519049 66542054 NM_183119 1.05 0.65 0.64 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
2210408I21Rik chr13 77274796 77752940 NM_001145676 0.64 0.38 0.42 108.82 0.22 0.855 107.47 0.15 0.873 102.69 0.04 0.966
3110070M22Rik chr13 120276063 120277191 NR_027974 1.09 0.5 0.15 3.27 0.53 NA 1.28 -0.14 NA 1.62 0.04 NA
Tmem267 chr13 120276845 120284312 NM_001039244 0.96 0.61 0.48 15.59 0.89 0.577 5.13 -0.47 0.779 32.13 2.53 5e-04
Sox21 chr14 118632455 118636252 NM_177753 1.22 0.13 0.28 1.02 -0.01 NA 1.03 -0.01 NA 2.22 0.69 NA
Gp1bb chr16 18620411 18622496 NM_010327 1.04 0.24 0.4 69.72 -0.24 0.885 87.78 0.31 0.736 75.81 -0.05 0.97
Gp5 chr16 30307770 30310867 NM_008148 0.92 0.21 0.46 7.65 -0.58 0.76 11.99 0.25 0.88 7.75 -0.63 0.645
2700054A10Rik chr17 13679886 13746960 NR_045437 1.52 0.7 0.25 5.3 0.18 0.942 8.58 0.85 0.532 6.05 0.4 0.815
Zfp960 chr17 17201066 17226595 NM_001163919 0.85 0.71 1.32 28.39 -0.72 0.594 32.12 -0.42 0.731 34.71 -0.18 0.879
Zfp97 chr17 17258346 17283842 NM_011765 0.81 0.63 1.34 186.1 -0.65 0.363 207.64 -0.35 0.581 205 -0.31 0.686
Zfp763 chr17 33153808 33170326 NM_028543 0.83 0.65 0.6 108.01 0.12 0.941 107.24 0.07 0.949 128.56 0.45 0.533
Olfr94 chr17 37333750 37334911 NM_001011518 0.91 0.31 0.27 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
2610044O15Rik8 chr17 95213816 95234160 NM_153780 0.7 0.72 1.06 149.31 -0.19 0.869 167.15 0.07 0.934 162.03 0 0.996
Prob1 chr18 35810004 35814853 NM_001270646 0.83 0.15 0.12 42.63 -0.9 0.374 41.65 -1.05 0.238 29.83 -2.02 0.0414
Pcdhb22 chr18 37678006 37681073 NM_053147 0.79 0.73 0.44 449.36 0.7 0.259 331.62 -0.07 0.932 391.42 0.32 0.6
Slc25a2 chr18 37797031 37798377 NM_001159275 0.45 0.73 0.41 16.44 0.71 0.644 13.8 0.41 0.788 9.38 -0.33 0.828
Stxbp3-ps chr19 9632095 9633738 NR_073559 0.62 0.51 0.29 47.66 0.8 0.456 40.39 0.47 0.663 44.69 0.64 0.405
Sox3 chrX 58144540 58146605 NM_009237 0.7 0.4 0.11 1.02 -0.01 NA 1.03 -0.01 NA 1.02 -0.03 NA
The genes listed are longer than 200 bp and showed an H3K9me3 level at least 3-fold higher than the genomic average in wt iMEFs. The 290026A02Rik gene depicted in Fig. 22 is listed in bold.
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Table S4: Common set of diﬀerentially expressed genes in SUV39H sn/dn iMEF cell lines compared to wt.
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Sema3e chr5 14025275 14256689 NM_011348 103.02 5.53 1.74e-18 204.03 6.20 2.85e-20 407.34 7.31 1.12e-23 0.59 0.61 0.72 1.27
Nlrp2 chr7 5250148 5302637 NM_177690 399.27 -5.37 2.05e-27 403.33 -6.38 1.91e-43 321.11 -7.20 1.72e-33 0.91 0.95 1.25 1.59
Arsj chr3 126066769 126143292 NM_173451 195.28 5.88 8.70e-21 103.30 5.53 6.39e-19 316.44 7.11 2.71e-28 0.70 0.76 0.73 1.12
Pogk chr1 168323741 168339959 NM_001142948 115.02 5.01 2.57e-12 254.78 6.34 1.14e-20 312.37 6.75 3.43e-18 0.72 0.71 0.62 0.64
2900026A02Rik chr5 113515342 113592333 NM_172884 147.53 5.60 8.19e-19 300.55 6.99 2.78e-35 264.91 6.54 2.19e-19 4.04 0.64 0.40 0.35
Slc1a6 chr10 78243240 78277570 NM_009200 102.28 4.12 1.38e-07 208.55 6.08 4.69e-23 425.53 6.24 3.49e-14 0.99 0.93 0.95 0.99
Apod chr16 31296277 31314682 NM_007470 413.9 -5.85 2.23e-32 416.96 -7.48 9.34e-42 337.28 -6.07 1.59e-29 0.54 0.81 0.73 0.54
Klhl29 chr12 5084273 5382488 NM_001164493 122.48 -4.25 3.03e-13 121.85 -5.63 4.18e-21 97.62 -6.06 3.14e-21 0.6 0.81 1.66 0.72
Fzd6 chr15 38837825 38869736 NM_001162494 53.34 3.37 1.93e-07 104.88 4.45 2.44e-15 321.67 6.05 8.82e-34 0.48 0.75 0.63 0.66
Fzd6 chr15 38837878 38869736 NM_008056 53.09 3.36 2.05e-07 105.38 4.45 2.07e-15 321.27 6.05 8.82e-34 0.48 0.75 0.63 0.67
Gfra2 chr14 71289936 71379645 NM_008115 303.61 -6.56 5.12e-35 308.74 -6.78 1.44e-37 248.84 -6.04 3.05e-24 0.92 0.84 1.37 0.82
Sytl2 chr7 97450864 97533680 NR_110348 73.27 3.43 8.08e-05 85.53 5.24 5.06e-16 198.99 5.95 6.74e-14 0.42 0.65 0.66 0.81
Kcnj15 chr16 95479164 95521865 NM_001039057 92.34 3.8 2.35e-07 151.13 5.17 1.9e-21 423.7 5.93 1.54e-15 0.72 0.92 0.9 0.74
Rab3c chr13 110844395 111070414 NM_023852 89.24 -4.44 1.22e-13 92.32 -3.93 2e-10 71.83 -5.8 9.51e-18 0.63 0.76 0.85 1.37
Plin4 chr17 56240013 56249225 NM_020568 53.07 3.36 3.03e-05 86.86 4.29 3.25e-09 242.29 5.77 2.7e-15 0.3 0.52 0.32 0.25
Fam134b chr15 25773052 25903451 NM_001034851 102.62 3.17 5.34e-05 85.44 3.62 3.69e-11 463.04 5.71 5.91e-22 0.44 0.68 0.71 0.69
Ms4a4d chr19 11611338 11632956 NM_025658 247.86 -3.01 1.06e-08 233.86 -5.16 1.47e-25 186.61 -5.7 6.84e-21 0.62 0.92 1.02 1.49
Fam134b chr15 25870456 25903451 NM_001277315 97.12 3.14 7.1e-05 80.19 3.58 1.4e-10 430.39 5.69 5.65e-22 0.41 0.58 0.63 0.81
Fam134b chr15 25870580 25903451 NM_001277316 96.12 3.13 7.32e-05 79.94 3.58 1.47e-10 430.19 5.69 5.91e-22 0.41 0.58 0.63 0.81
Fam134b chr15 25863306 25903451 NM_001277318 96.62 3.14 7.21e-05 78.94 3.56 2.3e-10 426.23 5.66 1.94e-21 0.4 0.62 0.61 0.76
Fam134b chr15 25872433 25903451 NM_001277317 96.62 3.14 7.21e-05 78.69 3.56 2.42e-10 426.22 5.66 2e-21 0.4 0.59 0.63 0.81
St3gal1 chr15 66934436 67008444 NM_009177 1868.01 -3.05 9.79e-13 1837.18 -3.79 8.89e-27 1412.49 -5.63 3.52e-41 0.53 0.75 0.62 0.57
Rnf130 chr11 49838832 49918235 NM_021540 86.59 4.28 2.99e-13 108.88 4.73 2.5e-17 230.25 5.57 1.64e-18 0.42 0.57 0.69 1.09
Ccl11 chr11 81871333 81876457 NM_011330 74.19 -3.02 1.53e-07 69.81 -5.25 5.89e-15 56.29 -5.46 4.02e-15 0.44 0.61 0.67 1.15
Sp100 chr1 87546624 87606023 NM_013673 100.51 -3.82 1.61e-08 104.35 -3.63 1.89e-10 80.45 -5.38 4.45e-15 0.87 2.02 1.66 1.19
Cdh3 chr8 109034751 109080811 NM_007665 269.27 6.6 4.87e-31 849.28 8.34 2.54e-55 177.22 5.32 2.37e-09 0.74 0.85 0.61 0.59
Slc24a3 chr2 145068346 145467675 NM_053195 76.77 4.38 9.72e-11 77.78 4.71 2.46e-13 137.04 5.26 4.53e-12 0.88 0.71 0.96 1.08
Ece2 chr16 20629923 20645988 NM_177942 51.78 3.56 2.16e-07 123.8 5.05 5.77e-20 161.11 5.18 1.78e-14 0.39 0.47 0.28 0.5
Scara3 chr14 66538231 66572581 NM_172604 516.84 5.94 5.56e-29 310.38 5.65 4.08e-36 260.17 5.13 4.16e-18 0.93 0.87 0.85 0.69
Slamf8 chr1 174511507 174520699 NM_029084 55.16 -4.61 4.27e-11 56.23 -4.69 6.33e-12 45.27 -5.09 7.02e-12 0.88 0.67 0.77 0.66
Gbp2b chr3 142257810 142282140 NM_010259 126.49 -5.1 1.16e-17 129.48 -4.82 5.2e-19 104.33 -5.01 4.67e-16 0.85 0.66 0.86 1.64
Pmaip1 chr18 66618257 66625212 NM_021451 134.78 5.69 2.67e-21 371.8 7.28 1.88e-39 115.51 5 1.62e-08 0.87 0.79 0.6 0.82
Il2rg chrX 98459725 98463545 NM_013563 61.41 -4.63 3.78e-12 62.76 -4.69 7.49e-13 50.64 -5 9.34e-14 0.77 0.75 0.79 0.92
Spats2l chr1 57831704 58005241 NM_144882 114.09 4.51 1.18e-16 58.13 3.6 5.9e-09 301.79 5 2.73e-09 0.58 0.69 0.78 0.89
Pax3 chr1 78097841 78193711 NM_001159520 39.04 -3.45 1.93e-06 38.64 -4.37 3.34e-09 31.02 -4.99 6.62e-10 0.63 0.86 0.83 1.03
Pax9 chr12 57796625 57812217 NM_011041 64.02 3.26 0.000269 38.53 4.18 4.96e-08 51.65 4.99 1.86e-10 0.93 0.31 0.48 0.33
Gng2 chr14 20691780 20795915 NM_001285911 181.27 4.54 9.39e-09 88.28 5.24 8.57e-14 55.28 4.95 1.39e-09 0.84 0.69 0.78 0.95
Gng2 chr14 20691780 20796471 NM_001285910 179.77 4.54 9.43e-09 86.78 5.2 2.03e-13 55.28 4.95 1.39e-09 0.84 0.69 0.78 0.95
Hoxd4 chr2 74560034 74567216 NM_010469 67.46 -3.9 5.3e-09 70.09 -3.49 1.39e-07 54.7 -4.95 1.55e-13 0.66 1.42 0.9 0.43
Itih2 chr2 10016217 10052310 NM_010582 701.1 5.61 1.3e-20 361.41 5.47 2.47e-35 449.24 4.94 2.52e-10 0.6 0.86 0.65 0.89
Spats2l chr1 57902414 58005241 NM_001164566 104.09 4.37 3.17e-15 54.63 3.5 2.8e-08 280.4 4.93 4.72e-09 0.58 0.67 0.75 0.82
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Dpt chr1 166726862 166754397 NM_019759 1058.76 -5.57 4.75e-25 1061.77 -8.17 1.71e-57 873.96 -4.88 7.47e-13 0.58 0.8 0.8 0.9
Col22a1 chr15 71628905 71864657 NM_027174 53.89 -3.22 8.22e-07 53.7 -3.65 6.87e-08 42.24 -4.88 7.25e-12 0.64 0.75 1.51 1.26
Gbp4 chr5 105544785 105568605 NM_001256005 73.5 -3.75 5.83e-09 72.54 -5.31 1.78e-15 59.25 -4.86 1.64e-12 1.22 0.94 1.59 1.47
Gbp4 chr5 105544785 105568571 NM_008620 73.5 -3.75 5.83e-09 72.54 -5.31 1.78e-15 59.25 -4.86 1.64e-12 1.22 0.94 1.58 1.48
Slpi chr2 164179805 164182243 NM_011414 177.09 -4.68 1.72e-22 179.68 -4.82 3.08e-20 145.5 -4.84 1.71e-17 1.9 3.01 1.46 0.59
Iﬁ27l2a chr12 104672082 104681890 NM_001281830 48.69 -4.27 8.59e-09 49.23 -4.62 2.47e-10 39.9 -4.82 1.09e-09 0.14 0.62 0.67 0.55
Tgm2 chr2 157942140 157972128 NM_009373 153.28 5.01 7.99e-16 475.3 3.71 4.4e-05 251.22 4.8 2.62e-07 0.49 0.81 0.5 0.39
Iﬁ27l2b chr12 104689107 104695433 NM_145449 45.21 -4.14 6.09e-09 48.41 -3.01 4.27e-05 37.02 -4.8 2.98e-10 0.48 0.87 0.55 1.1
Clec3b chr9 123060063 123066550 NM_011606 55.69 -4.03 6.74e-09 56.13 -4.44 9.89e-11 45.4 -4.73 1.67e-10 0.66 1.52 0.84 0.68
Fgd4 chr16 16422070 16560242 NM_139232 32.02 3.79 9.68e-07 77.78 5.35 7.09e-16 67.72 4.64 5.94e-07 0.76 0.59 0.78 1.31
Col10a1 chr10 34109786 34116891 NM_009925 23.77 3.36 4.6e-05 101.78 5.43 4.59e-15 59.44 4.63 3.34e-07 0.59 0.61 0.5 0.41
Iﬁ27l2a chr12 104680375 104681890 NM_029803 67.51 -4.51 1.53e-10 67.99 -5.07 4.93e-13 55.87 -4.6 1.91e-10 0.16 1 0.57 0.39
Robo1 chr16 72663393 73046345 NM_019413 300.07 4.41 2.32e-12 189.86 4.17 8.88e-14 288 4.59 3.95e-13 1.19 0.66 0.91 1
Ccdc3 chr2 5058821 5151912 NM_028804 63.97 -3.72 5.84e-09 64.96 -3.91 1.52e-10 51.81 -4.56 5.57e-11 0.81 1.03 0.88 0.89
Sec16b chr1 159456300 159498555 NM_001159986 103.31 3.09 1.79e-07 109.48 3.27 1.44e-09 330.84 4.52 2.71e-12 0.56 0.57 0.54 0.67
Sec16b chr1 159436926 159498555 NR_027641 105.07 3.06 2.41e-07 110.01 3.23 2.4e-09 338.65 4.5 3.29e-12 0.61 0.56 0.57 0.69
Eda chrX 97170944 97596099 NM_001177942 79.02 4.63 2.69e-10 49.78 4.05 8.04e-07 49.41 4.49 7.44e-07 0.74 0.74 0.97 1.47
Fam65b chr13 24730516 24825675 NM_029679 119.02 4.67 3.36e-12 101.03 4.93 7.36e-16 139.74 4.47 1.51e-06 0.59 0.64 0.65 0.68
Fam65b chr13 24674057 24825675 NM_001286100 114.77 4.63 5.45e-12 98.78 4.9 1.53e-15 136.97 4.45 1.82e-06 0.66 0.72 0.69 0.71
Ddit4l chr3 137286635 137291296 NM_030143 36.53 3.33 7.21e-05 111.55 5.2 1.11e-13 45.05 4.4 6.74e-08 0.81 0.59 0.84 0.71
Cacna1b chr2 24459408 24618672 NM_001042528 53.02 4.07 1.69e-07 98.53 5.41 5.22e-15 62.35 4.34 9.36e-06 0.9 0.84 0.82 0.75
Slc6a17 chr3 107270465 107320936 NM_172271 177.27 6.24 2.4e-25 222.78 5.91 1.88e-16 53.97 4.33 6.71e-06 0.64 0.51 0.53 0.65
Bicd1 chr6 149357505 149511848 NM_009753 93.02 4.91 1.32e-14 95.28 5.15 6.59e-16 60.83 4.26 1.24e-06 0.89 0.73 0.88 1.4
Iﬁ209 chr1 175560989 175578059 NM_175026 26.2 -3.32 3.85e-05 26.6 -3.57 6.13e-06 21.42 -4.2 8.06e-07 0.69 0.68 0.94 1.89
NA chr16 16435798 16504311 NM_139233 25.02 3.39 3.97e-05 55.03 4.85 3.71e-12 46.94 4.19 1.63e-05 0.72 0.57 0.74 1.44
Gngt2 chr11 95703981 95707045 NM_001038664 30.5 -3.14 8.49e-05 31.18 -3.28 1.34e-05 24.67 -4.18 5.07e-07 0.45 1.01 0.76 0.65
Gngt2 chr11 95703608 95707045 NM_023121 30.48 -3.13 9.26e-05 31.15 -3.27 1.45e-05 24.65 -4.18 5.79e-07 0.46 0.99 0.7 0.58
Sp140 chr1 87497277 87541611 NM_001013817 51.99 -3.73 3.77e-08 52.71 -3.88 1.1e-08 42.64 -4.17 7.61e-08 1.16 3.81 1.9 1.45
Gngt2 chr11 95704558 95707045 NM_001284397 30.23 -3.12 9.83e-05 30.9 -3.26 1.59e-05 24.45 -4.17 6.24e-07 0.46 1.05 0.76 0.65
Fhdc1 chr3 84246117 84284361 NM_001033301 62.12 3.11 5.62e-07 305.19 5.58 7.07e-37 129.23 4.08 1.44e-10 0.49 0.78 0.42 0.51
Fhdc1 chr3 84246117 84283413 NM_001205355 62.12 3.11 5.62e-07 306.19 5.58 6.26e-37 129.63 4.08 1.2e-10 0.51 0.81 0.44 0.54
NA chr16 16453566 16560289 NM_139234 23.77 3.32 6.51e-05 50.28 4.72 2.48e-11 42.35 4.08 3.06e-05 0.72 0.6 0.78 1.21
Tnfsf15 chr4 63385636 63406147 NM_177371 26.52 3.35 6.46e-05 126.78 5.67 1.48e-16 33.87 4.06 1.63e-05 0.39 0.65 0.69 0.85
Has1 chr17 17980289 17992152 NM_008215 56.87 -3.81 2.84e-09 57.95 -3.98 2.46e-10 47.4 -4.06 1.87e-09 0.32 0.6 0.5 0.64
Iﬁtm1 chr7 148153974 148155726 NM_001112715 100.51 -3.33 3.23e-09 98.32 -4.33 1.14e-14 81.26 -3.97 2.52e-09 0.39 0.71 0.31 0.36
A530032D15Rik chr1 85084713 85106428 NM_213615 26.51 -3.41 3.96e-05 27.06 -3.52 1.27e-05 22 -3.96 6.11e-06 1.23 4.09 1.94 1.47
Il1r2 chr1 40141612 40182070 NM_010555 25.9 -3.13 0.000106 25.77 -3.75 3.01e-06 21.15 -3.95 4.5e-06 0.5 0.81 0.77 0.78
C130026I21Rik chr1 85242918 85267141 NM_001037909 40.11 -3.97 4.64e-08 40.75 -4.23 4.23e-09 33.88 -3.92 2.91e-07 1.18 4.09 1.9 1.37
Tbc1d2 chr4 46617261 46663071 NM_198664 38.55 3.45 4.63e-06 160.83 5.43 5.83e-17 46.75 3.91 2.18e-06 0.47 0.47 0.32 0.31
Iﬁtm1 chr7 148153327 148155726 NM_026820 101.28 -3.25 5.85e-09 98.6 -4.33 9.58e-15 81.88 -3.86 2.2e-08 0.37 0.5 0.21 0.4
Mndal chr1 175787350 175810318 NM_001170853 144.23 -3.85 1.19e-15 145.03 -4.23 1.15e-18 119.81 -3.78 8.78e-08 0.56 0.88 0.68 1.34
Tram1l1 chr3 124023954 124026178 NM_146140 37.52 3.95 2.2e-07 94.28 5.47 5.44e-16 28.17 3.76 0.000142 0.84 0.71 0.76 0.49
Fam65b chr13 24730516 24797870 NM_001080381 61.02 3.94 5.96e-08 55.28 4.22 4.73e-10 67.6 3.72 0.000261 0.59 0.58 0.57 0.68
Iqgap2 chr13 96397131 96661877 NM_027711 208.46 -4.53 1.69e-23 209.2 -5.32 3.52e-26 173.49 -3.7 9.9e-05 0.71 0.76 0.82 0.88
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Eln chr5 135178465 135223124 NM_007925 85.17 -3.29 1.86e-06 82.53 -5.22 1.03e-15 70.26 -3.7 1.24e-06 0.54 0.81 0.7 0.59
Armcx6 chrX 131282993 131285958 NM_001007578 81.82 4.23 1.12e-11 50.86 3.72 9.05e-09 47.53 3.66 1.39e-07 0.52 0.51 0.38 0.29
Fam65b chr13 24706474 24797870 NM_178658 56.77 3.86 1.45e-07 53.03 4.15 1.25e-09 64.43 3.64 0.00041 0.62 0.59 0.58 0.68
Ccser1 chr6 61130318 62332857 NM_001164316 115.32 3.57 1.45e-08 87.86 3.24 1.58e-06 143.53 3.63 1.29e-05 0.83 0.6 1.02 1.62
Ano1 chr7 151774453 151924497 NM_001242349 32.52 3.38 1.49e-05 112.53 5.41 1.74e-18 55.3 3.57 0.000713 0.57 0.93 0.69 0.6
Xpnpep2 chrX 45461901 45490158 NM_133213 61.04 -3.62 5.11e-09 60.07 -4.82 6.29e-13 51.87 -3.57 1.96e-08 0.68 0.81 0.78 0.74
Arl4c chr1 90594800 90598766 NM_177305 927.91 3.34 5.38e-23 1002.41 3.47 3.24e-29 1278.64 3.53 1.01e-13 0.22 0.34 0.05 0.1
Vnn1 chr10 23614493 23625149 NM_011704 34.02 3.62 7.71e-06 173.28 5.22 1.5e-11 15.71 3.36 0.000523 1.15 0.71 0.59 0.91
Arhgap22 chr14 34030008 34183122 NM_153800 54.84 3.37 1.33e-06 110.38 4.6 6.58e-16 50.19 3.32 3.04e-05 0.85 0.71 0.6 0.56
Lrrc32 chr7 105642731 105650340 NM_001113379 710.83 5.02 2.78e-34 836.66 5.31 2.06e-42 231.02 3.29 1.18e-12 0.35 0.75 0.2 0.31
Dio3 chr12 111517439 111519307 NM_172119 55.77 3.54 2.49e-05 24.28 3.08 0.000492 33.8 3.26 0.00297 3.87 4.79 0.57 0.51
Hs3st3b1 chr11 63698194 63735786 NM_018805 103.3 -3.67 8.68e-10 108.87 -3.14 8.33e-10 89.07 -3.25 4.86e-06 0.62 0.91 0.71 0.6
Fndc1 chr17 7931432 7997839 NM_001081416 94.27 5.1 2.5e-15 73.53 4.92 4.45e-13 219.07 3.23 0.00703 0.79 0.85 0.88 0.78
Thy1 chr9 43851466 43856662 NM_009382 789.2 -3.67 2.35e-05 800.43 -7.48 6.35e-59 644.87 -3.21 0.00888 0.58 0.79 0.46 0.34
Cers4 chr8 4493404 4526079 NM_026058 182.17 3.64 1.04e-09 116.27 3.19 9.02e-09 131.45 3.2 7.53e-07 1 0.61 0.85 0.74
Gramd1c chr16 43980462 44016549 NM_153528 26.53 3.12 0.000112 35.3 3.7 8.84e-07 21.12 3.17 0.00043 0.66 0.58 0.59 0.85
Gramd1c chr16 43980462 44028058 NM_001172107 26.53 3.12 0.000112 35.05 3.69 9.53e-07 21.12 3.17 0.00043 0.76 0.57 0.66 0.92
Deptor chr15 54964990 55090828 NM_001037937 1023.04 -3.36 2.67e-25 1049.9 -3.24 1.59e-25 868.73 -3.11 2.42e-06 0.59 0.78 0.8 0.87
Deptor chr15 54943871 55090828 NM_145470 1046.49 -3.36 1.71e-25 1073.75 -3.25 4.48e-26 889.32 -3.1 2.51e-06 0.57 0.78 0.75 0.81
Fat2 chr11 55064111 55125759 NM_001029988 130.17 -4.35 1.92e-17 134.58 -3.84 2.07e-11 112.11 -3.09 0.00212 0.75 1.11 1.01 0.89
Cercam chr2 29725013 29738360 NM_207298 58.4 3.1 6.5e-07 124.49 4.31 3.98e-17 74.86 3.07 0.000635 0.29 0.6 0.33 0.34
Sytl4 chrX 130470923 130516322 NM_013757 20.02 3.1 0.000302 27.78 3.45 6.68e-05 31.78 3.06 0.00927 0.59 0.61 0.83 1.23
Dcxr chr11 120586686 120588595 NM_026428 203.01 3.97 7.09e-18 211.15 3.91 6.09e-13 115.44 3.03 3.5e-08 0.11 0.47 0.27 0.43
Rhbdl3 chr11 80114413 80169488 NM_139228 127.74 -4.56 4.14e-15 137.5 -3.15 5.56e-08 117.26 -3.02 9.42e-08 0.41 0.9 0.65 0.59
Diﬀerentially expressed genes with a log2-fold change <-3 or >3 and an adjusted p-value <0.01 were selected for this list. The H3K9me3 value is the corrected enrichment of H3K9me3 above genomic
average. The 290026A02Rik gene shown in Fig. 22 is listed in bold.
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V.2 Supplementary Figures
Figure S1: H3K9me3 at PCH in diﬀerent SUV39H sn/dn iMEF cell lines. (a) En-
richment of H3K9me3 and HP1 at PCH as determined by CLSM after IF staining. Enrichments
are normalized to chromatin density. (b) Percentage of ChIP-seq reads mapping to the major
satellite consensus sequence (Lehnertz et al. 2003). The corresponding aggregated plots for cell
lines with the same genotype are shown in Fig 17c&d.
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Figure S2: Stranded RNA-seq workﬂow. (a) RNA isolation with separation of small and
long RNA. (b) Stranded long RNA library preparation. Details on the experimental steps are
given in the Materials & Methods section.
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